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Preface 
 
This PhD Thesis deals with the synthesis of iminosugar alkaloids with pyrrolidine, piperidine 
and pyrrolizidine structures, their biological evaluation towards a range of commercially 
available glycosidases and their conjugation to gold glyconanoparticles in order to build 
novel multivalent iminosugars. 
Iminosugars are very attractive carbohydrate mimetics in which the oxygen endocyclic 
atom is replaced by a nitrogen atom. Many of these structures have been isolated from 
plants and microorganisms, and showed a potent inhibitory activity towards glycosidases, 
enzymes involved in a variety of physiological events. Due to the important role of 
glycosidases, their inhibition can be the key to develop new drugs for the treatment of 
several pathologies such as cancer, virus and bacterial infections, diabetes and genetic 
metabolic disorders (e.g. lysosomal storage disorders), as well as in the crop protection 
field as novel insecticides and fungicides. 
The possibility to create multivalent iminosugar structures has recently expanded the scope 
of iminosugars, showing that the concept of multivalency is important not only to study the 
interaction between multivalent ligands and lectins, but it can be applied to increase the 
biological response towards enzymes with a deep enzyme cavity. Therefore, in recent years 
the multivalency concept has been also applied to glycosidase inhibition. 
Chapter 1 describes the principal applications of iminosugars as potential drugs, their 
natural occurrence and a selection of the main synthetic strategies aimed at their synthesis 
and that of their structural analogs. Indeed, total synthesis is an important tool both for the 
structural confirmation of the natural compounds and also to provide new unnatural 
analogs with increased biological activity. 
Chapter 2 deals with the synthetic strategies developed in our group at the University of 
Florence to build pyrrolidine and pyrrolizidine iminosugars starting from enantiopure cyclic 
nitrones derived from carbohydrate precursors. A novel oxidation procedure to oxidize 
carbohydrate derived hydroxylamines to nitrones has been also developed. Using these 
strategies, two novel compounds suitable for further multimerization were synthesized. 
The synthesis of new pseudo disaccharides pyrrolidine iminosugars inhibitors of insect and 
porcine trehalase was reported using the CM (cross metathesis) strategy. This work has 
  
 
been partially published (D. Bini, M. Forcella, L. Cipolla, P. Fusi, C. Matassini, F. Cardona, 
Eur. J. Org. Chem. 2011, 3995-4000). 
Chapter 3 reports a novel straightforward synthetic methodology to obtain diversely 
funtionalized piperidine iminosugars through the double reductive amination (DRA) or the 
Strecker reaction followed by reductive amination of a key aldehyde intermediate derived 
from mannose. This latter strategy allowed the synthesis of trihydroxypipecolic acids and of 
aminomethylpiperidine iminosugars. This work has been partially published (C. Matassini, S. 
Mirabella, A. Goti, F. Cardona, Eur. J. Org. Chem.2012, 3920-3924; C. Matassini, S. 
Mirabella, X. Ferhati, C. Faggi, I. Robina, A. Goti, E. Moreno-Clavijo, A. J. Moreno-Vargas, F. 
Cardona, Submitted).  
Chapter 4 deals with the construction of novel multivalent iminosugars (whose synthesis 
was described in Chapters 2 and 3) by their conjugation to gold glyconanoparticles. This 
work has been achieved thanks to the nine months of the PhD Course spent in the 
Laboratory of GlycoNanotechnology of CIC biomaGUNE (San Sebastián, Spain) as a result of 
the collaboration with Prof. Soledad Penadés and Dr. Marco Marradi. In this Chapter, the 
preparation and characterization of novel gold glyconanoparticles decorated with 
piperidine and pyrrolizidine iminosugars is described. These new hybrid gold 
glyconanoparticles are under biological evaluation thanks to the collaboration with Prof. 
Inmaculada Robina (University of Sevilla, Spain). 
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Chapter 1 
Iminosugar alkaloids: potential therapeutic and 
industrial applications  
Iminosugars are structural analogues of carbohydrates where the endocyclic oxygen is 
replaced by a nitrogen atom (Figure 1.1). 
 
Figure 1.1: General carbohydrate structure compared with general iminosugar structure. 
At physiological pH the nitrogen atom of the iminosugar is protonated and this charged 
species perfectly mimics the oxocarbenium ion involved in the transition state of the 
hydrolysis catalyzed by glycosidase enzymes (Figure 1.2).  
 
Figure 1.2: Example of an inverting glycosidase mechanism. An oxocarbenium ion like transition 
state is always involved in the hydrolytic process. 
For this reason iminosugars can inhibit or moderate the activity of a wide range of this kind 
of enzymes,1 that can act on carbohydrates and can affect the function of other 
carbohydrate-recognising proteins. These effects can be exploited to modify the 
glycosylation of eukaryotic cells, the metabolism of carbohydrate and glycoconjugates, the 
carbohydrate-dependent properties of glycoproteins such as folding and transport and the 
carbohydrate-mediated interactions of the host cells with the infective agents.2 This is a 
                                                          
1
 For recent reviews, see: a) T. M. Gloster, G. J. Davies, Org. Biomol. Chem. 2010, 8, 305–320; b) A. E. 
Stütz, T. M. Wrodnigg, Adv. Carbohydr. Chem. Biochem. 2011, 66, 187-298. 
2
 Iminosugars: from synthesis to therapeutic applications (Eds.: P. Compain, O. R. Martin), Wiley-VCH, 
Weinheim, 2007. 
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very active area of research both in academia and industry,3 and several international 
patents have recently appeared on the use of iminosugars in the treatment of relevant 
pathologies such as cystic fibrosis, hyperglycemia, diabetes and several viral infections.4 
1.1 Intestinal glycosidases, obesity and diabetes  
Many natural α-glucosidase inhibitors, such as deoxynojirimycin (DNJ, 1) and 
castanospermine (2) can inhibit intestinal glycosidases and delay postprandial 
hyperglycemia, making them potential antidiabetic and obesity drugs (Figure 1.3). The 
synthetic derivative of DNJ, N-hydroxyethyl DNJ or Miglitol® (3), is approved for use in type 
II diabetes. It decreases moderately blood glucose, insulin and glycated hemoglobin levels 
but causes considerable gastrointestinal discomfort due to undigested polysaccharides. The 
pseudotetrasaccharide acarbose (4), which is not appreciably absorbed, has a similar action 
and was introduced by Bayer onto the German market in 1990, under the name of 
Glucobay®. 
 
Figure 1.3: Antibiabetic (type II) agents.  
                                                          
3
 G. Winchester, Tetrahedron: Asymmetry 2009, 20, 645-651. 
4
 a) G. W. J. Fleet. Preparation of pyrrolidine imino-sugars used in the treatment of cystic fibrosis, 
PCT Int. Appl. (2011), WO 2011086347. b) A. Kato, I. Adachi, H. Takahata, T. Imahori. Agent for 
ameliorating postprandial hyperglycemia, and pyrrolidine iminosugar or salt thereof, PCT Int. Appl. 
(2011), WO 2011058975 A1 20110519. c) F. X. Wilson, R. J. Nash, G. Horne, R. Storer, J. M. Tinsley, A. 
G. Roach. Treatment of energy utilization diseases. d) U. Ramstedt, B. Klose, N. Zitzmann, R. Dwek, T. 
D. Butters. Iminosugars and methods of treating viral diseases, PCT 2010, WO 2010096764 A1 
20100826. 
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The blood glucose level can also be regulated by controlling glycogenolysis. The pyrrolidine 
1,4-dideoxy-1,4-imino D-arabinitol (DAB-1, 5, Figure 1.3) is another potential drug for type II 
diabetes because it can decrease glucagon-induced and spontaneous hyperglycemia by 
inhibition of hepatic glycogen phosphorylase.5 Miglitol® has also shown to inhibit 
glycogenolysis and the effects of several other iminosugars on glycogenolysis have been 
studied in vitro.6 
1.2 Glycoprotein processing 
Iminosugars can also inhibit specific processing glycosidases in the endoplasmic reticulum 
(ER) and in the Golgi apparatus, altering the cellular ensemble of N-linked (or asparagine-
linked) glycans on glycoproteins. For instance, the inhibition of molecules 6-10 is indicated 
in Figure 1.4. 
 
Figure 1.4: Inhibition of processing glycosidases. The structures of compounds 6-10 are reported in 
Figure 1.5. Taken from Ref. 
3
 
Inhibition of an early enzymatic step in processing can block the formation of a precursor 
for a certain glycan, leading the processing to an alternative pathway. This has been 
extensively exploited to investigate the function of the glycosylation of specific 
                                                          
5
  T. Latsis, B. Andersen, L. Agius, Biochem. J. 2002, 368, 309–316. 
6
 N. Wang, S. Minatoguchi,  X. Chen, Y. Uno, M. Arai, C. J. Lu, G. Takemura, T. Fujiwara, H. Fujiwara, 
Br. J. Pharmacol. 2004, 142, 983–990. 
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glycoproteins and to alter cellular glycosylation for therapeutic purposes such as a 
modulation of the immune response,7 cancer therapy8 and anti-viral activity.9  
 
Figure 1.5: Structures of iminosugar inhibitors of processing glycosidases. 
1.3 Anti-infective drugs 
Specific inhibition of an enzyme, which is expressed in an infecting organism but not in the 
host, is an ideal drug target. Such an enzyme is the elongating α-D-mannosylphosphate 
transferase of the Leishmania parasite. This enzyme is involved in the synthesis of cell 
surface phosphoglycans, essential for the survival and the infectivity of the parasite but not 
expressed in the mammalian hosts. Novel iminosugars (1-oxabicyclic β-lactams, Figure 1.6) 
11 have been synthesized based on the transition state of the enzyme and have shown to 
be potent inhibitors of the enzyme.10 Pyrrolidine analogue of D-galacto-furanose and L-
galactofuranose 12-15 can inhibit Mycobacterium galactan biosynthesis (Figure 1.6).11 
Attempts to find iminosugars with antifungal activity have been less successful. 12 
On the contrary, the piperidine derivative, Siastatin B (16, Figure 1.6), which can be isolated 
from Streptomyces, inhibits mammalian, viral and bacterial neuraminidase (a glycosidase 
                                                          
7 B.Winchester, The Development of Iminosugars as Drugs. In Glycobiology; C. Sansom, O. Markman, 
Eds.; Scion Publishing Limited, Bloxham: Oxfordshire, UK, 2006; 308–324. 
8
 T. M. Wrodnigg, A. J. Steiner, B. Ueberbacher, J. Anticancer Agents Med. Chem. 2008, 8, 77–85. 
9
 a) P.Greimel; J. Spreitz, A. Stutz, E.; T. M. Wrodnigg, Curr. Top. Med. Chem. 2003,3, 513–523. b) C. 
N. Scanlan, J. Offer, N. Zitzmann, R. A. Dwek, Nature 2007, 446, 1038–1045. 
10 D. Ruhela, P.Chatterjee, R. A. Vishwakarma, Org. Biomol. Chem. 2005, 3, 1043–1048. 
11 a) R. E. Lee, M. D. Smith, R. J. Nash, R. C. Griffiths, M. McNeil, R. K Grewal, W. Yan, G. S. Besra, P. J. 
Brennan, G. W. J. Fleet, Tetrahedron Lett. 1997, 38, 6733–6736. B) S. Cren, C. Wilson, N. R. Thomas, 
Org. Lett. 2005, 7, 3521–3523. 
12 I. Gautier-Lefebvre, J.-B. Behr, G. Guillerm, M. Muzard, Eur. J. Med. Chem. 2005, 40, 1255–1261. 
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that cleaves the glycosidic bond of neuraminic acid) and its 3-epimer is a particulary good 
inhibitor of influenza virus neuraminidase.13 
 
Figure 1.6: Anti-infective drugs structures. 
1.4 Lysosomal storage disorders 
Lysosomal storage disorders (LSDs) are a group of genetic diseases caused by defects of 
activity, transcription, post-translational modifications and trafficking of soluble lysosomal 
hydrolases. These defects cause impaired intracellular turnover and lead to accumulation of 
a variety of substrates such as glycosphyngolipids, glycogen, mucopolysaccharides and 
glycoproteins.14 Deficiencies in metabolic enzymes required for the degradation of such 
substances provoke inflammations, cell damages, and tissue dysfunctions. 
More than 50 disorders of this type have been identified15 and Gaucher disease is the most 
common LSD, with an occurrence of approximately 10000 patients in developed countries. 
Most of LSDs are neuronopathic, with Central Nervous System (CNS) involvement, 
progressive neurodegeneration and cognitive impairment. In all LSDs clinical heterogeneity 
is present. The most severe forms occur in infants with onset in utero (i.e. Sialidosis, 
Galactosialidosis, GM1 gangliosidosis, Gaucher type II, MPSIVA) or within 6 months and 
outcome in the second year of life. In the less severe forms, clinical symptoms eventually 
appear during adulthood and are the cause of reduced life expectation.  
                                                          
13Y. Nishimura, Curr. Top. Med. Chem. 2003, 3, 575–591. 
14
 B. Winchester, A. Vellodi, E. Young, Biochem. Soc. Trans. 2000, 28, 150. 
15
 a) P. J. Meikle, J. J. Hopwood, A. E. Clague, W. F. Carey, JAMA 1999, 281, 249. b) J. A. Rider, D. L. 
Rider, Mol. Gen. Metab. 1999, 66, 231. c) P. Santavuori, Brain Dev. 1988, 10, 80. 
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Figure 1.7: The degradation of glycosphingolipids occurs in lysosomes and involves various enzymes 
which are responsible for the removal of each terminal sugar unit. The deficiency in one enzyme 
results in the accumulation of the undegraded substrate, leading to a specific lysosomal storage 
disease. Taken from Ref.
3
 
In particular the sphyngolipidosis are characterized by the deficiency of the glycosidases 
involved in the catabolism of glycosphingolipids in the lysosome (Figure 1.7).  
Over the last 20 years, several therapeutic approaches have been developed for the 
treatment of LSDs such as increasing of enzyme activity by Enzyme Replacement Therapy 
(ERT) and/or by reduction of accumulated substrates known as Substrate Reduction 
Therapy (SRT).16 More recently, an emerging therapeutic strategy using small molecules as 
potential oral drugs has received great attention: the active-site-specific chaperone (ASSC) 
therapy, also referred to as pharmacological chaperone therapy.17 
Surprisingly, all the three different therapeutic approaches involve the use of iminosugars 
alkaloids. 
                                                          
16 G. Parenti EMBO Mol. Med. 2009, 1, 268. 
17 a) J.-Q.Fan, Trends Pharmacol. Sci. 2003, 24, 355–360. b) R. J. Desnick, E. H. Schuchman, Nat. Rev. 
Genet 2002, 3, 954–966. 
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1.4.1 Preparation of human recombinant therapeutic enzymes with modified 
glycosylation 
Ingestion of iminosugars was originally considered to cause a lysosomal storage disease by 
inhibition of lysosomal hydrolases in situ, for example, in swainsona toxicosis or locoweed 
poisoning. This phenomenon was used to provide evidence for the feasibility of enzyme 
replacement therapy by showing that the lysosomal storage induced in cells by swainsonine 
was reversed when the inhibitor was removed and endogenous activity restored. 
Recombinant human lysosomal enzymes produced in mammalian cells for enzyme 
replacement therapy contain a mixture of N-linked glycans, including complex, hybrid and 
at least one high mannose with the mannose-6-phosphate motif for delivery of the enzyme 
to the lysosome by the mannose-6-phosphate receptor system. However, enzyme 
replacement therapy for Gaucher disease does not utilize the mannose-6-phosphate 
receptor system but targets the enzyme to the mannose-receptor on macrophages. For this 
reason, recombinant β-glucocerebrosidase is processed chemically and with high costs, 
after production to expose mannose-residues on its N-linked glycans. Therefore the 
development of a technology which allowed to produce recombinant proteins with defined 
patterns of glycosylation has been a challenge for a long time. Today this goal is achieved 
producing recombinant β-glucocerebrosidase with high mannose chains by including an 
iminosugar in the fermentor culture medium.3 
1.4.2 Substrate reduction therapy 
The first evidence that iminosugars could affect the metabolism of glycosphingolipids came 
from treating normal fibroblasts in culture with castanospermine (2), a powerful inhibitor of 
α-and β-glucosidases. The appearance of two additional major glycosphingolipids in the 
treated cells, which were not present in untreated normal cells or in cells from a patient 
with Gaucher’s disease, suggested that glycosphingolipid biosynthesis had been disturbed 
or that the castanospermine was inhibiting an unknown enzyme in the catabolic pathway. 
Subsequently, Butter co-workers showed that α-glucosidase inhibitor N-butyl-DNJ (6) 
inhibited ceramide glucosyl-transferase (the first step in the biosynthesis of most 
glycosphingolipids) acting as a mimic of ceramide.18 This suggested that N-butyl-DNJ could 
be a generic drug for decreasing the rate of synthesis of all glycosphingolipids for which 
glucosylceramide is the precursor and, in consequence, decreasing the rate of accumulation 
of these glycosphingolipids in the glycosphingolipidoses in which their catabolism is 
                                                          
18
 F. M. Platt, G. R. Nieses, G. Reinkensmeir, M. J. Townsend, V. H. Perry, R. L. Proia, B. Winchester, R. 
A. Dwek, T. D. Butter, Science 1997, 276, 428–431. 
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impaired (Figure 1.7). This is the basis of substrate reduction therapy (SRT). On the basis of 
an encouraging clinical trial, N-butyl-DNJ (also known as OGT 918, Zavesca or Miglustat) has 
been licensed in Europe (2002) and USA (2003) for treatment of non-neuronopathic 
Gaucher disease type 1, in which there is some residual ceramide glucosyltransferase 
activity. Unfortunatly N-butyl-DNJ did not have any appreciable effect on the neurological 
manifestations of neuronopathic Gaucher disease type 3.19 Clinical trials of SRT with N-
butyl-DNJ for other glycosphingolipidoses, such as Fabry, Tay-Sachs and Sandhoff diseases 
did not show clinical benefit and have been abandoned. Several other compounds including 
some iminosugars are being evaluated in preclinical trials.20 
1.4.3 Pharmacological chaperone therapy 
It had been common knowledge among enzymologists for many years that the addition of 
simple sugars protected glycosidases during their extraction from tissues and that imino- 
and amino-sugars were excellent ligands for affinity chromatographic media for the 
purification of glycosidases. It had also been observed that sometimes iminosugars could 
activate rather than inhibit glycosidases in assays in vitro, suggesting in all cases that the 
tight binding of the iminosugars to the active sites of glycosidases stabilized them.  
 
Figure 1.8: Endoplasmic reticulum (ER) quality-control system and active-site-specific chaperone 
(ASSC) therapy. Taken from Ref.
2
 
                                                          
19 R. Schiffmann, E. J.Fitzgibbon, C.Harris, C.DeVile, E. H.Davies, L. Abel, I. N. van Schaik, W. Benko, 
M.Timmons, M. Ries, A.Vellodi, Ann. Neurol. 2008, 64, 514–522. 
20
 T. M. Cox, Acta Paedtr. 2005, 94, 69–75. 
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However, it was not until 1999 that Fan and co-workers introduced the concept of active 
site-specific chaperone therapy (ACCS therapy or pharmacological chaperone therapy) for 
lysosomal storage diseases using iminosugars to prevent misfolding and premature 
degradation of mutant enzymes in the endoplasmic reticulum (Figure 1.8).21  
They showed that sub-inhibitory concentrations of the potent α-galactosidase inhibitor, 
deoxygalactonojirimycin (DGJ, 17, Figure 1.9) increased the residual activity in lymphoblasts 
from patients with Fabry disease by seven- to eightfold over 5 days, whereas higher 
concentrations decreased the activity.  
 
Figure 1.9: Iminosugars for active-site-specific chaperone (ASSC) therapy. 
Comparison of a series of derivatives of DGJ indicated a correlation between potency as an 
inhibitor and effectiveness as a chaperone.22  
Even infusions of galactose, the product of the enzymic reaction and a weak inhibitor of the 
enzyme, led to clinical improvement in a Fabry patient with residual α-galactosidase 
activity.23 A Phase I clinical trial of DGJ in healthy volunteers was started by a company  in 
2004 and a Phase II/III clinical trial in Fabry patients was carried out in 2005-2007. The 
preliminary results are encouraging. As iminosugars and their derivatives are usually water 
soluble and inert, can be taken orally and can cross the blood–brain barrier, they are 
attractive drugs for attempting to treat lysosomal storage diseases, especially those with 
CNS involvement. Several iminosugars and derivatives are being tested as chaperones for 
Gaucher’s disease, in particular Phase I and II clinical trials with isofagomine (IFG, 18, Figure 
1.9) are in progress.24 
 
                                                          
21
J.-Q. Fan, S. Ishii, N. Asano, Y.Suzuki, Nat. Med. 1999, 5, 112–115. 
22 N. Asano, S. Ishii, H. Kizu, K. Ikeda, K. Yasuda, A. Kato, O. R. Martin, J. Q. Fan, Eur. J. Biochem. 2000, 
267, 4179–4186. 
23 A. Frustaci, C. Chimenti, R. Ricci, L. Natale, M. A. Russo, M. Pieroni, C. M. Eng, R. J. Desnick, N. Engl. 
J. Med. 2001, 345, 25–32. 
24 R. E. Boyd, G. Lee, P. Rybczynski, E. R. Benjamin, R. Khanna, B. A. Wustman, K. J. Valenzano, J. Med. 
Chem. 2013, 56, 2705−2725. 
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1.5 Agrochemical: trehalase inhibitors 
Glycosidase inhibitors also find applications in the field of crop protection and specifically 
many iminosugar alkaloids have been shown a potent inhibition activity towards trehalase. 
Trehalose is a blood sugar in insects and a major storage sugar in fungi and yeast. Trehalase 
hydrolizes trehalose into two units of glucose and therefore plays the essential role in the 
transport of glucose in insects and fungi, while vertebrates do not depend on the hydrolysis 
of trehalose.25 
 
Figure 1.10: Structures of trehalose and its inhibitors: 20 and 21 contain an iminosugar alkaloid unit. 
For this reason trehalase inhibitors are expected to have potential as nontoxic insecticides 
or fungicides. All powerful trehalase inhibitors reported to date are pseudodisaccharide 
type of inhibitors, such as validoxylamine A (19),26 MDL 25637 (α-homonojirimycin-7-O-β-D-
glucopyranoside, 20)27 and casuarine-6-O-α-D-glucopyranoside (21,28 Figure 1.10). These 
compounds are powerful competitive inhibitors of porcine kidney trehalase. The extremely 
high affinity of pseudodisaccharide inhibitors derives from the synergistic interactions of an 
alkaloid unit and a sugar unit with two enzyme’s subsites.29 However, these trehalase 
inhibitors are not practical as insecticides because they have poor percutaneous absorption 
                                                          
25
 a) Elbein, A. D. Adv.Carbohydr. Chem. Biochem. 1974, 30, 227-256. b) Elbein, A. D.; Pan, Y. T.; 
Pastuszak, I.; Carroll, D. Glycobiology 2003, 13, 17R-27R. 
26
 a) N. Asano, T. Yamaguchi, Y. Kameda, K. Matsui, J. Antibiot 1987, 40, 526-532. b) Y. Kameda, N. 
Asano, T. Yamaguchi, K. Matsui, J. Antibiot 1987, 40, 563-565. 
27
 P. B. Anvenzano, L. J. Creemer, J. K. Daniel, C. –H. R. King, P. S. Liu, J. Org. Chem 1989, 54, 2539-
2542. 
28
 Kato, A.; Kano, E.; Adachi, I.; Molyneux, R. J.; Watson, A. A.; Nash, R. J.; Fleet, G. W. J.; Wormald, 
M. R.; Kizu, H.; Ikeda, K.; Asano, N. Tetrahedron: Asymmetry 2003, 14, 325-331.  
29
 Asano, N.; Kato, A.; Matsui, K. Eur. J. Biochem. 1996, 240, 692-698. 
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through the insect skin. The design of trehalase inhibitors or prodrugs with good 
percutaneous absorption will lead to practical use as insecticides. 
1.6 Synthesis of Iminosugar Alkaloids 
In the past fifty years, more than 100 polyhydroxylated alkaloids have been isolated from 
plants and microorganisms, with structures belonging to the classes of polyhydroxylated 
piperidines, pyrrolidines, indolizidines, pyrrolizidines and nortropanes (Figure 1.11). 
Iminosugar alkaloids have been widely investigated and their potential therapeutic 
applications in many different fields have interested many research groups.30  
 
 
Figure 1.11: Classes of natural occurring polyhydroxylated alkaloids. 
In particular, since the synthesis and the biological evaluation of pyrrolidine, piperidine and 
pyrrolizidine alkaloids represents the subject of this research project, the natural 
occurrence and the main synthetic methodologies for the obtainment of iminosugars 
(natural and not natural analogues) belonging to these three families will be presented 
more in detail in this introduction. Indeed, total synthesis is important not only for the 
stereochemical confirmation of the natural compounds, but also to access unnatural 
analogues for SAR studies.  
1.6.1 Pyrrolidine Alkaloids 
Natural occurrence: 2,5-Dihydroxymethyl-3,4-dihydroxypyrrolidine (DMDP, 9 Figure 1.5) 
was the first pyrrolidine iminosugar isolated.31 It was extracted from the leaves of Derris 
elliptica in 1976, however its biological activity was not discovered until several later 
years.32 Afterwards it was shown to be present in many different species of plants and 
microorganism,33 indicating that this is a common metabolite. In 1991, 2,3-dideoxy-2,5-
                                                          
30
 a) Iminosugars: from synthesis to therapeutic applications. Ed. P. Compain, O.R. Martin, 2007 
Wiley-VCH. b) R. J. Nash, A. Kato, C.-Y. Yu, G. W. J. Fleet, Iminosugars as therapeutic agents: recent 
advances and promising trends. Fut. Med. Chem. 2011, 3, 1513-1521; c) G. Horne, F. X. Wilson, 
Progr. Med. Chem. 2011, 50, 135-176. 
31
 A. Welter, J. Jadot, G. Dardenne, M. Marlier, J. Casimir, Phytochemistry 1976, 15, 747-749. 
32
 A. D. Elbein, M. Mitchell, B. A. Sanford, L. E. Fellows, S. V. Evans, J. Biol, Chem. 1984, 259, 2409-
2413. 
33
 Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochemistry. 2001, 56, 265-
295. 
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imino-D-glucitol (DGDP, 22) was synthesized and was shown to have potent α- and β-
glucosidase inhibition. Since then DGDP has been isolated from the Thai traditional 
medicine “Non tai yak” (Stemona tuberosa).  
 
Figure 1.12: Naturally occurring pyrrolidine iminosugars. 
The 1,4-dideoxy-1,4-imino-D-arabinol DAB-1 (5, Figure 1.3) was originally isolated from the 
fruit of Anglylocalyx boutiqueanus34 and subsequently in many other species of plants as 
well as DMDP.33 The first isolated 1,2-dideoxy iminosugar, 2-hydroxymethyl-3-
hydroxypyrrolidine (CYB-3, 23), was extracted from Castanospermum australe in 1985. 35 
More recently, a number of new glycosyl pyrrolidine iminosugars have also been isolated. 
In 2005 Asano and coworkers extracted Thai medicinal plants and, in combination with 
several previously identified iminosugars, isolated 3-O-β-D-glucopyranosyl-DMDP (24).36 In 
2008, Kato and coworkers extracted ten iminosugars from the leaves of the African 
medicinal tree Baphia nitida and discovered the novel 1-O-β-D-fructofuranoside of DMDP 
(25).37  
Synthetic strategies: in 1984 Fleet reported the synthesis of 1,4-dideoxy-1,4-imino-D-
mannitol (26, DIM),38 the first pyrrolidine iminosugar able to inhibit a sugar processing 
enzyme. Until that point the mimicry of the pyranose substrates of these enzymes was 
                                                          
34
 R. J. Nash, E. A. Bell, J. M. Williams, Phytocheistry. 1985, 24 1620-1622. 
35
 R. J. Nash, E. A. Bell, G. W. J. Fleet, R. H. Jones, J. M. Williams, J. Chem. Soc. Chem. Commun. 1985, 
738-740. 
36
 N. Asano, T. Yamauchi, K. Kgamifuchi, N. Shimizu, S. Takahashi, H. Takatsuka, K. Ikeda, H. Kizu, W. 
Chuakul, A. Ketawan, T. Okamoto, J. Nat. Prod. 2005, 68, 1238-1242. 
37
 A. Kato, N. Kato, S. Miyauchi, Y. Minoshima, I. Adachi, K. Ikeda, N. Asano, A. A. Watson, R. J. Nash, 
Phytochemistry 2008, 69, 1261-1265. 
38
 G. W. J. Fleet, P. W. Smith, S. V. Evans, L. E. Fellows, Chem. Commun. 1984,1240-1241. 
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ascribed only to six-membered piperidines such as DNJ (1). It is now clear, through the 
synthesis of many potent inhibitors, that pyrrolidines such as DIM (26) are at least as good, 
if not better than their piperidine counterparts, probably due to their close conformational 
resemblance to the postulated half-chair conformation of the transition state of 
glycosidases (Figure 1.13) and acid–base interactions with catalytic residues in active sites.39 
 
Figure 1.13: Conformational resemblance between the postulated transition state of glycosidases 
and pyrrolidine DIM (26) or piperidine DNJ (1), elaborated from Ref.39. 
The synthesis of DIM was obtained in 32% from benzyl mannoside, suitable protected to 
allow the introduction of an azido moiety at C-4. Reduction of this key intermediate formed 
an amine at C-4, deprotected C-1 and then allowed intramolecular reductive amination to 
form DIM (26) in very good yield (Figure 1.14). 
 
Figure 1.14: Synthesis of DIM (26), reported by Fleet in 1984. 
Ever since, reductive amination continues to be a popular method for the synthesis of a 
variety of polyhydroxylated pyrrolidines. For example improved syntheses of 2,5 dideoxy-
2,5-imino-D-mannitol (DMDP, 9) and 2,5-dideoxy-2,5-imino-D-glucitol (DGDP, 22) were 
recently developed by Fernández and co-workers.40 In this case, an effective intramolecular 
benzyl protection/delivery system was employed (Figure 1.15) using the D-fructose-derived 
                                                          
39
 B. G. Davis, Tetrahedron: Asymmetry 2009, 20, 652-671. 
40
 M. I. Garca-Moreno, M. Aguilar, C. O. Mellet, J. M. G. Fernández, Org. Lett. 2006, 8, 297–299. 
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3-O-(2-bromomethyl)benzyl ether 27 to form the alcohol 28 that possessed a fused eight-
membered ring o-xylylene tether between the C-3 and C-4 hydroxy groups.  
Conversion of alcohol 28 into the iodide and subsequent treatment with sodium azide gave 
azide 29 with net retention of stereochemistry. Acidic conditions removed the acid labile 
protecting groups in 29 and catalytic hydrogenation effected a one-pot reductive 
amination-cyclisation to yield DMDP 9 in excellent yield. Conversely, elaboration of the 5-
isomer of 29 (formed via azide substitution of the triflate of 28) led to the isolation of DGDP 
(22, Figure 1.12).  
 
Figure 1.15: Recent synthesis of DMDP (9), by Fernández and co-workers. 
Among the amination methodologies, nucleophilic substitution reactions involving the 
displacement of good leaving groups by primary and secondary amines represent a method 
of choice for the formation of iminosugars. In particular, the introduction and subsequent 
displacement of a mesyl group by an amine has been largely exploited by many different 
groups.41  
In an interesting application of mesylate displacement, Moriarty et al. recently reported a 
facile synthesis of five membered ring iminosugars from pentonolactones (Figure 1.16).42 
Here, alkylation of lactone 30 with Grignard reagents (e.g. MeMgBr, nBuMgBr, n-
                                                          
41
 Selected examples: a) J. S. Reddy, A. R. Kumar, B. V. Rao, Tetrahedron: Asymmetry 2005, 16, 3154–
3159; b) A. J. Moreno-Vargas, A. T. Carmona, F. Mora, P. Vogel, I. Robina, Chem. Commun. 2005, 
4949–4951. c) J. S. Reddy, B. V. Rao, J. Org. Chem. 2007, 72, 2224–2227; d) M. Bosco, P. Bisseret, P. 
Constant, J. Eustache, Tetrahedron Lett. 2007, 48, 153–157; e) J.-B. Behr, G. Guillerm, Tetrahedron 
Lett. 2007, 48, 2369–2372; f) M. A. Alam, A. Kumar, Y. D. Vankar, Eur. J. Org. Chem. 2008, 29, 4972–
4980; g) A. E. Håkansson, J. van Ameijde, L. Guglielmini, G. Horne,R. J. Nash, E. L. Evinson, A. Kato, G. 
W. J. Fleet, Tetrahedron: Asymmetry 2007, 18, 282–289. 
42
 R. M. Moriarty, C. I. Mitan, N. Branză-Nichita, K. R. Phares, D. Parrish, Org. Lett. 2006, 8, 3465-
3467. 
Chapter 1 
21 
 
C9H19MgBr) produced keto sugars 31, which were subsequently reacted with ammonia to 
yield the endo-imine 33 following rearrangement of the initially formed exo-amine 32. 
Imine products 33 could also be readily hydrogenated to provide the saturated pyrrolidine 
product, some of which showed potent antiviral activity. 
 
Figure 1.16: An example of mesylate displacement strategy, reported by Moriarty and co-workers. 
The aldol reaction represents another example of well-precedented procedure, which has 
been recently extended to its enzymatically catalysed version, allowing the preparation of a 
variety of pyrrolidine iminosugars in remarkable few steps.  
This methodology, employing different aldolases and different donors, has been 
investigated essentially by the two groups of Wong and Clapés, allowing the synthesis of 
different iminocyclitols, such as L-iminoglucitol (34, Figure 1.17)43 or DAB-1 and 5-deoxy 
DAB-1,44 respectively.  
 
Figure 1.17: Synthesis of L-iminoglucitol (34) through RhaD catalysed aldol reaction, by Wong and co-
workers. 
With the advent of more potent, functional group tolerant, and commercially available 
catalysts (Figure 1.18), the Ring-Closing Metathesis (RCM) reaction has become a popular 
                                                          
43 a) M. Sugiyama, Z. Hong, L. J. Whalen, W. A. Greenberg, C.- H. Wong, Adv. Synth. Catal. 2006, 348, 
2555–2559; b) M. Sugiyama, Z. Hong, P.-H. Liang, S. M. Dean, L. J. Whalen, W. A. Greenberg, C.-H. 
Wong, J. Am. Chem. Soc. 2007, 129, 14811–14817. 
44 a) L. Espelt, J. Bujons, T. Parella, J. Calveras, J. Joglar, A. Delgado, P. Clapés, Chem. Eur. J. 2005, 11, 
1392–1401; b) A. L. Concia, C. Lozano, J. A.Castillo, T. Parella, J. Joglar, P. Clapés, Chem. Eur. J. 2009, 
15, 3808–3816. 
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strategy to synthesise cyclic molecules. In the construction of iminosugars, the combination 
of RCM and cis-hydroxylation has become an especially valuable methodology.  
 
Figure 1.18: Metathesis catalysts. 
A large number of 1,4-dideoxy-1,4-imino-hexitols have been prepared using this dual 
strategy with a typical procedure for the preparation of an iminohexitol involving the RCM 
of a suitably functionalized nitrogen containing diene to yield a dehydropyrrolidine that is 
subsequently dihydroxylated, often using OsO4. To synthesise the required diene, a variety 
of reaction conditions have been used. For example, Rao and co-workers45 used a Grignard 
addition to prepare the diene of desired stereochemistry for the synthesis of 1,4-dideoxy-
1,4-imino-D-allitol 39 (Figure 1.19). Here, (R)-2,3-O-isopropylidine glyceraldehyde (35) was 
condensed with benzylamine and subjected to a Grignard reaction with vinylmagnesium 
bromide to provide alkene 36. The nitrogen in 36 was then Boc-protected, debenzylated, 
and allylated to give diene 37. RCM of the nitrogen tethered diene provided pyrrole 38, 
which was subsequently dihydroxylated and finally deprotected to give imino-D-allitol 39. 
The syntheses of 1,4-dideoxy-1,4- imino derivatives of L-allitol and D-talitol were also 
accomplished using similar methodology. 
 
Figure 1.19: Example of Ring-Closing Metathesis methodology by Rao and co-workers. 
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 B. Chandrasekhar, A. Madhan, B. V. Rao, Tetrahedron 2007, 63, 8746–8751. 
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Nucleophilic addition to nitrones, imides and imines has been well documented and 
recently exploited as a key methodology for the synthesis of a variety of polyhydroxylated 
pyrrolidines.46 In particular, the anti-addition of an organometallic reagent to a nitrone 
carbon atom represents one of the strategy investigated by our group and it has been 
addressed in depth in Chapter 2.1.1. 
Conversely, a novel and efficient approach to the stereoselective construction of densely 
functionalised pyrrolidines, based on the addition to aldehydes with in situ cyclisation, was 
recently reported by Somfai and co-workers.47  
 
Figure 1.20: Addition to aldehyde with in situ cyclisation methodology, by Somfai and co-workers. 
Here they employed a Lewis acid promoted [3+2]-annulation of N-tosyl-α-amino aldehydes 
40 and 1,3-bis-(silyl)propenes. In this strategy, silane 41 functioned as a 1,2-dipole 
equivalent, and stereoselectively reacted with amino aldehyde 40 to yield a β-silyl cation 
that underwent a subsequent annulation reaction to form pyrrolidine 42 (Figure 1.20). A 
number of N-pTs-α-amino aldehydes were amenable to these reaction conditions and gave 
a variety of substrates suitable for further synthetic transformations. For example, the 
addition of silane 41 to 40 (where R = CH2OTBS) yielded pyrrolidine 42 (R = CH2OTBS) which 
was subsequently transformed into DGDP (22) following desilylation, a stereospecific 
Tamao–Fleming oxidation, and detosylation. 
Finally, the recent growth in environmental concern and awareness has seen a 
development of more efficient and less hazardous chemical processes. This also holds true 
for the synthesis of iminosugars with several groups having developed methodologies that 
allow for the synthesis of iminosugars without the need for protecting groups. In Stocker 
and co-workers protecting group free synthesis of pyrrolidines, two novel reaction 
                                                          
46
 Selected examples: T. Machan, A. S. Davis, B. Liawruangrath, S. G. Pyne, Tetrahedron 2008, 64, 
2725–2732; b) S. Lauzon, F. Tremblay, D. Gagnon, C. Godbout, C. Chabot, C. Mercier-Shanks, S. 
Perreault, H. DeSève, C. Spino, J. Org.Chem. 2008, 73, 6239–6250;c) Y. Ichikawa, T. Ito, M. Isobe, 
Chem. Eur. J. 2005, 11, 1949– 1957; d) T. Sengoku, Y. Satoh, M. Oshima, M. Takahashi, H. Yoda, 
Tetrahedron 2008, 64, 8052–8058; e)  D. Declerck, S. Josse, A. Nguyen Van Nhien, D. Postel, 
Tetrahedron Lett. 2009, 50, 2171–2173; f) M. Moura, S. Delacroix, D. Postel, A. Nguyen Van Nhien, 
Tetrahedron 2009, 65, 2766–2772. 
47 a) P. Restorp, A. Fischer, P. Somfai, J. Am. Chem. Soc. 2006, 128, 12646–12647; b) P. Restorp, M. 
Dressel, P. Somfai, Synthesis 2007, 1576–1583. 
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methodologies were developed: the formation of primary amines via a modified 
Vasella/reductive amination reaction and the stereoselective formation of cyclic 
carbamates from alkenylamines.48  
 
Figure 1.21: An example of protecting group-free synthesis by Stocker and co-workers. 
The synthesis of the D-xylo-pyrrolidine 46 started with the conversion of D-xylose into the 
corresponding methyl iodoglycoside 43 (Figure 1.21). The modified Vasella/reductive 
amination protocol, which involves the addition of satd. NH4OAc and NH3 to a solution of 
methyl glycoside 43 in ethanol, gave linear alkenylamine 44 as the only product. 
Alkenylamine 44 was then subjected to aqueous NaHCO3 and iodine to give carbamate 45 
via an unprecedented, highly diastereoselective, iodine-mediated carbamate annulation 
reaction. Hydrolysis of carbamate 45 then gave D-xylo pyrrolidine 46 in excellent yield. In 
summary, 1,4-dideoxy-1,4-imino-D-xylitol 46 was prepared in five steps and in a 57% overall 
yield. 1,4-Dideoxy- 1,4-imino-L-lyxitol and 1,2,4-trideoxy-1,4-imino-L-xylitol were also 
prepared via similar methodology and in good overall yields.  
1.6.2 Pyrrolizidine Alkaloids 
Natural occurrence: pyrrolizidine structure is composed by two fused pyrrolidines with a 
bridgehead nitrogen atom. The first compound of this group to be isolated from natural 
sources was alexine (47, Figure 1.22), extracted in 1988 from the seeds of Alexa 
leiopetala.49 At about the same time, australine (48, Figure 1.22), the 7a-epimer of alexine, 
was isolated from the seeds of Castanospermum australe.50 Pyrrolizidines 47 and 48 
present a pattern of substitution, on the pyrrolidine ring A, that is repeated in a large 
                                                          
48 E. M. Dangerfield, M. S. M. Timmer, B. L. Stocker, Org. Lett. 2009, 11, 535–538. 
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 R. J.Nash, L. E. Fellows, J. V. Dring, G. W. J Fleet, A. E. Derome, T. A.Hamor, A. M. Scofield, D. J. 
Watkin, Tetrahedron Lett. 1988, 29, 2487-2490. 
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number of other pyrrolizidines and which reminds the structure of DMDP (9, Figure 1.5) 
and castanospermine (2, Figure 1.22). 
Another very interesting pyrrolizidine is casuarine (49, Figure 1.22). This molecule was 
found, with its 6-O-α-glucoside (21, Figure 1.10), in the barks of Casuarina equisetifolia, a 
plant used in traditional medicine in Samoa for the treatment of breast cancer. Both 
compounds were also isolated from the leaves of Eugenia jambolana, which is a well-
known tree in India for the therapeutic value of its seeds, leaves and fruits against diabetes 
and bacterial infections.51 More recently a series of pyrrolizidines with highly diversified 
structures were isolated from Hyacinthoides non-scripta and Scilla campanulata (both from 
Hyacinthaceae family) and named hyacinthacines (for instance, hyacinthacine C1 50 or 
hyacinthacine A2 51, Figure 1.22).
52 
 
Figure 1.22: Naturally occurring pyrrolizidine iminosugars. 
Finally an important example is 7a-epialexaflorine (52, Figure 1.22), extracted from Alexa 
grandiflora,53 in which the castanospermine hydroxymethyl group has been replaced with a 
carboxyl group. This is the first example of a natural amino acid in which the carboxyl group 
is in position 3 of the pyrrolizidine nucleus. 
Synthetic strategies: since pyrrolizidines are pyrrolidine-containing compounds, all the 
methodologies reported in Chapter 1.6.1 for the synthesis of pyrrolidine iminosugars 
(amination, aldol condensation, organometallic catalysis, nucleophilic addition, protecting 
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 a) R. J. Nash, P. I. Thomas, R. D. Waigh, G. W. J. Fleet, M. R. Wormald, P. M.de Q. Lilley, D. J. 
Watkin, Tetrahedron Lett. 1994, 35, 7849–7852; b) M. R. Wormald, R. J. Nash, A. A. Watson, B. K. 
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group-free strategies) could be successfully employed also in the synthesis of pyrrolizidine 
iminosugars. Therefore only few strategies exclusively related to these bicyclic compounds 
synthesis will be reported herein. 
For example, the Wittig reaction is a versatile means by which to synthesise a variety of 
pyrrolizidine and indolizidine iminosugars where, in general, the olefination reaction is used 
to extend a suitably protected pyrrolidine with an alkyl chain that is subsequently used for 
the generation of a second ring. Notably, Izquierdo and coworkers have used this 
methodology to create a number of pyrrolizidines from the hyacinthacine A and casuarine 
families whereby D-fructose was used as the starting material.54  
 
Figure 1.23: Synthesis of (–)-3-epi-hyacinthacine A5 (56), by Izquierdo and co-workers. 
As reported in Figure 1.23 for the synthesis of (–)-3-epi-hyacinthacine A5 Iba, pyrrolidine 53 
was Cbz-protected, oxidized, and subjected to a Wittig olefination with 1-
(triphenylphosphoranylidene)-2-propanone to give the α,β-unsaturated ketone 54. Ketone 
54 was then hydrogenated, which resulted in the one-pot reduction of the double bond, N-
deprotection and in situ cyclisation to give the protected pyrrolizidine 55 Global 
deprotection then gave (–)-3-epi-hyacinthacine A5 (56).  
Though less common than other amination strategies, radical reactions have nonetheless 
been elegantly used during the synthesis of several bicyclic iminosugars, as recently 
reported by Chabaud et al.55 and Chen and Tsai.56 In Chabaud’s synthesis of (+)-
                                                          
54 a) I. Izquierdo, M. T. Plaza, J. A. Tamayo, F. Sánchez-Cantalejo, Eur. J. Org. Chem. 2007, 6078–6083; 
b) I. Izquierdo, M. T. Plaza, J. A. Tamayo, V. Yáñez, D. L. Re, F. Sánchez-Cantalejo, Tetrahedron 2008, 
64, 4613–4618; c) I. Izquierdo, M. T. Plaza, J. A. Tamayo, M. Rodríguez, A. Martos, Tetrahedron 2006, 
62, 6006–6011. 
55
 L. Chabaud, Y. Landais, P. Renaud, Org. Lett. 2005, 7, 2587–2590. 
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hyacinthacine A1 60 and its 3-epimer, the stereocontrolled carboazidation of chiral 
allylsilane 57 with xanthate 58 provided the required carbon framework 59 (Figure 1.24). C–
Si bond oxidation and reduction of the azide, with ring-closure, completed the total 
synthesis and established the absolute configuration of (+)-hyacinthacine A1 60.
57 
 
Figure 1.24: Synthesis of (+)-hyacinthacine A1 (60), by Chabaud and co-workers. 
In the field of organometallic catalysis, of particular note in the past few years has been the 
use of RCM as an essential tool in determining the correct structure of uniflorine A. 
Following seminal work by Pyne and co-workers who eluded to differences in the 
spectroscopic data for the isolated and synthesised uniflorine A,58 a number of groups have 
sought to resolve this disparity.  
 
Figure 1.25: Proposed and revised structures of Uniflorine A. 
Dhavale and co-workers employed RCM of a D-glucose derived diene-substrate containing a 
nitrogen functionality, followed by asymmetric dihydroxylation to afford a variety of 
”uniflorine A” analogues, however all had different spectroscopic data to that of the 
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 D. Díez, M. T. Benéitez, M. J. Gil, R. F. Moro, I. S. Marcos, N. M. Garrido, P. Basabe, J. G. Urones, 
Synthesis 2005, 565–568. 
58 A. S. Davis, S. G. Pyne, B. W. Skelton, A. H. White, J. Org. Chem. 2004, 69, 3139–3143. 
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isolated material.59 In 2008, Pyne and co-workers used RCM and a stereoselective osmium- 
catalysed dihydroxylation reaction to achieve the synthesis of the 2-epimer 61 and the 1,2-
di-epimer 62 of the putative structure of uniflorine A (63) (Figure 1.25).60 From a 
comparison of the NMR spectroscopic data of uniflorine A with that of casuarine and 
known synthetic pyrrolizidine isomers, the structure of uniflorine A was thus suggested to 
be 6-epi-casuarine (64). In addition, Pyne and co-workers showed that uniflorine B is in fact 
the known alkaloid casuarine (49, Figure 1.22). 
Moreover the synthesis of another important pyrrolizidine alkaloid, the hyacinthacine A2 
(51, Figure 1.22), was accomplished by using a Cross-Methathesis (CM) reaction as key 
step.61 Dewi-Wulfing and Blechert employed CM between allylamine 65 (prepared via the 
enzymatic resolution of (±)-N-Cbz-vinylglycine) and enone 66 using the Hoveyda–Grubbs 
ruthenium catalyst (D, Figure 1.18) to obtain the (E)-alkene which was subsequently 
dihydroxylated with AD-mix-β to yield diol 67 (88% de, Figure 1.26). 
 
Figure 1. 26: Synthesis of hyacinthacine A2 (51), by Dewi-Wulfing and Blechert. 
Attempts to cyclise diol 67 were first made using a one-pot four-step procedure, however 
this resulted in low yields and the formation of side products. A sequential double reductive 
cyclisation protocol was then employed involving hydrogenation to afford 68, followed by 
treatment with HCl to cleave the dioxolane and the TBS protecting groups, which gave 
iminium salt 69. Imine 69 was further hydrogenated, and then neutralised via the addition 
of amberlite (OH– form), to give hyacinthacine A2 (51) in an overall yield of 39% for the four 
steps. 
Polyhydroxylated enantiopure cyclic nitrones derived from sugar are attractive key building 
blocks for the synthesis of pyrrolizidine alkaloids. For instance the addition of lithiated 
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 N. S. Karanjule, S. D. Markad, D. D. Dhavale, J. Org. Chem. 2006, 71, 6273–6276. 
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allene 71 to nitrone 70 furnished the oxazine 72 which was subjected to 
hydroboration/oxidation to yield 73 (Figure 1.27). Subsequently ring cleavage and 
cyclization afforded the most straightforward and high yielding total synthesis of casuarine 
reported to date (84% overall yield and six steps from nitrone 70).62 
 
Figure 1.27: Total synthesis of casuarine (49), by employing addition of lithiated allene 71 to nitrone 
70 as the key step. 
Lastly, pericyclic reactions have to be considered one of the most potent tools for the 
synthesis of polyhdroxylated bicyclic alkaloids, allowing access to a large variety of 
structures with optimal control of relative and absolute configuration of the stereogenic 
centers, with few simple and selective steps. In particular, our group achieved the synthesis 
of many different pyrrolizidine and indolizidine iminosugars by a general strategy consisting 
of a highly stereoselective 1,3-dipolar cycloaddition of polyhydroxylated nitrones, followed 
by simple transformations of the isoxazolidine adducts.63 Some examples of this 
methodology will be presented in detail in Chapter 2.1.2. 
 
Figure 1. 28: Stereocontrolled cyclic nitrone cycloaddition strategy by Goti and co-workers. 
1.6.3 Piperidine Alkaloids 
Natural occurrence: in 1966, Inouye et al. discovered the first natural polyhydroxylated 
alkaloid, nojirimycin (74, NJ, Figure 1.29).64 Isolated from a Streptomyces filtrate, it was 
shown to actively inhibit α- and β-glucosidases and was therefore the first natural glucose 
                                                          
62 C. Parmeggiani, F. Cardona, L. Giusti, H.-U. Reissig, A.Goti, Chem. Eur. J. 2013, 19, 10595–10604. 
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mimic. Nojirimycin B (75, commonly called mannonojirimycin, Figure 1.29) and galactostatin 
(76, galactonojirimicyn, Figure 1.29) were isolated soon after.65,66 However these 
iminosugars with a hydroxyl group at C-1 were found to be relatively difficult to isolate and 
handle due to their low stability.  
1-Deoxynojirimycin (1, DNJ, Figure 1.3) was first prepared by chemical synthesis from L-
sorbofuranose in 196667 and by reduction of nojirimycin in 196868 but later isolated from 
the roots of Mulberry trees69 as well as Streptomyces cultures.70 Its mannose analogue, 1-
deoxy-mannojirimycin (7, DMJ, Figure 1.5) was isolated from the seeds of the legume 
Lonchocarpus sericeus and later from the neotropical liana Omphalea diandra as well as 
from Streptomyces cultures.71 
 
Figure 1.29: Naturally occurring piperidine iminosugars. 
A further DNJ analogue is the 1,2-dideoxynojirimycin, fagomine (77, Figure 1.29). Initially 
found in the seeds of Fagopyrum escuelentum,72 it was later discovered in the leaves and 
roots of Xanthocercis zambesiaca together with other fagomine analogues and 
derivatives.73 
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In 1984, Cenci di Bello et al. extracted from the seeds of Baphia racemosa the first naturally 
occurring mimic of glucuronic acid, (2S)-carboxy-(3R,4R,5S)-trihydroxypiperidine (78, Figure 
1.29), which was found to inhibit the human liver β-D-glucuronidase and α-L-iduronidase.74 
Synthetic strategies: Since nojirimycin (74) was isolated from natural source, many 
different polyhydroxylated piperidines have been synthesized and evaluated towards 
glycosidases, in order to find compounds with higher potency and selectivity. As a 
consequence, a great number of synthetic approaches has been proposed, most of which 
employ carbohydrates as starting materials.75 Generally the conversion of a sugar into an 
iminosugars occurs through the introduction of an amino moiety and subsequent amino 
cyclization. Actually, there are quite a few combinations of reactions that can be exploited 
to reach the target molecule. Aldoses, alditols, or glyconolactones can be used as 
substrates, the nitrogen atom can be introduced variously as an amine, as a hydroxylamine, 
or as an azide, and the amino-cyclization can be performed by exploiting an intramolecular 
nucleophilic displacement, a reductive amination, an epoxide ring-opening or a nucleophilic 
attack on an activated double bond. The strategies from carbohydrates, even though very 
popular, usually lack of versatility, since the utilization of chiral pool compounds enforce to 
change starting material for each synthesis. This drawback has been overcome by 
developing methodologies which allow access to libraries of compounds, employing a 
common synthetic pathway or functionalizing a common scaffold compound in many 
different ways. The generation of libraries of molecules is particularly useful in the search 
for powerful and specific inhibitors of a selected target enzyme, since the rational design of 
inhibitors is often extremely difficult due to the limited information regarding the structure 
of enzyme active sites. The first application of this concept was reported by Lin and 
coworkers, with the preparation of a library of fuconojirimycin derivatives,76 through 
condensation of the amino group of fuconojirimycin derivative 79 (Figure 1.30) with 60 
aliphatic and aromatic carboxylic acids in a microtiter plate. 
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Figure 1.30: Generation of a library of fuconojirimycin inhibitors. 
As an alternative to classical synthesis of iminosugars from carbohydrates, many total 
synthesis from non carbohydrate, chiral and nonchiral, starting materials have been also 
reported in recent years. Malacria and coworkers77 reported the synthesis of 1-
deoxymannojirimycin (7, Figure 1.5) starting from the silylated butendiol dicarbonates 80, 
which was converted in intermediate 81, through a chemo- and stereoselective palladium-
catalysed amination (Figure 1.31). Two more steps, the conversion into the epoxyaldehyde 
83 and the subsequent intramolecular aldolization, were necessary to obtain the piperidine 
skeleton (83, major compound). Regioselective epoxide ring opening and Tamao–Flemming 
oxidation of the C-Si bond led to the protected 1-deoxymannojirimycin 84 which was then 
completely deprotected. 
 
Figure 1.31: Synthesis of 1-deoxymannojirimycin (7) hydrochloride, by Malacria and co-workers. 
Moreover, chiral synthons such as enantiomerically pure 2-(1’-amino-2’-
hydroxyalkyl)furans, are very useful tools in total synthesis. In particular, Yao and 
coworkers78 accessed piperidine derivative 90 starting from compound 86, in turn obtained 
with an efficient route from L-serine (Figure 1.32). The oxidation of furan 86 followed by 
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hemiaminal trapping afforded ketone 87 which was stereoselectively reduced to compound 
88. Then, the ethoxy group was removed, leading to the allylic alcohol 89 which was 
stereoselectively hydroxylated and deprotected to the final piperidine derivative 90. 
 
Figure 1.32: Synthesis of piperidine derivative 90, by Yao and co-workers. 
Han and coworkers reported the use of a readily available olefin (91) as valuable starting 
material for the synthesis of hydroxyl piperidines 95.79 As generally shown in Figure 1.33, a 
regioselective asymmetric aminohydroxylation (AA) reaction led to the formation of a syn-
aminoalcohol with excellent stereoselectivity (>20:1). Then the aminoalcohol 92 was 
converted to the intermediate 93 which, through an RCM reaction, afforded the key cyclic 
olefin 94 which was dihydroxylated and converted to a series of 1-deoxyiminosugars. 
 
Figure 1.33: General approach to 1-deoxyiminosugars from olefin 91, by Han and co-workers.. 
Another interesting example is the de novo synthesis of six membered-ring iminosugars 
reported by Còrdova and coworkers. The one-pot, tandem organocatalytic asymmetric 
Mannich–Wittig olefination performed on aldehyde 96, is the key step of the whole 
methodology (Figure 1.34). The subsequent diastereoselective dihydroxylation allowed 
access to compound 99, precursor of the final δ-lactam 100. Only three steps were 
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necessary in this case to access the piperidine skeleton, with a high control of the newly 
formed stereocenters. 
 
Figure 1.34: De novo synthesis by Còrdova and co-workers. 
Lastly, difluoromethylenated analogues of polyhydroxylated piperidines can be prepared to 
evaluate the influence of each hydroxyl group in the interaction with the enzyme active 
site. These structures are able to modify the binding characteristics by changing the pKa of 
the nitrogen: when the CF2 group was introduced in place of a CHOH group important for 
binding, a decrease in binding affinities was observed.80 An example for the synthesis of 
such useful compounds was reported by Qing and coworkers: starting from (R)-
glyceraldehyde acetonide 101 and 3-bromo-3,3-difluoro propene 102, the 1,4-dideoxy-4,4-
difluoro-D-mannonojirimycin 105 was obtained (Figure 1.35). 
 
Figure 1.35: Synthesis of 1,4-dideoxy-4,4-difluoro-D-mannonojirimycin 105, by Qing and co-workers. 
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1.7 Aim of the work 
Iminosugars continue to be of great synthetic interest, due to the intrinsic pharmacological 
potential of many of them and the need for more active and selective compounds. Because 
of the difficulties encountered in their synthesis, the development of novel synthetic 
approaches remains a main challenge. 
The first part of this work is aimed to investigate novel synthetic strategies for the synthesis 
of diversely functionalized analogues of iminosugars belonging to the class of pyrrolidine, 
pyrrolizidine and piperidine alkaloids. Indeed, versatile methodologies coupled with 
accessible biological screening of inhibitory activities, can provide important informations 
on the interactions with glycosidase active sites. All the presented methodologies are highly 
stereoselective and employ readily available starting materials.  
In Chapter 2, methodologies well established in our group, which employ 
polyahydroxylated cyclic nitrones as key building blocks, were exploited for the synthesis of 
novel iminosugar-based trehalose mimetics and for further nitrogen functionalization of 
natural pyrrolidine-containing alkaloids.  
In Chapter 3, a completely new synthetic route was developed for the preparation of 
diversely funtionalized trihydroxypiperidines, by employing a D-mannose derived 
dialdehyde as starting material. All the novel iminosugars compounds reported in these 
chapters were also tested on commercial glycosidases to evaluate a specific inhibitions (i.e. 
trehalase inhibitors) or to investigate the role played by different functionalization in the 
inhibitory activity.  
Finally, at the light of outstanding results recently reported in the context of multivalent 
glycosidases inhibitors, we embarked on the multimerization of some of our iminosugars 
analogues, by employing different scaffolds. In particular, the immobilization of multiple 
copies of pyrrolizidine and piperidine iminosugars on gold glyconanoparticles was reported 
in Chapter 4. 
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Chapter 2 
Synthesis of pyrrolidine-containing iminosugars: 
exploiting past experience for new 
functionalization 
2.1 Introduction 
Given the enormous therapeutic potential of iminosugars, the development of improved 
synthetic methodologies for their synthesis has become the objective of many synthetic 
chemists. In particular, among the four structural classes of iminosugars containing a five-
membered ring, pyrrolidine and pyrrolizidine alkaloids hold a prominent role.The post 2005 
developments in the synthesis of pyrrolidine containing iminosugars have been 
exhaustively reported by Timmer and co-workers in a recent Microreview, classifying the 
synthetic methodologies on the basis of their key steps.81  
Our research group contributed to the synthesis of a variety of natural iminosugars and 
related structural analogues by preparing enantiopure five-membered ring cyclic nitrones 
starting from chiral pool building blocks, such as L-malic, D- and L-tartaric acids or D- and L-
protected pentoses.  
 
Figure 2.1: Dual synthetic strategy starting from polyhydroxylated enantiomerically pure cyclic 
nitrones. 
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The cyclic nitrones themselves proved to be versatile precursors for the synthesis of both 
pyrrolidine and pyrrolizidine iminosugars (Figure 2.1). In the former case these nitrones 
have been used as susbstrate for highly diastereoselective nucleophilic additions to afford 
enantiomerically pure polyhydroxylated pyrrolidines, after reduction of the hydroxylamine 
adducts. On the other hand, nitrones have been conveniently used in 1,3-dipolar 
cycloaddition reactions with different dipolarophiles for the synthesis of bicyclic 
pyrrolizidine alkaloids of the casuarine and hyacinthacine families. 
2.1.1 Pyrrolidine Alkaloids 
The addition of different reagents to five membered enantiopure cyclic nitrones 106, 107 
and 7082,83 derived from L-malic acid and D-arabinose (Figure 2.2) has been investigate over 
the last decade, providing a straightforward approach to the synthesis of diversely 
substituted chiral pyrrolidines. 
 
Figure 2.2: Five membered cyclic nitrones 106, 107 and 70 derived from L-malic acid and D-
arabinose. 
As the starting point, C-2 epimers of 2-aminomethyl and 2-hydroxymethyl pyrrolidines were 
synthesised by the stereocontrolled addition of TMSCN or LiCH2OMOM to the nitrone 107, 
easily accessible from D-arabinose, and subjection of the resulting hydroxylamine to an 
oxidation-reduction inversion sequence.84 On the basis of these preliminary results a more 
general synthetic strategy was developed to access 2-substituted polyhydroxylated 
pyrrolidines with abundant configurational diversity.85  
                                                          
82
 a) S. Cicchi, A. Goti, A. Brandi, J. Org. Chem. 1995, 60, 4743–4748; b) R. Saladino, V. Neri, 
F.Cardona, A. Goti, Adv. Synth.Catal. 2004, 346, 639–647. 
83
 a) S. Cicchi, M. Marradi, P. Vogel, A. Goti, J. Org. Chem. 2006, 71, 1614–1619; b) F. Cardona, E. 
Faggi, F. Liguori, M. Cacciarini, A. Goti, Tetrahedron Lett. 2003, 44, 2315–2318. 
84
 M. Marradi, S. Cicchi, J. Ignacio Delso, L. Rosi, T. Tejero, P. Merino, A. Goti, Tetrahedron Lett. 2005, 
46, 1287–1290. 
85
 P. Merino, I. Delso, T. Tejero, F. Cardona, M. Marradi, E. Faggi, C. Parmeggiani, A. Goti, Eur. J.Org. 
Chem. 2008, 17, 2929–2947. 
Chapter 2 
 39   
 
 
Figure 2.3: Synthetic strategy for the synthesis of polyhydroxylated pyrolidines 
The adopted methodology, based on an oxidation/reduction protocol involving 
hydroxylamine/nitrone pairs (Figure 2.3) allowed access to DMDP, 6-deoxy-DMDP, DAB-1, 
CYB-3, nectrisine and radicamine B (Figure 2.4). 
 
Figure 2.4: Synthesis of natural polyhyroxylateted pyrrolidine alkaloids from nitrone 70. 
Several analogues of these compounds with inverted configuration at one or more 
stereocenters were also prepared, demonstrating the use of reagent- and substrate-derived 
stereocontrol. 
2.1.2 Pyrrolizidine Alkaloids 
As depicted in Figure 2.5, nitrone 70 has also the correct stereochemistry of ring A of many 
natural pyrrolizidine alkaloids and could be easily prepared in four steps starting from D-
arabinose. For this reason our group has employed this compound as starting material for 
the total synthesis of casuarine (49), hyacinthacine A2 (51), (-)-uniflorine A (64) and their 
structural analogues, through the 1,3-dipolar cycloaddition strategy. 
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Figure 2.5: Synthesis of natural polyhyroxylateted pyrrolizidine alkaloids from nitrone 70. 
The general synthetic strategy followed for the synthesis of the these pyrrolizidine alkaloids 
is outlined in Figure 2.6. We took advantage of a stereocontrolled cyclic nitrone 
cycloaddition strategy63 employing polyfunctionalized nitrone 70 and suitable (Z)-
configurated dipolarophiles 108, that afforded isoxazolidine adducts readily converted into 
pyrrolizidinone derivatives 110 by reductive ring opening/cyclization. Intermediates 110 
bear a free hydroxyl group on C-6 of the pyrrolizidine ring, thus allowing selective 
glucosylation in this position. A good choice of the dipolarophile is crucial for the success of 
the strategy. 
 
Figure 2.6: Synthetic strategy for the synthesis of pyrrolizidines 
The most preferred approach of alkenes to nitrone 70 occurs through exo-anti transition 
states (Figure 2.7). 
Indeed, the stereoselectivity of the cycloaddition is in general controlled by the C-3 
stereocenter of the five-membered nitrone. An approach of the dipolarophile anti to the 
alkoxy group at C-3 is by far the most preferred at the transition state over the other 
possible syn approach. The extent of diastereoselectivity is accordingly influenced by the 
bulkiness of the alkoxy group. The exo approach of the dipolarophile is also the preferred 
pathway; the ratio again depends on the bulkiness and nature of the protecting group.  
The characteristic feature of the process is the transfer of stereochemical information from 
the nitrone stereocenter to the newly formed stereocenters in the cycloadduct, with the 
bridgehead H assuming a cis-relationship with respect to the vicinal alkoxy group. 
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Figure 2.7: Favorite transition state of cycloaddition 
In the case of nitrone 70, the substituents at C-3 and C-5 allow to obtain exclusively anti 
cycloadducts and the steric bulk of substituent at C-4 ensures an excellent exo selectivity. 
The complete stereoselectivity of the 1,3-dipolar cycloaddition, which allowed the selective 
installation of the three new stereocenters (corresponding to C-6, C-7 and C-7a in the target 
molecules) in one step with the required configuration, may be ascribed to the peculiar all-
trans disposition of the benzyloxy groups in nitrone 70, which hampered any endo or syn 
approaches.83b,86 
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The 1,3-dipolar cycloaddition of nitrone 70 to dimethylacryl amide 111 was the first key-
step for the synthesis of hyacintacine A2 (51) and 7-deoxycasuarine 114 (Figure 2.8).
83b,87 
The cycloaddition reaction gave regio- and stereo-selectively isoxazolidine 112 in very good 
yield and the subsequent N-O bond cleavage afforded lactam 113, which was then 
converted into 7-deoxycasuarine 114, through reduction and catalytic hydrogenation. 
 
Figure 2.8: Synthesis of 7-deoxycasuarine (114) and hyacintacine A2 (51). 
Deoxygenation at C-6, necessary to afford hyacinthacine A2 (51), was obtained by 
mesylation of intermediate 113 followed by treatment of mesylate 115 with LiAlH4 in 
refluxing THF. Finally catalytic hydrogenation allowed access to natural hyacinthacine A2. 
The same methodology, with the introduction of a further hydroxy group at C-7, allowed an 
efficient synthesis of casuarine and its 6-O-α-D-glucoside 21. In this case, in order to obtain 
the proper regioselectivity, dipolarophile 116 was chosen for the cycloaddition reaction 
(Figure 2.9).87,88 The 1,3 dipolar cycloaddition reaction of 70 with acrylate 116 provided the 
isoxazolidine 117 with complete stereoselectivity and excellent regioselectivity. Reduction 
of the alkoxyamine in 117 led to spontaneous cyclisation into lactam 118. Finally, oxidative 
cleavage of the silane and reduction of the carbonyl gave diol 120, which, following 
deprotection, yielded casuarine (49). The binding of casuarine and casuarine 6-O-α-D-
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glucoside 21 to glucoamylase NtMGAM and trehalase Tre37A, respectively, was then 
investigated and revealed interesting similarities in the catalytic sites of these two 
enzymes.88 
 
Figure 2.9: Synthesis of casuarine (49). 
By manipulating isoxazolidine 117 in a different way, the total synthesis of (-)-uniflorine A 
(64) was also attained,89 providing evidence that (-)-uniflorine A is 6-epicasuarine, as 
previously proposed by Pyne and co-workers.58 
In this case, the synthesis proceeded via inversion of configuration of the OH group at C-6 
achieved through a Mitsunobu reaction with benzoic acid on the key intermediate 121 
(Figure 2.10), previously synthesized by in situ protection and Tamao-Fleming reaction on 
isoxazolidine 117.  
 
Figure 2.10: Synthesis of (-)-uniflorine A (64). 
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More recently, the total synthesis of natural (+)-hyacinthacine A1 124, (+)-7a-epi 
hyacinthacine A1 125 and their 6-hydroxy analogues was achieved
90 using the same nitrone 
cycloaddition strategy, but employing the parent D-ribose-derived cyclic nitrone 12691 as 
the dipole and tert-butyl acrylate 127 as the dipolarophile. 
 
Figure 2. 11: Nitrone 126 as the key building block for the synthesis of (+)-hyacinthacine A1 (124) and 
7a-epi-hyacinthacine A1(125). 
All the reported examples highlight how the success of our strategies mainly depends on a 
practical access to enantiomerically pure nitrones, whose synthesis remains one of the 
primary goals of our group. The most widely used nitrone 70 has been obtained through N-
alkylation of the tribenzyl D-arabinose derived oxime, with a double inversion of 
configuration (Figure 2.12). 
 
Figure 2. 12: Synthesis of nitrone 70, starting from tribenzyl D-arabinose 
Although this strategy resulted very efficient and versatile (parent nitrones, such as 126 
could be obtained by employing different starting sugar derivatives), many other methods 
for the synthesis of polyfunctionalized nitrones are described in the literature.86a Among 
them, oxidative methods have recently received a renovated interest in order to develop 
environmentally friendly synthetic strategies, which avoid the use of toxic oxidants and 
prefer metal-catalyzed processes in which O2 or air are used as oxidants and the catalyst 
could be recovered and reused.  
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In this context we envisaged in hypervalent iodine(V) reagents, extensively used for the 
oxidation of alcohols, potentially good candidates to develop a metal-free oxidation 
strategy to obtain nitrones from hydroxylamines, in a regio- and stereoselective manner. 
2.2 Synthesis of nitrones through metal-free oxidation of 
hydroxylamines with hypervalent iodine reagents.  
Cyclic hypervalent iodine reagents (Figure 2.13), such as Dess-Martin periodinane (DMP), 2-
iodoxybenzoic acid (IBX) and diacetoxyiodobenzene (DIB) have broad applications in a 
number of oxidation processes.92 However, to the best of our knowledge, the use of cyclic 
hypervalent iodine reagents for the synthesis of nitrones has no precedent in the literature.  
 
Figure 2.13: Structures of hypervalent iodine reagents employed in our study. Dess-Martin 
periodinane (DMP) and 2-iodobenzoic acid (IBX) belong to iodine (V) compounds while 
diacetoxyiodobenzene (DIB) is a iodine (III) compound. 
As a first attempt we studied the feasibility of the oxidation of commercial or readily 
available symmetric hydroxylamines, by screening the three different reagents reported in 
Figure 2.13. Since 1991,93 DMP has emerged as the reagent of choice for the oxidation of 
primary and secondary alcohols to aldehydes and ketones, respectively. The mild reaction 
conditions (room temperature and neutral pH), high chemoselectivity, and convenience of 
use have made this reagent especially suitable for the oxidation of substrates containing 
sensitive functional groups.94 Moreover an example of oxidation of hydroxamic acids, N-
hydroxyureas and N-hydroxycarbamates with the Dess-Martin periodinane to generate the 
corresponding acyl nitroso compounds has been reported.95  
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Although synthesized by Hartmann and Meyer96 more than 100 years ago, IBX has attracted 
increasing interest as mild and selective oxidizing reagent only in recent years. The 
synthetic applications of IBX have been summarized in an excellent review by Duschek and 
Kirsch,97 where the great versatility of this reagent was underlined. In particular, the 
oxidation of two hydroxylamines to the corresponding oximes, reported by Nicolaou and 
co-workers98 resulted of great interest to our purpose. 
Despite its low reactivity towards alcohols,92b we decided to include also DIB in our study 
since it resulted much more accessible (ten times cheaper respect to IBX) and stable than 
DMP and IBX. 
The following general procedure was followed for the oxidation reactions in order to 
compare the effectiveness of the three reagents: the hydroxylamine was treated with 1.5 
equivalents of oxidation reagent in dry dichloromethane (0.09 M) at room temperature for 
two hours. The results with hydroxylamines 128-130 are reported in Table 2.1. 
 
Entry Substrates Nitrone yield %[a] 
DMP IBX DIB 
1 
 
 
67% 96%[b] 77% 
2 
 
 
75% 88% 79% 
3 
 
 
71% 96% 72% 
Table 2.1: [a] Isolated yield after flash column chromatography; [b] Yield of the crude, >95% purity as 
evaluated by 
1
H NMR spectroscopy. 
The reaction mixture was subsequently washed several times with a saturated solution of 
Na2CO3 and the crude nitrones purified by flash chromatography. These preliminary data, 
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summarized in Table 2.1, proved that cyclic hypervalent iodine reagents are able to oxidize 
hydroxylamines to nitrones with very good to excellent yields. The best results have been 
obtained with IBX, which in a particular case (Table 2.1 entry 1) allowed to access the 
corresponding nitrone in 96% yield after basic quench, without any further purification. 
Interestingly, DIB provided similar or even better results with respect to DMP, suggesting 
that the more accessible DIB could be easily employed for routinary oxidations. 
These encouraging results prompted us to test the protocol on more complex and 
challenging non symmetric substrates, in order to evaluate the regioselectivity of the 
reaction for the three different oxidation agents. The chiral hydroxylamine 132 was thus 
synthesized starting from D-mannose derivative 131 (Scheme 2.1), modifying the protocol 
usually employed in our group,99 to avoid the use of pyridine as solvent. Under these 
cleaner conditions, the desired hydroxylamine was obtained with a higher yield (96% vs 
73%) and purification by flash column chromatography resulted unnecessary. The following 
oxidation to nitrone, occurred cleanly and with excellent yield only with IBX. The oxidation 
reaction with DIB and DMP, although the formation of the less favored nitrones was not 
observed, afforded nitrone 133 with lower yields after column chromatography purification 
(Scheme 2.1). 
 
Scheme 2.1: Synthesis of chiral hydroxylamine zb5 and subsequent oxidation with hypervalent 
iodine reagents DMP, IBX and DIB. Reagents and conditions: a) BnNH2OH
.
HCl, Na2SO4, NEt3, CH2Cl2, 
rt, 3 days, 96%; b) oxidant (1.5 equiv.), CH2Cl2, rt, 2h. 
We then extended our study to a panel of non symmetric hydroxylamines, available in our 
laboratory for different applications, ie, cyclic hydroxylamines 134-136 derived from 
tribenzyl pentoses, which possess the configuration of D-xylose, D-ribose and D-arabinose, 
respectively. With these hydroxylamines, the formation of aldo-nitrones a should be 
favored by statistic and steric effects; on the other hand, formation of keto-nitrones b 
should be favored on a thermodynamic ground. The results obtained with IBX (Table 2.2) 
agree with the theoretical prediction based on steric considerations in all of three cases, 
since the reactions afforded selectively aldo-nitrones a in very good yields. In particular 
                                                          
99
 S. Cicchi, M. Marradi, M. Corsi, C. Faggi, A. Goti, Eur. J. Org. Chem. 2003, 4152-4160. 
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with hydroxylamine 135 (Table 2.2, entry 2), the oxidation occurred in a completely 
regioselective manner and only the nitrone a was observed.  
 
Entry Substrates 
a : b ratio 
(total yield %) 
DMP IBXa) DIB 
1 
 
 
< 5 : 95 b) 
(8%) 
6 : 1c) 
(100%) 
3.5: 1b) 
(36%) 
2 
 
 
2 : 1 
(42%) 
 
> 95 : 5 c) 
(94%) 
 
1.1 : 1 b) 
(38%) 
3 
 
 
1 : 1 c) 
(35%) 
5 : 1 c) 
(89%) 
1 : 1.2 c) 
(44%)  
Table 2.2: a) Yield of the crude, > 95% purity as evaluated by 
1
H NMR spectroscopy; b) a:b ratio 
determined on the basis of isolated yields after flash column chromatography; c) a:b ratio 
determined by 
1
H NMR spectroscopic analysis of the crude mixture.  
Conversely, both DMP and DIB have proved to be poorly regio- and chemo-selective 
reagents for oxidation of this hydroxylamine class: almost equal mixture of aldo- and keto-
nitrones and very low yields were generally observed. Moreover, in case of compound 134 
(Table 2.2, entry 1) a completely inverted selectivity was observed for DMP with respect to 
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IBX and DIB, since only keto-nitrone b was isolated, however only in 8% yield. An attempt to 
increase the selectivity in the oxidation of 136, performing the reaction at -20 °C and slowly 
raising the temperature to 10 °C during 2 hours, was unsuccessful, since these conditions 
affected negatively both the conversion and the regioisomeric ratio, leading to only 33% 
conversion and 4.2:1 a:b ratio. 
These preliminary results show that IBX is a superior reagent among the screened 
hypervalent iodine reagents, and can be efficiently employed for the regioselective 
oxidation of non symmetric hydroxylamines. 
Entry Substrate Products ratio yield 
1 
            
3.7 : 1 92% 
2 
            
6 : 1 38% 
4 
      
1 : 4.4 100% 
5 
       
1 : 4.2 91% 
6 
   
1 : 1 100% 
7 
   
69 : 1 
73% 
Table 2.3: Preliminary results for the oxidation of different hydroxylamines with IBX. For reaction 
conditions see Table 2.2. 
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For this reason, other hydroxylamines, differently substituted, cyclic and acyclic, have been 
prepared in our laboratories and evaluated as substrates for the oxidation with IBX. We 
carried out the oxidation of different hydroxylamines, as reported in Table 2.3, with IBX 
under the optimal conditions (room temperature, 2 h). The regioisomeric ratios and yields 
were determined by 1H NMR spectroscopic analysis of the crude mixtures. The selectivity of 
oxidation strongly depends on the substituents position. Selectivity among differently 
substituted methylene groups in acyclic hydroxylamines is null (entry 6). In case of 3-alkoxy 
substituted N-hydroxypyrrolidines (entries 1 and 2) the abstraction of the vicinal proton is 
favored, but selectivity is significantly lower compared to other oxidants, such as MnO2. 
However, when a further substituent is present in the α-position the aldo-nitrone is the 
major product, independently on the steric hindrance and the electronic effects of the 
substituent (entry 4 vs entry 5). Remarkably, with substrate in entry 5 we found a good 
enhancement of the selectivity with respect to the use of MnO2, previously reported for the 
oxidation of the same substrate.100 Magnification of this effect was obtained with the 
acyclic hydroxylamine in entry 7, which gave an impressive 69:1 selectivity in favor of the 
less hindered aldo-nitrone. These preliminary results demonstrate the potential of 
polyvalent iodine reagents to replace toxic transition metal reagents for this 
transformation, an hot topic in synthesis which is continuing to generate enormous 
interest. 
2.3 Synthesis of novel iminosugar-based trehalase inhibitors by cross 
metathesis reactions 
Following our ongoing interest in the synthesis of trehalase inhibitors for agrochemical 
applications and due to the reported activity against trehalases of some pyrrolidine 
iminosugars such as DAB-1 (5), we envisaged the possibility to synthesize novel trehalase 
inhibitors containing pyrrolidine iminosugars derived from cyclic nitrones 70 and 126. As 
briefly described in Chapter 1, being trehalose a disaccharide, the most potent trehalase 
inhibitors reported to date are pseudodisaccharides. Thus, in order to mimic the 
disaccharidic structure, two iminosugars units could be linked by a short and flexible alkyl 
bridge. In particular, the Grubbs Ru-carbene-catalyzed cross-metathesis (CM) reaction101 
                                                          
100
 A. Goti, S. Cicchi, V. Mannucci, F. Cardona, F. Guarna, P. Merino, T Tejero, Org. Lett. 2003, 5, 4235-
4238. 
101
 See, for examples: a) D. V. Jarikote, P. V. Murphy, Eur. J. Org. Chem. 2010, 4959–4970; b) R. H. 
Grubbs, Tetrahedron 2004, 60, 7117–7140. 
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was used to connect the two moieties suitably functionalised with a double bond as 
outlined in the retrosynthetic scheme (Scheme 2.2).102 
 
Scheme 2.2: Retrosynthetic scheme for the synthesis of trehalase inhibitors. 
Two different allyl-iminofuranoses were synthesised and used for the CM reaction (Scheme 
2.3), possessing a 1,4-dideoxy-1,4-imino-D-arabinitol or a 1,4-dideoxy-1,4-imino-D-ribitol 
core, respectively, and with the endocyclic nitrogen atom protected as a carbamate.  
 
Scheme 2.3: Synthesis of the pyrrolidine scaffolds. Reagents and conditions: a) CbzCl, H2O/dioxane, 
NaHCO3, rt, 16 h, 80%; b) Allylmagnesium bromide, THF, 0 °C, 3h, quant. yield; c) Zn, AcOH/H2O, rt, 
40 min., 80%; d) CbzCl, H2O/dioxane, NaHCO3, rt, 20 h, 79%. 
                                                          
102
 D. Bini, M. Forcella, L. Cipolla, P. Fusi, C. Matassini and F. Cardona Eur. J. Org. Chem., 2011, 3995-
4000. 
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The synthesis of the α-C-allyl iminoarabinofuranosyl derivative 143 (Scheme 2.3A) 
proceeded via Grignard addition to nitrone 70, as recently described.103 Final 
carbamoylation of intermediate 145 by Cbz-chloride in water/dioxane104 afforded 143 
(80%).103 On the contrary, the synthesis of the β-C-allyl iminoribofuranosyl derivative, which 
had not precedents in literature, was obtained starting from nitrone 126,91 as illustrated in 
Scheme 2.3B. The Grignard reaction on nitrone 126 occurred with total stereoselectively 
and only the anti isomer was formed, according to the expected stereochemical outcome; 
reduction of hydroxylamine 146 to the corresponding amine 147, followed by 
carbamoylation afforded the β-C-allyl iminoribofuranosyl derivative 144 suitable to be 
employed in the CM reaction. The two scaffolds were then used for homodimerisation and 
heterodimerisation reaction by CM, as outlined in Scheme 2.4.  
 
Scheme 2.4: Dimerisation of pyrrolidine structures by cross-metathesis. Reagents and conditions: a) 
Hoveyda-Grubbs Catalyst 2
nd
 Generation, DCM, rt, overnight; b) Pd(OH)2/C, H2, EtOAc/EtOH 1:1. 
The cross metathesis reactions were performed in anhydrous CH2Cl2 at room temperature, 
employing Grubbs 1,3-dimesityl-4,5-dihydroimidazol-2-ylideneruthenium carbene 
(Hoveyda-Grubbs Catalyst 2nd Generation, 5% in weight) and afforded dimers 140, 141 and 
                                                          
103
 I. Delso, T. Tejero, A. Goti, P. Merino, Tetrahedron 2010, 66, 1220-1227. 
104
 F. Sladojevich, A. Trabocchi, A. Guarna, Org. Biomol. Chem. 2008, 6, 3328-3333. 
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142 in 54%, 42% and 12% yields, respectively. Actually, the lower yield of 
heterodimerisation was expected due to the typical formation of homodimerization and 
starting material by-products. Finally, hydrogenolysis afforded deprotected compounds 
137, 138 and 139.  
Thanks to a collaboration with Prof. Laura Cipolla group (University of Milan-Bicocca), we 
had the opportunity to synthesize also the corresponding iminopiranose homodimer with a 
nojirimycin core (149, Scheme 2.5A), by following the same protocol. Moreover, in order to 
assess the relevance of the nitrogen atom in the inhibition assays with iminosugar-based 
trehalase inhibitors, the homodimer of the α-C-allyl glucoside 152 and the heterodimer 
containing one nojirimycin unit and one glucose unit 153 were synthesised (Scheme 2.5B). 
 
Scheme 2.5: A) Homodimerization of nojirimycin derivative. B) Homo and heterodimerization of 
glucose derivative. Reagents and conditions: a) Hoveyda-Grubbs Catalyst 2
nd
 Generation, DCM, rt, 
overnight; b) Pd(OH)2/C, H2, EtOAc/EtOH 1:1. 
All the deprotected compounds (i.e. 137-139, 149, 152, 153,) were tested for their 
inhibitory activity against porcine trehalase. To examine the potential of each member of 
the library as trehalase inhibitor, preliminary screening assays at a fixed concentration (1 
mM) of potential inhibitors was carried out, and dose-response curves were established for 
most active compounds in order to determine the Ki values. Experiments were performed 
at fixed substrate concentration, close to the Km value (2.5 mM), in the presence of 
increasing inhibitor concentrations. The inhibitory activity is shown as a percentage at the 
fixed concentration in Figure 2.14. 
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Compound 149, that is a nojirimycin dimer, resulted to be the most active derivative of the 
series, showing a Ki = 44 µM. At 1 mM concentration compounds 137 ,138, 139 and 153 
showed, 14%, 28%, 43% and 25%of inhibition, respectively, with respect to the control in 
the absence of inhibitor. On the other hand, reference glucose dimer 152 did not show any 
inhibition at 1 mM concentration. 
 
Figure 2.14: Inhibition data of the synthesised compounds 137, 138, 139, 149 and 153 against 
porcine trehalase observed at 1 mM inhibitor concentration.  
2.4 Functionalization of pyrrolidine-containing iminosugars for the 
construction of multivalent systems 
The concept of multivalency, essentially unexplored concerning specific glycosidase 
inhibition using iminosugar as glycomimetics up to 2010, has recently received a newly born 
interest from the scientific community (see Chapter 4.1 for a more detailed discussion). The 
ensemble of reported results highlights the importance of building new and diversified 
multivalent iminosugars in the search for more selective glycosidase inhibitors. Following 
our interest in this field, we have recently started exploring the multimerization of our 
biologically active iminosugars by employing as scaffolds both dendrmeric alkynes and gold 
nanoparticles.In the former case the functionalization of imosugars with an azido moiety 
was required to perform CuI-catalyzed azide-alkyne cycloadditions (CuAAC), while in the 
second case the presence of an amino group was necessary for further functionalization 
with suitable linkers in order to attach the molecules to gold nanoparticles. We reasoned 
that the best strategy to pursue was the synthesis of azido derivatives, which in turn could 
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be converted into the corresponding amino derivatives, through a simple reduction 
reaction (Figure 2.15). 
 
Figure 2.15: Synthetic strategy for preparation of multivalent iminosugar inhibitors, by employing 
alkyne or gold nanoparticles scaffolds. 
A pyrrolidine N-alkyl analogue of DAB-1 and a pyrrolizidine analogue of casuarine have 
been selected as peripheral ligands for the construction of multivalent structures. Their 
functionalization with azido and amino moieties are reported hereafter. 
2.4.1 Pyrrolidine derivatives 
Compared to the parent iminosugars, the N-alkylated structures tend to exhibit better 
biological activities in vivo, partially due to the improvement of lipophilicity of the 
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compounds, and sometimes because the alkylated chains contribute additional binding to 
the pocket of the receptor.105 Indeed the N-octyl analogue of DAB-1, whose synthesis has 
been recently reported by our group,106 resulted to inhibit (Figure 2.16) not only 
commercial α-glucosidases but also human α-mannosidase, the most promising target to 
evaluate the multivalent effect in glycosidase inhibition.  
 
Figure 2.16: Inhibition data of N-octyl-DAB1 against commercial and human glycosidases observed at 
1 mM inhibitor concentration. 
According to these preliminary results, we decided to functionalize DAB-1, by introducing 
the azido moiety at the end of the N-alkyl chain. In particular, the N-6-azidohexyl derivative 
of DAB-1 156 has been prepared starting from nitrone 70 (Scheme 2.6). The conversion of 
nitrone 70 into corresponding protected amine was achieved through a stepwise reduction 
with LiAlH4, followed by treatment with Zn in acetic acid. The crude compound 154 resulted 
pure enough to be employed in the following step without any further purification. The 
alkylation reaction with 1-azido-6-bromohexane107 155 was performed in a MW reactor at 
150° for 4h, since complete conversion of the starting material was not observed at room 
temperature. Under these conditions compound 156 was obtained in 86% yield after flash 
column chromatography and employed in the synthesis of tri- and tetravalent compounds 
through click reactions with dendrimeric alkyne scaffolds.108 The simple catalytic 
hydrogenation of compound 156 allowed access to amino derivative 157, which has 
                                                          
105
 Wang G.-N., L. Yang, L.-H. Zhang, X.-S.-Ye, J. Org. Chem. 2011, 76, 2001-2009.  
106
 D. Bini, F. Cardona, M. Forcella, C. Parmeggiani, P. Parenti, F. Nicotra, L. Cipolla, Beilstein J. Org. 
Chem. 2012, 8, 514-521. 
107
 F, Coutrot, E. Busseron, Chem. Eur. J. 2009, 15, 5186-5190. 
108
 F. Cardona, G. D’Adamio, C. Matassini, A. Goti, “Synthesis of multivalent iminosugars”, 26
th
 
International Carbohydrate Symposium, ICS, Madrid, July 22
nd
-27
th
 2012. 
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subsequently been coupled with a suitable thiol-ending linker for further multimerization 
on gold nanoparticle scaffolds (see Chapter 4.2). 
 
 
Scheme 2.6: Synthesis of the pyrrolidine derivatives 156 and 157. Reagents and conditions: a) LiAlH4, 
dry THF, 0° C to reflux, 1.5 h, b) Zn, AcOH/H2O, rt, 2 h, 79% over two steps; c) K2CO3, CH3CN, MW, 
150° C, 2h, 86% d) Pd/C, H2, MeOH, HCl, rt, 3 days then DOWEX 50WX8, 65%. 
2.4.2 Pyrrolizidine derivatives 
The azide “casuarine-like” key intermediates 159 was obtained exploiting the cyclic 
polyhydroxylated nitrone cycloaddition chemistry of nitrone 70,63 previously presented in 
Chapter 2.1.2 (Figure 2.8).  
 
Scheme 2.7: Synthesis of the pyrrolizidine derivatives 159 and 160. Reagents and conditions:a) 
CH2Cl2, rt, 3 d, 78%; b) DPPA (1.3 equiv.), PPh3 (1.1 equiv.), DIAD (1.1 equiv), dry THF, rt, 2 h, 87%; c) 
H2, Pd/C, MeOH, HCl, rt 1 day, then Dowex 50WX8-200, quant. yield.  
Briefly, cycloaddition of D-arabinose derived nitrone 70 to N,N-dimethylacrylamide 111 
afforded isoxazolidine 11283b,87 with 78% yield. This compound, after N-O bond cleavage 
with Zn in acetic acid and reduction of the C=O bond with LiAlH4 in THF afforded compound 
15887 with a 77% overall yield. Straightforward introduction of the azido group was 
achieved by direct Mitsunobu reaction of 158 with 1.3 equivalents of diphenylphosphoryl 
azide (DPPA) in the presence of 1.1 equiv. of PPh3 and diisopropyl azodicarboxylate (DIAD) 
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at room temperature in dry THF,109 which furnished the 6-azido intermediate 159 in 87% 
yield (Scheme 2.7). Confirmation of the occurred inversion of configuration at C-6 was given 
by 1D NOESY correlations between H-6 and H-1 and between H-6 and H-3 observed for 
compound 159. The “casuarine like” azide 159 has been used in the CuAAC cycloaddition 
with different alkyne scaffolds for the synthesis of the first examples of multivalent 
pyrrolizidine iminosugars.110 Catalytic hydrogenation in acidic MeOH followed by basic 
treatment furnished (6S)-6-aminohyacinthacine A2 160 in quantitative yield (Scheme 2.7), 
subsequently incorporated onto gold nanoparticles (see Chapter 4.2). 
Thanks to a collaboration with the group of Prof. I. Robina (University of Seville), the amino 
derivatives 157 and 160 were assayed toward a panel of eleven commercially available 
glycosidases (Table 2.4).  
ENZYME 157 160 
α-L-fucosidase EC 3.2.1.51 
1-bovine kidney 
n.i. n.i. 
α-galactosidase EC 3.2.1.22 
2-coffee beans 
n.i. n.i. 
-galactosidase EC 3.2.1.23 
5-Escherichia coli 
8-Aspergillus orizae 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
-glucosidase EC 3.2.1.20 
10-yeast  
11-rice 
 
78 
18 
 
n.i. 
n.i. 
amyloglucosidase EC 3.2.1.3  
13-Aspergillus niger 
98 (12.9 M)  
Ki =6.5 M 
98 (15.3 M) 
Ki=18.2 M 
-glucosidase EC 3.2.1.21 
15-almonds 
n.i. 24 
-mannosidase EC 3.2.1.24 
16-jack beans 
74 n.i. 
-mannosidase EC 3.2.1.25 
18-snail
n.i. n.i. 
-N-acetylglucosaminidase EC 3.2.1.30 
21-jack beans
n.i. 44 
Table 2.4: Inhibitory activities of compounds 157 and 160 toward glycosidases. Percentage of 
inhibition at 1 mM, IC50 (in parenthesis, M). Optimal pH, 35°. 
a)
 For conditions of measurements see 
Ref.
111
; 
b)
 n.i.: no inhibition was detected at 1 mM concentration of the corresponding compound. 
                                                          
109
 K. Kamikawa, T. Watanabe, A. Daimon, M. Uemura, Tetrahedron 2000, 556, 2325-2337. 
110
 A. Goti, F. Cardona et al., Manuscript in preparation. 
111
 a) R. Saul, J. P. Chambers, R. J. Molyneux and A. D. Elbein, Arch. Biochem. Biophys. 1983, 221, 593-
597; b) A. Brandi, S. Cicchi, F. M. Cordero, R. Frignoli, A. Goti, S. Picasso and P. Vogel, J. Org. Chem. 
1995, 60, 6806-6812. 
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Both compounds showed to be potent and competitive inhibitors of amyloglucosidase from 
Aspergillus niger, with IC50 values in the µM range. Compound 157 also modestly inhibits α-
glucosidases from yeast (78% at 1mM) and α-mannosidase from  jack beans (74% at 1mM). 
While compound 160 inhibits, although to a lesser extent, β-glucosidase from almonds and 
β-N-acetylglucosaminidase from jack beans (24% and 44% at 1mM, respectively).  
2.5 Conclusions 
In this chapter different applications related to the use of polyhydroxylated cyclic nitrones 
in the synthesis of pyrrolidine-containing iminosugars have been reported. First of all, a 
reactivity study aimed to obtained these key intermediates via hydroxylamine oxidation 
with iodine hypervalent reagents was presented. Then, we described the synthesis of 
iminosugar-based trehalase inhibitors possessing a pseudodisaccharidic structure, obtained 
by cross-metathesis reactions between suitably functionalized pyrrolidine iminosugars. 
Final dimeric structures were preliminarily assayed for their activity against porcine 
trehalase. Lastly, the functionalization with azido and amino moieties was carried out on 
two different polyhyroxilated alkaloids: a N-alkyl derivative of DAB1 and a casuarine 
analogue. These modified compounds have been subsequently employed as active 
components in the preparation of gold glyconanparticles (see Chapter 4). 
2.6 Experimental Section 
General methods: Commercial reagents were used as received. All reactions were carried 
out under magnetic stirring and monitored by TLC on 0.25 mm silica gel plates (Merck 
F254). Column chromatographies were carried out on Silica Gel 60 (32-
gel (230–400 mesh, Merck). Yields refer to spectroscopically and analytically pure 
compounds unless otherwise stated. 1H NMR spectra were recorded on a Varian Mercury-
400 or on a Varian INOVA 400 instruments at 25 °C. 13C NMR spectra were recorded on a 
Varian Gemini-200 or on a Varian Gemini-300. Chemical shifts are reported relative to TMS 
(1H: δ=0.00 ppm) and CDCl3 (13C: δ=77.0 ppm). Integrals are in accordance with 
assignments, coupling constants are given in Hz. For detailed peak assignments 2D spectra 
were measured (COSY, HSQC, NOESY, and NOE as necessary). Small scale microwave-
assisted syntheses were carried out in a Microwave apparatus for synthesis CEM Discover 
with an open reaction vessel and external surface sensor. IR spectra were recorded with a 
BX FT-IR Perkin–Elmer System spectrophotometer. Mass spectra were recorded with a 
System Applied Biosystems MDS SCIEX instrument (Q TRAP, LC–MS–MS, turbon ion spray) 
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or with a System Applied Biosystem MDS SCIEX instrument (Q STAR elite nanospray). ESI-
MS spectra were recorded with a Thermo Scientific™ LCQ Fleet Ion Trap Mass 
Spectrometer. Elemental analyses were performed with a Perkin-Elmer 2400 analyzer. 
Optical rotation measurements were performed on a JASCO DIP-370 polarimeter. 
General Procedure for the Cross-Metathesis Reaction: To a 0.1 m solution of the 
appropriate allyl monomers in anhydrous CH2Cl2 was added the Grubbs catalyst (5% in 
weight). The mixture was stirred overnight at room temperature and concentrated. The 
residue was purified directly on a silica gel column using a suitable eluent. All the products 
obtained by CM were the (E) isomers (>95% as determined by NMR). 
General Procedure for the Hydrogenolysis Reaction: A 0.02 m solution of the appropriate 
dimer dissolved in AcOEt/EtOH (1:1) was treated with Pd(OH)2/C (100% in weight). The 
reaction was stirred for 5 d under a H2 atmosphere. Palladium was then removed by 
filtration through a Celite pad followed by washing with EtOH and water. Evaporation of the 
solvents afforded the corresponding deprotected compounds in quantitative yields. 
Homodimer 137: 1H NMR (D2O): δ = 4.19–3.05 (m, 12 H, 1-H, 2-H, 3-H, 4-H, 5-H), 1.88–1.58 
(m, 4 H, CH-CH2-CH2), 1.48–1.27 ppm (m, 4 H, CH2-CH2-CH2-CH2); 
13C NMR (D2O): δ = 79.1, 
73.7 (C-2, C-3), 64.9, 64.0 (C-1, C-4), 60.6 (C-5), 27.4 (CH-CH2-CH2), 26.5 ppm (CH2-CH2-CH2-
CH2); C14H28N2O6 (320.39): calcd. C 52.48, H 8.81, N 8.74; found C 52.41, H 8.80, N 8.75. 
Homodimer 138: 1H NMR (D2O): δ = 4.30–3.17 (m, 12 H, 1-H, 2- H, 3-H, 4-H, 5-H), 1.80–1.49 
(m, 4 H, CH-CH2-CH2), 1.47–1.26 ppm (m, 4 H, CH2-CH2-CH2-CH2); 
13C NMR (D2O): δ = 75.8, 
73.0 (C-2, C-3), 65.2, 62.9 (C-1, C-4), 59.9 (C-5), 32.2 (CH-CH2-CH2), 27.8 ppm (CH2-CH2-CH2-
CH2); C14H28N2O6 (320.39): calcd. C 52.48, H 8.81, N 8.74; found C 52.43, H 8.80, N 8.73. 
Heterodimer 139: 1H NMR (D2O): δ = 4.17–3.19 (m, 12 H, 1-H, 2-H, 3-H, 4-H, 5-H), 1.82–1.50 
(m, 4 H, CH-CH2-CH2), 1.48–1.27 ppm (m, 4 H, CH2-CH2-CH2-CH2); 
13C NMR (D2O): δ = 80.7, 
76.9, 75.8, 73.0 (C-2, C-2’, C-3, C-3’), 64.9, 64.9 63.9, 63.9 (C-1, C-1’, C-4, C-4’), 60.6, 59.9 (C-
5, C-5’), 32.2, 32.2 (CH-CH2-CH2), 27.7, 27.7 ppm (CH2-CH2-CH2-CH2); C14H28N2O6 (320.39): 
calcd. C 52.48, H 8.81, N 8.74; found C 52.52, H 8.82, N 8.74. 
Protected Homodimer 140: Flash column chromatography (PE/AcOEt, 87.5:12.5). 1H NMR 
(CDCl3): δ = 7.48–6.97 (m, 40 H, ArH), 5.39–5.25 (m, 2 H, CH=CH), 5.23–4.98 (m, 4 H, CH2 
Cbz), 4.69–4.21 (m, 12 H, OCH2Ph), 4.21–3.40 (m, 12 H, 1-H, 2-H, 3-H, 4-H, 5-H), 1.26 ppm 
(t, J = 7.1 Hz, 4 H, CH2-CH=CH). 13C NMR (CDCl3): δ = 154.4 (C=O, Cbz), 138.7–136.7 (C Ar), 
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129.9 (CH=CH), 128.7–127.6 (CH Ar), 83.6, 82.7, 64.5, 63.0 (C-1, C-2, C-3, C-4), 73.2, 71.2 
(OCH2Ph), 68.9, 68.0 (C-5,5’), 67.1 (CH2 Cbz), 29.9 ppm (CH2-CH=CH). MS (TOF): m/z = 
1127.54 [M + H]+; found 1127.20. C72H74N2O10 (1127.38): calcd. C 76.71, H 6.62, N 2.48; 
found C 76.75, H 6.61, N 2.48. 
Protected Homodimer 141: Flash column chromatography (PE/AcOEt, 80:20). 1H NMR 
(CDCl3): δ = 7.36–7.11 (m,40 H, ArH), 5.51–5.25 (m, 2 H, CH=CH), 5.17–5.03 (m, 4 H, CH2 
Cbz), 4.58–4.22 (m, 12 H, OCH2Ph), 4.21–3.41 (m, 12 H, 1-H, 2-H, 3-H, 4-H, 5-H), 1.25 ppm 
(t, J = 7.1 Hz, 4 H, CH2-CH=CH); 13C NMR (CDCl3): δ = 155.9 (C=O, Cbz), 138.5–136.9 (C Ar), 
128.7–127.7 (CH=CH, CH Ar), 77.6, 76.6, 61.9, 61.3 (C-1, C-2, C- 3, C-4), 73.3, 71.7 (OCH2Ph), 
68.3 (C-5), 67.1 (CH2 Cbz), 30.0 ppm (CH2-CH=CH);  MS (TOF): m/z = 1127.54 [M + H]
+; 
found 1127.30. C72H74N2O10 (1127.38): calcd. C 76.71, H 6.62, N 2.48; found C 76.77, H 6.63, 
N 2.48. 
Protected Heterodimer 142: Flash column chromatography (PE/AcOEt, 85:15). 1H NMR 
(CDCl3): δ = 7.56–7.00 (m, 40 H, ArH), 5.54–5.24 (m, 2 H, CH=CH), 5.23–4.94 (m, 4 H, CH2 
Cbz), 4.69–4.21 (m, 12 H, OCH2Ph), 4.20–3.40 (m, 12 H, 1-H, 2-H, 3-H, 4-H, 5-H), 1.29–1.24 
ppm (m, 4 H, CH2-CH=CH); 
13C NMR (CDCl3): δ = 156.3 (C=O, Cbz), 138.5–136.9 (C Ar), 
128.7– 127.8 (CH=CH, CH Ar), 82.9, 76.7, 62.6, 61.3 (C-1, C-2, C-3, C-4), 73.3, 71.4 (OCH2Ph), 
68.9 (C-5), 67.1 (CH2 Cbz), 29.9 ppm (CH2-CH=CH); C72H74N2O10 (1127.38): calcd. C 76.71, H 
6.62, N 2.48; found C 76.67, H 6.63, N 2.48. 
(2S,3S,4R,5R)-2-Allyl-3,4-bis(benzyloxy)-5-(benzyloxy-methyl)pyrrolidine-1-carboxylate 
(144): Allyl ammine 147 (575 mg, 1.3 mmol) was dissolved in water (5 mL) and NaHCO3 (218 
mg, 2.6 mmol) was added. The suspension was stirred until complete dissolution of the salt, 
then dioxane (6 mL) was added. The resulting mixture was cooled at 0 °C with an ice bath 
and Cbz-Cl (186 μL, 1.3 mmol) was added dropwise. After 10 minutes the ice bath was 
removed and the reaction mixture was stirred for 20 h at room temperature. After have 
added EtOAc (27 mL) and water (8 mL) the aqueous layer was separated and washed with 
EtOAc (3 x 10 mL); the combined organic extracts were washed with 1 M HCl (2 x 10 mL), 
brine, and dried over Na2SO4. The solvent was evaporated and the residue purified by flash 
column cromatography to afford pure 144 (590 mg, 1.02 mmol, 79 %) as a colorless oil. 
Rf=0.74 (PE/AcOEt 2:1); [α]D
23 = -10.3 (c =0.93, CHCl3);
 1H NMR (CDCl3): δ = 7.51-7.10 (m, 20 
H, ArH), 5.73-5.29 (m, 1 H, CH2CH=CH2), 5.18-5.11 (m, 2 H, CH2 Cbz), 5.05-4.82 (m, 2 H, 
CH2CH=CH2), 4.53-4.40 (m, 6 H, OCH2Ph), 4.20-4.01 (m, 3 H, H-1, H-2, H-4) 3.79 (t, J = 4.2 Hz, 
1 H, H-3), 3.72-3.46 (m, 2 H, H-5), 2.50-2.32 ppm (m, 2 H, CH2CH=CH2);
 13C NMR (CDCl3, 50 
Chapter 2 
62 
 
MHz): δ = 151.1 (C=O Cbz), 137.9-136.3 (C Ar), 133.8 (CH2CH=CH2), 128.1-127.0 (C Ar), 117.2 
(CH2CH=CH2), 78.4 (C-3), 77.4 (C-2), 72.9, 71.3, 71.0 (OCH2Ph), 67.8 (C-5), 66.6 (CH2 Cbz), 
61.5-60.43 (C-1, C-4), 36.4-35.9 ppm (CH2CH=CH2). MS (ESI) m/z (%): 600.54 (79) [M + Na]
+. 
IR (CDCl3): ν =3672, 3089, 3067, 3033, 2973, 2929, 2868, 2248, 1952, 1875, 1809, 1695, 
1641, 1497, 1103 cm-1; elemental analysis calcd (%) for C37H39NO5 (577.71): C, 76.92; H, 
6.80; N, 2.42; found: C, 76.85; H, 6.81; N, 2.42. 
(2S,3S,4R,5R)-2-Allyl-3,4-bis(benzyloxy)-5-(benzyloxy-methyl)pyrrolidin-1-ol (146): To a 
cooled (0 °C) solution of nitrone 70 (960 mg, 2.3 mmol) in anhydrous THF (30 mL), 
allylmagnesium bromide (6.9 mL of a 1.0 M solution in diethyl ether, 6.9 mmol) was added 
dropwise. After stirring for 3 h at 0 °C the reaction was quenched with saturated aqueous 
NH4Cl (20 mL). The reaction mixture was diluted with diethyl ether (25 mL), the organic 
layer was separated and the aqueous layer was extracted with diethyl ether (2 x 20 mL). 
The combined organic extracts were washed with brine (20 mL), dried over Na2SO4, filtered, 
and the solvent was eliminated under reduced pressure to afford the crude product 146 
(1.05 g, quantitative) which was employed in the following step without further 
purification. A sample of crude product was purified by FCC to give pure 146 as a white 
solid, necessary to the characterisation. Rf=0.54 (PE/AcOEt 3:1); Mp 63-65 °C; [α]D
24 = -22.1 
(c =1.035, CHCl3); 
1H NMR (CDCl3): δ = 7.32-7.29 (m, 15 H, ArH), 5.94-5.83 (m, 1 H, 
CH2CH=CH2), 5.08-5.00 (m, 2 H, CH2CH=CH2), 4.58-4.51 (m, 5 H, OCH2Ph), 4.43 (d, J = 11.7 
Hz, 1 H, OCH2Ph), 3.72 (t, J = 5.4 Hz, 1 H, H-3), 3.56 (dd, J = 5.3, 2.3 Hz, 2 H, H-5), 3.47 (dd, J 
= 7.3, 5.8 Hz, 1 H, H-2), 3.39-3.30 (m, 2 H, H-1, H-4), 2.46-2.32 ppm (m, 2 H, CH2CH=CH2); 
 
13C NMR (CDCl3): δ = 138.2, 138.1, 138.0 (C Ar), 135.5 (CH=CH2), 128.4-127.7 (C Ar), 116.7 
(CH=CH2), 77.3 (C-2), 75.4 (C-3), 73.3 (C-4), 71.9, 71.7, 71.4 (OCH2Ph), 70.1 (C-1), 69.7 (C-5), 
36.0 ppm (CH2CH=CH2); MS (ESI) m/z (%): 482.42 (100) [M + Na]
+. IR (CDCl3): ν =3576, 3087, 
3067, 3031, 2866, 2246, 1951, 1810, 1496, 1097 cm-1; elemental analysis calcd (%) for 
C29H33NO4 (459.58): C, 75.79; H, 7.24; N, 3.05; found: C, 75.47; H, 6.91; N, 3.41. 
(2S,3S,4R,5R)-2-Allyl-3,4-bis(benzyloxy)-5-(benzyloxy-methyl)pyrrolidine (147): A solution 
of hydroxylamine 146 (923 mg, 2.0 mmol) in acetic acid (10 mL) and water (10 mL) was 
treated with Zn powder (2.6 g, 40.0 mmol). The resulting mixture was stirred at room 
temperature for 40 minutes, diluted with water (50 mL) and treated with Na2CO3 (9.3 g) 
until bubbling of CO2 stopped. The reaction mixture was extracted with DCM (3 x 50 mL) 
and the combined organic extracts were washed with NaOH 3 M (50 mL) and brine, dried 
(Na2SO4) and evaporated under reduced pressure to give pure ammine 32 (704 mg, 1.6 
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mmol, 80%), as a colorless oil, which did not need further purification. An analytically pure 
sample was obtained after purification by FCC . Rf=0.41 (CHCl3/Et2O 2:1); [α]D
23 = -14.5 (c 
=0.99, CHCl3); 
1H NMR (CDCl3): δ = 7.36-7.24 (m, 15 H, ArH), 5.78 (ddt, J = 17.1, 10.1, 7.0 Hz, 
1 H, CH2CH=CH2), 5.08-5.01 (m, 2 H, CH2CH=CH2), 4.60-4.45 (m, 6 H, OCH2Ph), 3.74 (t, J=5.3 
Hz, 1 H, H-3), 3.51- 3.40 (m, 4 H, H-2, H-4, H-5), 3.35-3.30 (m, 1 H, H-1), 2.41-2.35 (m, 1 H, 
CH2CH=CH2), 2.08 ppm (td, J = 14.2, 6.9 Hz, 1H, CH2CH=CH2);
 13C NMR (CDCl3): δ = 138.3-
138.2 (C Ar), 135.2 (CH=CH2), 128.3-127.6 (C Ar), 117.1 (CH2CH=CH2), 81.3 (C-2), 78.2 (C-3), 
73.2, 71.8, 71.6 (OCH2Ph), 71.1 (C-5), 61.6 (C-4), 60.6 (C-1), 38.4 (CH2CH=CH2); MS (ESI) m/z 
(%): 444.42 (100) [M + H]+; IR (CDCl3): ν =3067, 3031, 2865, 2246,1710, 1640, 1496, 1434, 
1364, 1027 cm-1; elemental analysis calcd (%) for C29H33NO3 (443,58): C, 78.52; H, 7.50; N, 
3.16; found: C, 78.59; H, 7.50; N, 3.15. 
Synthesys of (3R,4R,5R,)-1-(6-azidohexyl)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl] 
pyrrolidine (156):  To a suspension of LiAlH4 (183 mg, 4.89 mmol) in dry THF (40 mL) a 
solution of 70 (680 mg, 1.63 mmol) in dry THF (40 mL) was added dropwise at 0 °C, under 
N2 atmosphere. The reaction mixture was heated to reflux and left stirred for one hour and 
half. The reaction mixture was cooled to room temperature and then a saturated solution 
of Na2SO4 was added dropwise, under vigorous stirring. The mixture was extracted with 
AcOEt, dried over anydrous Na2SO4 and the solvent was evaporated to obtain 607 mg (1.45 
mmol, 89%) of corresponding hydroxylamine as the only product. To a solution of crude 
hydroxylamine in AcOH (7.4 mL) Zn powder (1.89 g, 29.00 mmol) and H2O (7.4 mL) were 
added. The mixture was left stirring for 2 hours at room temperature and then diluted with 
40 mL of H2O. A saturated solution of NaHCO3 was added until complete neutralization of 
AcOH (pH = 7) and the mixture was extracted with CH2Cl2 (3 x 40 mL) The combined organic 
layers were washed with 3M NaOH and brine, dried over anydrous Na2SO4 and the solvent 
was evaporated under vacuum, affording 520 mg (1.29 mmol, 89%) of compound 2,112 
which was employed in the following step without further purification.  
To a solution of 154 (173 mg, 0.43 mmol) and 1-azido-6-bromohexane 155 (163 mg, 0.77 
mmol) in CH3CN (4.2 mL) K2CO3 (77 mg, 0.56 mmol) was added. The reaction mixture was 
left stirring in the microwave at 150 °C, for two hours and then filtered over Celite®, 
washing with CH2Cl2. The filtrate was concentrated under vacuum and the residue was 
purified by FCC affording 156 (195 mg, 0.37 mmol) as a yellowish oil in 86% yield. Rf=0.48 
(EP/AcOEt 5:1); [α]D
30 = -25.1 (c =1.30, CHCl3); 
1H-NMR (400 MHz, CDCl3) δ = 7.35-7.25 (m, 
                                                          
112
 Spectroscopic data in agreement with: X. Zhou, W.-J. Liu, J.-L. Ye, P.-Q. Huang, Tetrahedron 2007, 
63, 6346–6357. 
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15H, Ar), 4.57-4.42 (m, 6H, Bn), 3.92 (d, J = 4.8 Hz, 1H, 3-H), 3.88 (d, J = 3.9 Hz, 1H, 4-H), 
3.62-3.50 (m, 1H, 6-Ha), 3.52 (dd, J = 9.8, 6.3 Hz, 1H, 6-Hb), 3.24 (t, J = 7.1 Hz, 2H, 6’-H), 
3.24-3.19 (m, 1H, 2-Ha), 2.88-2.81 (m, 1H, 1’-Ha), 2.71 (b s, 1H, 5-H), 2.55 (dd, J = 10.3, 4.9 
Hz, 1H, 2-Hb), 2.38-2.31 (m, 1H, 1’-Hb), 1.59 (quin, J = 7.1 Hz, 2H, 5’-H), 1.54-1.48 (m, 2H, 2’-
H), 1.41-1.25 ppm (m, 4H, 3’-H + 4’-H); 13C-NMR (50 MHz, CDCl3) δ = 138.5, 138.4, 138.3 (s, 
3C, Ar), 128.3-127.6 (d, 15C, Ar), 85.5 (d, C-4), 81.7 (d, C-3), 73.2 (t, CH2Bn) 71.3 (t, CH2Bn), 
71.2 (t, CH2Bn), 71.0 (t, C-6), 69.4 (d, C-5), 57.3 (t, C-2), 55.5 (t, C-1’), 51.4 (t, C-6’), 28.8 (t, C-
5’), 28.0 (t, C-2’), 27.0, 26.6 ppm (t, 2C, C-3’ + C-4’); MS (ESI): m/z (%) = 529.42 (100) [M+H]+, 
551.42 (38) [M+Na]+; IR (CDCl3): ν = 3088, 3066, 3032, 3009, 2937, 2862, 1496, 1453, 1365, 
1261 cm-1; elemental analysis calcd (%) for C32H4N4O3 (504.49): calcd. C, 72.70; H, 7.63; N, 
10.60; found C 72.32, H 7.23, N 10.59. 
 
Synthesys of (3R,4R,5R)-1-(6-aminohexyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol (157): To 
a solution of 156 (89 mg, 0.17 mmol) in MeOH (5 mL) and HCl 12M (6 drops) Pd /C (45 mg) 
was added and the reaction mixture was left stirring at room temperature under H2 
atmosphere for three days. The catalyst was filtered through Celite® and the filtrate was 
concentrated under vacuum, to yield quantitative the hydrochloride of 3 which was eluted 
through an ion-exchange resin (DOWEX® 50XW8-100) with MeOH, H2O and 6% NH4OH to 
give the free amine 157 (25 mg, 0.11 mmol, 65%). [α]D
20 = - 49.4(c =0.69, H2O); 
1H-NMR 
(400 MHz, D2O) δ = 3.98 (dt, J = 5.4, 2.4 Hz, 1H, 3-H), 3.80 (dd, J = 4.9, 2.9 Hz, 1H, 4-H), 3.63-
3.54 (m, 2H, 6-H), 2.87 (dd, J = 11.2, 2.4 Hz, 1H, 2-Ha), 2.72-2.65 (m, 3H, 1’-Ha, 6’-H), 2.60 
(dd, J = 11.2, 5.8 Hz, 1H, 2-Hb), 2.39 (dd, J = 10.5, 5.1 Hz, 1H, 5-H), 2.24 (td, J = 10.7, 5.4 Hz, 
1H, 1’-Hb), 1.48-1.19 ppm (m, 8H, 2’-5’-H); 13C-NMR (50 MHz, D2O) δ = 79.3 (d, C-4), 75.5 (d, 
C-3), 71.9 (d, C-5), 61.4 (t, C-6), 58.3 (t, C-2), 55.3 (t, C-1’), 39.8 (t, C-6’), 28.2-25.5 ppm (4C, 
t, C2’-C5’); MS (ESI): m/z (%) = 233.23 (100) [M+H]+; elemental analysis calcd (%) for 
C11H24N2O3 (232.32): C 56.87, H 10.41, N 12.06; found C 56.36, H 10.31, N.11.84. 
(1R,2R,3R,6S,7aR)-1,2-Bis(benzyloxy)-3-[(benzyloxy)methyl]-6-azido-hexahydro-1H-
pyrrolizidine (159): To a solution of 158 (914 mg, 1.99 mmol) in dry THF (19 ml) under 
nitrogen atmosphere triphenylphosphine (626 mg, 2.39 mmol) was added. The reaction 
mixture was cooled to 0 °C and DIAD (470 µL, 2.39 mmol) was added dropwise, forming a 
yellow precipitate. After addition of diphenylphosphorilazide (823 mg, 2.99 mmol), the 
suspension was raised to room temp. and stirred under nitrogen atmosphere for 2 h, until 
TLC analysis (CH2Cl2:MeOH 10:1) showed disappearance of the starting material (Rf=0.22) 
and formation of a new product (Rf=0.95). The solvent was removed under reduced 
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pressure and the crude was purified by FCC affording pure 159 (838 mg, 1.73 mmol, 87% 
yield) as a yellow oil. Rf=0.21 (PE/AcOEt 4:1); [α]D
27 = +3.96 (c =1.06, CHCl3); 
1H-NMR (400 
MHz, CDCl3): =7.30-7.18 (m, 15H, H-Ar), 4.60-4.48 (AB system, J=11.7 Hz, 2H, H-Bn), 4.50-
4.41 (AB system, J=11.7 Hz, 2H, H-Bn), 4.48-4.42 (AB system, J=12.2 Hz, 2H, H-Bn), 4.10-4.06 
(m, 1H, H-6), 3.96 (dd, J=6.3, 5.4 Hz, 1H, H-2), 3.76 (t, J=4.9 Hz, 1H, H-1), 3.59-3.54 (m, 1H, 
H-7a), 3.50 (dd, J=9.2, 5.3 Hz, 1H, Ha-8), 3.43 (dd, J=9.2, 6.3 Hz, 1H, Hb-8), 3.07 (dd, J=11.7, 
3.4 Hz, 1H, Ha-5), 2.98 (dd, J=11.7, 5.4 Hz, 1H, Hb-5), 2.93 (q, J=6.3 Hz, 1H, H-3), 1.96 (ddd, 
J=13.2, 6.8, 3.4 Hz, 1H, Ha-7), 1.81 ppm (ddd, J=13.6, 8.3, 6.3 Hz, 1H, Hb-7); 13C-NMR (50 
MHz, CDCl3): =138.4, 138.2, 137.9 (s, C-Ar), 128.4-127.5 (d, 15C, C-Ar), 88.3 (d, C-1), 85.9 
(d, C-2), 73.3 (t, C-Bn) 72.4 (t, 2C, C-Bn, C-8), 71.9 (t, C-Bn), 69.2 (d, C-3), 66.7 (d, C-7a), 62.1 
(d, C-6), 59.9 (t, C-5), 37.0 ppm (t, C-7); IR (CDCl3): ν =3081, 3064, 3032, 2926, 2864, 2102, 
1496, 1453, 1365, 1264, 1099 cm-1; MS (ESI): m/z (%) = 485.33 (100) [M+H+]; elemental 
analysis calcd (%) for C29H32N4O3 (484.59): C 71.88, H 6.66, N 11.56; found: C 71.45, H 6.54, 
N 11.68. 
(1R,2R,3R,6S,7aR)-6-Amino-3-hydroxymethylhexahydro-1H-pyrrolizidine-1,2-diol (160): 
To a solution of 159 (325 mg, 0.67 mmol) in 25 ml of methanol 163 mg of 10% Pd/C and five 
drops of 37% HCl were added under nitrogen atmosphere, then the mixture was stirred 
under hydrogen atmosphere at room temp. for 1 day. TLC analysis (PE:AcOEt 3:1) showed 
the disappearance of the starting material (Rf=0.35) and formation of a new product 
(Rf=0.00). The mixture was filtered through Celite
® and the solvent was removed under 
reduced pressure affording a crude yellow oil (150 mg). Free amine was obtained by 
passing the hydrochloride through a Dowex 50WX8 ion-exchange resin. Elution with 6% 
NH4OH afforded the free base 160 (126 mg, 0.67 mmol, 100% yield over two steps) as a 
waxy brown solid. [α]D
23=+16.7 (c =1.01, MeOH); 1H-NMR (400 MHz, D2O): =3.66-3.59 (m, 
3H, H-1, H-2, Ha-8), 3.49 (dd, J=11.7, 6.3 Hz, 1H, Hb-8), 3.46-3.40 (m, 1H, H-6), 3.15 (td, 
J=7.8, 3.9 Hz, 1H, H-7a), 2.85 (dd, J=11.7, 6.3 Hz, 1H, Ha-5), 2.59 (ddd, J=9.8, 6.3, 3.9 Hz, 1H, 
H-3), 2.47 (dd, J=11.7, 7.8 Hz, 1H, Hb-5), 1.96 (ddd, J=12.7, 6.4, 3.9 Hz, 1H, Ha-7), 1.62 ppm 
(dt, J=12.7, 8.3 Hz, 1H, Hb-7); 13C-NMR (50 MHz, D2O): =80.3 (d, C-1) 76.6 (d, C-2), 69.4 (d, 
C-3), 65.1 (d, C-7a), 62.9 (t, C-8), 60.9 (t, C-5), 49.4 (d, C-6), 37.7 ppm (t, C-7); MS (ESI): m/z 
189.09 (100) [M+H+]; elemental analysis calcd (%) for C8H16N2O3 (188.22): C 51.05, H 8.57, N 
14.88; found: C 51.66, H 8.98, N 15.08. 
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Chapter 3 
Polyhydroxylated piperidine iminosugars and 
pipecolic acid analogs: synthesis from a D-
mannose derived aldehyde 
3.1 Introduction 
Polyhydroxylated piperidines such as 1-deoxynojirimycin (1) and 1-deoxymannojirimycin (7) 
(Figure 3.1) are natural products widely found essentially in plants and microorganisms and 
are among the most attractive carbohydrate mimetics reported to date. Their inhibitory 
activity against glycosidic enzymes has prompted an intense research for the synthesis of 
the natural products and unnatural analogs in order to develop new therapies against 
cancer, virus, diabetes and hereditary metabolic disorders (See Chapter 1).  
 
Figure 3.1: Natural and synthetic piperidine iminosugars 1, 7, 18, amino derivative 161 and 
polyhydroxypipecolic acid 162. 
Synthetic amino derivatives such as 6-acetylamino-1,6-dideoxymannojirimycin (161, Figure 
3.1) also showed a very high activity as glycosidase inhibitors.113 More recently, the 
antibacterial activity of synthetic hydroxyamino piperidines and other iminosugar 
derivatives was discovered.114 Polyhydroxypipecolic acid 162, the only natural 
                                                          
113
 I. McCort, S. Fort, A. Duréault, J.-C. Depezay, Bioorg. Med. Chem. 2000, 8, 135-143. 
114
 a) N. L. Segraves, P. Crews, J. Nat. Prod. 2005, 68, 118-121; b) Y. Zhou, V. E. Gregor, B. K. Ayida, G. 
C. Winters, Z. Sun, D. Murphy, G. Haley, D. Bailey, J. M. Froelich, S. Fish, S. E. Webber, T. Hermann, D. 
Wall, Bioorg. Med. Chem. Lett. 2007, 17, 1206-1210; c) L. Zhang, F. Sun; Q. Wang, J. Zhou, L.-H. 
Zhang, X.-L. Zhang, X.-S. Ye, ChemMedChem 2009, 4, 756-760; d) D. Rejman, A. Rabatinová, A. R. 
Pombinho, S. Kovačková, R. Pohl, E. Zborníková, M. Kolář, K. Bogdanová, O. Nyč, H. Šanderová, T. 
Látal, P. Bartůnĕk, L. Krásný, J. Med. Chem. 2011, 54, 7884-7898. 
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trihydroxypipecolic acid known, was also isolated from the seeds of Bathia racemosa115 and 
proved to be a specific inhibitor of human liver -D-glucuronidase,116 and displayed anti 
HIV117 as well as antimetastatic properties.118 
 
Figure 3.2: Natural glycosidase inhibitor trihydroxypiperidine alkaloids. 
In particular, 3,4,5-trihydroxypiperidines 163-165 (Figure 3.2), also referred to as 1-N-
azasugars or isofagomine (18) analogues, were isolated in 1995 from Eupatorium fortunei 
TURZ119 and have shown to be the active components of the extracts of this plant, 
traditionally used in Chinese and Japanese folk medicine as a diuretic, antipyretic and 
antidiabetic agent. As a consequence, in recent years there has been a great deal of interest 
not only in the synthesis of the natural products themselves, but also in the synthesis of 
chemically modified analogues. 
All the methodologies described in the literature can be divided into two big general 
families: “chiral pool” and “enantioselective” strategies.  
3.1.1 Chiral pool strategies 
Before their natural occurrence was discovered, compounds 163, 164 and the unnatural 
ent-164, were synthesized by Ganem120 starting from D-glucose, D-galactose and D-
mannose, respectively. After this first example, many other “chiral pool” strategies, 
employing a carbohydrate as starting material have been reported. 
In 1996 Winchester and co-workers121 presented a simple method for the preparation of all 
trihydroxypiperidines 163, 164, ent-164 and 165 from 5-substituted aldonolactones/aldonic 
acid derivatives. When the latter compounds were treated with aqueous ammonia, 5-
amino-5-deoxy-1,5-lactams were formed in a single step and subsequently reduced to 
target molecules (Scheme 3.1). It is worth noting that in this synthesis only cheap and ready 
available reagent have been used, and all compounds have been crystallized directly. 
                                                          
115
 K. S. Manning, D. G. Lynn, J. Shabanovitz, L. E. Fellows, M. Singh, B. D. Schrire, J. Chem. Soc. Chem. 
Commun. 1985, 127-129. 
116
 I. C. de Bello, P. Dorling, L. E. Fellows, B. Winchester, FEBS Lett. 1984, 176, 61-64. 
117
 G. M. Makeev, M. I. Kumskov, N. D. Zelinsky, Mendelev Commun. 1996, 1, 27-29. 
118
 T. Tsuruoka, H. Fukuyasu, M. Ishii, T. Usui, S. Shibahara, S. Inouye, J. Antibiot. 1996, 49, 155-161. 
119
 T. Sekioka, M. Shibano, G. Kusano, Nat. Med. 1995, 49, 332–335. 
120
 R. C. Bernotas, G. Papandreou, J. Urbach, B. Ganem, Tetrahedron Lett. 1990, 31, 3393–3396. 
121
 M. Godskesen, I. Lundt, R. Madsen, B. Winchester, Bioorg. Med. Chem. 1996, 4, 1857–1865. 
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Scheme 3.1: Synthetic strategy reported by Winchester. In a similar manner compounds 164 and 165 
were obtained from D-ribonolactone while D-xylonic acid was converted in 163 in five steps. 
At the same time, Ichikawa and co-workers122 evaluated the glycosidase inhibitor activity of 
many natural trihydroxypiperidines and their synthetic analogues obtained through 
intramolecular reductive amination of azido derivatives, resulting from different pentoses 
such as D-ribose (Scheme 3.2A) or D-lyxose.  
 
Scheme 3.2: Example of “chiral pool” synthetic strategy by Ichikawa (A) and Dhavale (B). 
                                                          
122
 a) Y. Igarashi, M. Ichikawa, Y. Ichikawa, Bioorg. Med. Chem. Lett. 1996, 6, 553–558; b) Y. Ichikawa, 
Y. Igarashi, M. Ichikawa, Y. Sahara, J. Am. Chem. Soc. 1998, 120, 3007–3008. 
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Furthermore, Dhavale and co-workers123 exploited a very similar azido intermediate to 
synthesize trihydroxypiperidines 163, 165 and its analogue with a hydroxyethyl substituent 
on C-4, starting from D-glucose (Scheme 3.2B). 
From 2002, Pandey group124 also provided examples of “chiral pool” synthesis not 
employing carbohydrates as starting materials, in order to overcome the typical lack of 
versatility of these strategies. In particular, two general precursors were obtained using 
enantiopure tartaric acids. The piperidine skeleton was synthesized via PET (photoinduced 
electron transfer)-mediated cyclization of α-trimethylsilylmethylamine radical cation to a 
tethered acetylene functionality (Scheme 3.3). Starting from D- tartaric acid complete 
synthesis of isofagomine, natural compounds 163, ent-164 and other analogues 
functionalized at C-5 were reported. In a similar manner, employing L-tartaric acid as 
starting material the corresponding enantiomeric azasugars were prepared.  
 
Scheme 3.3: Example of “chiral pool” synthetic strategy starting from D- and L-tartaric acid, from the 
Pandey group. 
 
                                                          
123
 N. T. Patil, S. John, S. G. Sabharwal, D. D. Dhavale, Bioorg. Med. Chem. 2002, 10, 2155–2160. 
124
 a) G. Pandey, M. Kapur, Org. Lett 2002., 4, 3883-3886; b) G. Pandey, M. Kapur, M. I. Khan, S. M. 
Gaikwad, Org. Biomol. Chem. 2003, 1, 3321–3326; c) G. Pandey, K. C. Bharadwaj, M. I. Khan, K. S. 
Shashidhara, V. G. Puranik, Org. Biomol. Chem. 2008, 6, 2587–2595. 
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3.1.2 Enantioselective strategies 
The syntheses of polyhydroxylated piperidines starting from carbohydrates require, in 
general, a large number of steps to reach the specific target and lack generality for diversity 
oriented syntheses. Thus, the development of new methods for the enantioselective 
synthesis of these compounds have involved many groups and still constitutes an area of 
great interest. 
In the early 2000, Bosh and co-workers125 demonstrated the potential of chiral non racemic 
bicyclic lactams derived from (R)-or (S)-phenylglycinol as versatile building block for the 
enantioselective synthesis of ent-164, as well as of the monohydroxy (C-3) and dihydroxy 
analogues (Scheme 3.4A-C). 
 
Scheme 3.4: Example of enantioselective synthesis employing nonracemic bicyclic lactams by Bosh 
group. 
A few years later a complete asymmetric methodology for the synthesis of compounds 163 
and 164 was developed by Han:126 a readily available achiral olefin was transformed into 
the target molecules via regioselective asymmetric aminohydroxylation (AA), ring-closing 
metathesis (RCM), and diastereoselective dihydroxylation reactions by installing all 
stereocenters in a highly stereocontrolled fashion (Scheme 3.5).  
                                                          
125
 M. Amat, N. Lior, M. Huguet, E. Molins, E. Espinosa, J. Bosch, Org. Lett 2001, 3, 3257-3260. 
126
 H. Han, Tetrahedron Lett. 2003, 44, 1567–1596. 
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Scheme 3.5: A complete asymmetric synthesis of polyhydroxypiperidines 163 and 164 by Han. 
In 2005 Takahata and co-workers127 provided a very general method for the synthesis of all 
the natural 3,4,5-trihydroxypiperidines 163-165 and some unnatural analogues starting 
from a chiral N-Boc-5-hydroxy-3-piperidene. This precursor was readily obtained in its 
racemic form from butadiene monoxide and allylamine in two steps and good yield. Its 
enzymatic resolution (achieved through the Pseudomonas cepacia lipase) allowed the 
synthesis of isofagomine, homoisofagomine and 5’-deoxyisofagomine via stereoselective 
epoxidation and regioselective ring-cleavage, together with the stereoselective synthesis of 
3,4,5-trihydroxypiperidines 163, 164, ent-164 and 165 (Scheme 3.6).  
 
Scheme 3.6: Example of enantioselective synthesis by Takahata and co-workers. 
A completely different approach for the synthesis of 163 and 164 was recently reported by 
Clapés and co-workers128 in a more extensive study on the synthesis of polyhydroxylated 
compounds catalyzed by D-fructose 6-phosphate aldolase (FSA). In particular, a suitably N-
protected aminohydroxy propanale resulted a good acceptor for a FSA catalyzed 
                                                          
127
 H. Ouchi, Y. Mihara, H. Takahata, J. Org. Chem. 2005, 70, 5207-5214. 
128
 X. Garrabou, J. A. Castillo, C. Guérard-Hélaine, T. Parella, J. Joglar, M. Lemaire, P. Clapés, Angew. 
Chem. 2009, 121, 5629; Angew. Chem. Int. Ed. 2009, 48, 5521–5225. 
Chapter 3 
 73   
 
asymmetric cross-aldol reaction of glycolaldehyde, affording desired iminosugar cyclic 
derivatives in quantitative conversion. Subsequent removal of Cbz protecting group 
followed by reductive amination led to final compounds 163 and 164 (Scheme 3.7).  
 
Scheme 3.7: Example of asymmetric cross-aldol reaction catalyzed by D-fructose-6-phosphate 
aldolase (FSA) reported by Clapés and co-workers. 
3.1.3 Our Synthetic Strategy: Double Reductive Amination and Selective Strecker Reaction 
of a D-Lyxaric Aldehyde 
Following our ongoing interest in the synthesis of polyhydroxylated alkaloids and unnatural 
analogs, we recently envisaged in the D-mannose derived aldehyde 166129 a possible 
common building block for the synthesis of natural 165, ent-164 and some new unnatural 
N-alkylated analogs (Scheme 3.8) using a double reductive amination procedure (DRA).130 
 
Scheme 3.8: Retrosynthetic analysis for the synthesis of polyhydroxyamino piperidines and pipecolic 
acid analogs from D-mannose derived aldehydes 166 and 167. 
                                                          
129
 F.-E. Chen, J.-F. Zhao, F.-J. Xiong, B. Xie, P. Zhang, Carbohydr. Res. 2007, 342, 2461–2464. 
130
 Preliminary communication: C. Matassini, S. Mirabella, A. Goti, F. Cardona, Eur. J. Org. Chem. 
2012, 3920-3924. 
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While many examples of this reaction have been reported on diketones or ketoaldehyde 
derivatives,131 the same approach with dialdehydes has been less exploited. In 1994 Bols 
reported the first synthesis of isofagomine, using ammonia as nitrogen source in the 
cyclization of a pentadialdose derived from Cerny epoxide, with a total 6% yield over 10 
steps (Scheme 3.9).132 
 
Scheme 3.9: Synthesis of isofagomine by Bols group: the double reductive amination reaction was 
performed employing ammonia as amine source and hydrogen as the reducing agent 
In more recent years other few examples have been reported.133 Wroding and coworkers 
exploited the cyclization via double reductive amination on xylo-pentadialdose with the 
respective amino group of lysine and serine derivatives, in order to synthesize some 
iminosugar-amino acid hybrids, with excellent inhibitory activity against β-xylosidase 
(Scheme 3.10A).133a 
 
Scheme 3.10: Double reductive amination (DRA) strategies with dialdehydes reported until today by 
Wroding (A), Martin (B) and Crich (C). 
                                                          
131
 For a recent review, see: P. Compain, V. Chagnault, O. R. Martin, Tetrahedron: Asymmetry 2009, 
20, 672-711. 
132
 T. M. Jespersen, M. Bols, M. R. Sierks, T. Skrydstrup, Tetrahedron 1994, 50, 13449-13460. 
133
 a) A. J. Steiner, A. E. Stütz, C. A. Tarling, S. G. Withers, T. M. Wrodnigg, Aust. J. Chem. 2009, 62, 
553-557; b) F. Oulaïdi, S. Front-Deschamps, E. Gallienne, E. Lesellier, K. Ikeda, N. Asano, P. Compain, 
O. R. Martin, ChemMedChem 2011, 6, 353-361; c) G. Malik, X. Guinchard, D. Crich, Org. Lett. 2012, 
14, 596-599; d) G. Malik, A. Ferry, X. Guinchard, T. Cresteil, D. Crich, Chem. Eur. J. 2013, 19, 2168-
2179. 
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A properly protected analogue of the same dihaldehyde has been subsequently employed 
by Martin and coworkers for the synthesis of a series of 2-O-alkyl-iminoxylitol derivatives, 
with promising chaperoning activity towards xylosidase (Scheme 3.10B).133b Finally, Crich 
and co-workers exploited the double reductive amination strategy on functionalized 1,5-
dialdehydes with various hydroxylamines en route to the synthesis of polyhydroxylated N-
alkoxypiperidines xylosidase (Scheme 3.10C).133c,dOur early encouraging results130 led us to 
continue with the exploitation of the scope of this strategy, which allowed a versatile 
access to novel 1-N-alkyl polyhydroxypiperidines 168 and amino piperidines 169 (Scheme 
3.8). A change in the anomeric protecting group on aldehyde 166 gave us the opportunity 
to exploit the Strecker reaction on aldehyde 167 en route to the synthesis of new 
polyhydroxypipecolic acid analogs 170-171 and 6-aminopiperidine iminosugars 172 
(Scheme 3.8). The results of the Strecker reaction on 167 also furnished a firm proof of the 
mechanism proposed for the stereoselective formation of 2-cyano piperidines as side 
products of the double reductive amination reaction.130 
3.2 Results and Discussion 
3.2.1 Synthesis of N-alkyl piperidines and 5-amino piperidines vi the DRA strategy 
The aldeyde 166 was easily synthesized in four steps and 80% overall yield from D-mannose 
without the need of any chromatographic purification, by following a slight modification of 
the published procedure129 (Scheme 3.11). 
 
Scheme 3.11: Synthesis of aldehyde 166 from D-mannose. Reagents and conditions: a) Acetone, I2, rt, 
2h; b) KOH, BnBr, THF, 18-crown-6, rt, 16h; c) CH3COOH, H2O, rt, 18 h; d) Silica Gel Supported, NaIO4, 
CH2Cl2, rt, 50 min, 80% over four steps.  
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Our first aim was the introduction of lipophilic chains on the nitrogen atom of the target 
piperidine iminosugars, which is expected to improve the pharmacokinetics properties in 
vivo and the suitability of such molecules as pharmacological chaperones.134 
We initially investigated the reductive amination reaction on 166 using different amine 
sources and hydrogen as the reducing agent, since this could allow removal of the benzyl 
protecting group at the anomeric position of 166 in the same step and therefore the 
liberation of the second aldehyde moiety necessary to perform the required cyclization. 
However, this reaction suffered from low reproducibility in our hands, it proved to be 
scarcely versatile and also showed unexpected drawbacks. Most of the problems 
encountered probably derived from the inclination of 166 to undergo quick hydration by air 
humidity, that hampers the reaction. Indeed, the reaction of 166 with benzylamine (1 
equiv.) in MeOH in the presence of 3 Å molecular sieves, followed by treatment with 
Pd(OH)2/C and H2 (balloon) for 25 h was successful, affording piperidine ent-164 after 
deprotection of the acetonide protecting groups (175) in HCl/MeOH in 69% overall yield 
(Scheme 3.12).130 
 
Scheme 3.12: The double reductive amination strategy using aldehyde 166 and hydrogen as reducing 
agent. Reagents and conditions: a) BnNH2, MeOH, 3 Å MS, rt, 40 min; b) Pd(OH)2/C, MeOH, H2, rt, 25 
h; c) MeOH, 1M HCl; d) DOWEX 50WX8, 100%; e) R’NH2, MeOH, 3 Å MS, CH3CO2H, f) Pd(OH)2/C, 
MeOH, H2, rt, 25 h; rt, 7 days. 
                                                          
134
 D. S. Alonzi, R. A. Dwek, T. D. Butters, Tetrahedron: Asymmetry 2009, 20, 897-901; b) G. Godin, P. 
Compain, O. R. Martin, K. Ikeda, L. Yu, N. Asano, Bioorg. Med. Chem. Lett. 2004, 14, 5991-5995; c) T. 
S. Rasmussen, A. Allman, G. Twigg, T. D. Butters, H. H. Jensen, Bioorg. Med. Chem. Lett. 2011, 21, 
1519-1522; d) L. Yu, K. Ikeda, A. Kato, I. Adachi, G. Godin, P. Compain, O. Martin, N. Asano, Bioorg. 
Med. Chem. 2006, 14, 7736-7744; e) Z. Yu, A. R. Sawkar, L. J. Whalen, C.-H. Wong, J. W. Kelly, J. Med. 
Chem. 2007, 50, 94-100. 
Chapter 3 
 77   
 
However, the same protocol employing butylamine or octylamine required more prolonged 
reaction times (7 days) and the presence of 2 equiv. of AcOH to achieve complete 
conversion of the starting aldehyde, and piperidines 176a and 176b were obtained in 
moderate overall yields (35% and 41%, respectively). Moreover, upon reaction of 166 with 
benzylamine and AcOH for 4 days, N-isopropyl piperidine 176c was isolated in 27% yield 
(Scheme 3.12), probably deriving from partial acetonide deprotection and subsequent 
reductive amination of the acetone liberated in situ with the formed piperidine. Therefore, 
in this case a one-pot triple reductive amination occurred, together with debenzylation and 
acetonide deprotection. The low yield, however, in a process composed of six consecutive 
reactions which may afford a 50% maximum yield, may be ascribed to formation of 
oligomers by cross reductive amination reactions. Deprotection of 176c performed as usual 
afforded compound 168a in quantitative yield. 
Due to problems encountered with the reductive amination strategy on aldehyde 166, we 
sought to perform the same task by working on dialdehyde 177, obtained quantitatively by 
catalytic hydrogenation of 166. It is worth noting that this compound can be viewed (in its 
open-chair form) either as a 2,3-di-O-protected D-lyxaric aldehyde or a 3,4-di-O-protected 
D-arabinaric aldehyde (Scheme 3.13).  
 
Scheme 3.13: Deprotection of aldehyde 166 led to dialdehyde 177, here represented in its open–
chair forms. Reagents and conditions: a) Pd(OH)2/C, H2, MeOH, rt, 4 h, 100%. 
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In solution, the 1H NMR spectrum of 177 was rather complicated, showing the presence of 
a complex mixture of different forms. 
In our hands, the reaction of dialdehyde 177 with different amine sources (0.9 equiv.), 
NaBH3CN (3.0 equiv.) and AcOH (2 equiv.)
133b was much more reliable and reproducible 
than the above mentioned hydrogenation procedure on masked dialdehyde 166, affording 
protected piperidines 176a-b in slightly higher yields (48% and 56%, respectively) and the 
N-benzyl substituted piperidine 176d, obviously not achievable through a catalytic 
hydrogenation procedure, in excellent yield (93%). Deprotection of 176a-b and 176d with 
methanolic HCl followed by ion-exchange resin afforded the N-alkylated piperidines 168b-d 
(Scheme 3.14). The use of NaBH3CN instead of H2 as the reducing agent for the double 
reductive amination on 177 also allowed the synthesis of piperidines functionalized on the 
alkyl chain. The reaction of 177 with 1 equivalent of 3-azidopropyl-1-amine,135 NaBH3CN 
(3.0 equiv.) and AcOH (2 equiv.) afforded N-alkylated piperidine 176e in 67% yield (Scheme 
3.14), which upon usual deprotection performed gave compound 168e in 90% yield. 
 
Scheme 3.14: The double reductive amination strategy using dialdehyde 177 and NaBH3CN as the 
reducing agent. Reagents and conditions: a) RNH2, MeOH, 3 Å MS, NaBH3CN, CH3CO2H, rt, 3-7 days; 
b) MeOH, HCl, rt; 18; c) DOWEX 50WX8; d) Pd(OH)2/C, MeOH, HCl, rt, 3 days, 100%; e) Ac2O, Py, rt, 
18 h, 86%; f) Ambersep® 900-OH, MeOH, rt 2h, 71%. 
Catalytic hydrogenation followed by ionic exchange resin eluting with 15% NH4OH afforded 
the primary amine 168f, which curiously presented split signals (both in 1H and 13C NMR 
spectra) for the propyl chain atoms. This phenomenon can be ascribed to an high tendency 
of this compound to protonation, possibly through reaction with atmospheric CO2 as 
                                                          
135
 O. E. Vercillo, C. K. Z. Andrade, L. A. Wessjohann, Org. Lett. 2008, 10, 205-208. 
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evidenced by the 13C NMR spectra that showed signals around δ = 160 ppm. Moreover an 
intramolecolar cyclization, via hydrogen bond, of the endocyclic nitrogen with the primary 
amine of the propyl chain (Figure 3.3) to form a six-membered ring, cannot be excluded.  
Complete acetylation by reaction of 168f with an excess of acetic anhydride in pyridine 
afforded 178 in 86% yield. Final treatment with the strongly basic resin Ambersep 900 OH 
in MeOH gave the trihydroxypiperidine 168g in quantitative yield. 
 
Figure 3.3: Hypothetical salification and cyclization of amino-propyl chain of compound 168f. 
Compound 176e has been successively employed in the synthesis of a multivalent 
compound with an alkyne tetravalent scaffold (see below Chapter 3.2.3), while the amino 
derivative 168f has been conjugate with a proper thiol linker for further multimerization on 
gold nanoparticles (see Chapter 4). 
In order to access natural trihydroxypiperidine 165, an inversion of configuration at C5-OH 
in compound 179 was required to access This was achieved through an oxidation-reduction 
procedure, since Mitsunobu conditions failed on the Boc protected piperidine 179. 
Therefore, oxidation of 179 with the Dess-Martin periodinane followed by NaBH4 reduction 
of ketone 180 afforded stereoselectively alcohol 181, that gave 165 upon deprotection in 
acidic medium (Scheme 3.15). 
 
Scheme 3.15: The oxidation-reduction procedure: synthesis of natural 165. Reagents and conditions: 
a) NaHCO3, Boc2O, MeOH/H2O, rt, 48 h, 93%; b) Dess-Martin, CH2Cl2, rt, 2h, 98%; c) NaBH4, EtOH, rt, 
18 h, 76%; d) MeOH, HCl, rt, 18 h; e) DOWEX 50WX8, 100% 
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We envisaged in ketone 180 a suitable intermediate to introduce an exocyclic amino moiety 
in the piperidine skeleton affording piperidines 182. Indeed, the high stereoselectivity 
observed in the reduction of 180 to 181 by the hydride anion, deriving from a favoured 
axial attack to C=O at C-5 anti to the vicinal C-O bond according to a Felkin-Anh model, 
could be exploited in the reduction of a C=N bond formed by reaction of 180 with different 
amines. 
Therefore, we investigated the reductive amination reaction on ketone 180 (Scheme 3.16). 
We initially employed the best reaction conditions previously found for the synthesis of 
piperidine 176d from dialdehyde 177: dry MeOH, 3Å molecular sieves, BnNH2 (0.9 equiv.), 
NaBH3CN (3.0 equiv.) and AcOH (2.0 equiv.). After 6 days the conversion was complete, but 
unexpectedly a 1:2 mixture of the desired aminopiperidine 182a together with alcohol 181 
was recovered (Table 3.1, Entry 1). Employing a slight  excess of BnNH2 (1.1 equiv.) and 
waiting 40 minutes before addition of NaBH3CN in lower excess (1.5 equiv.) gave a similar 
result (Table 3.1, Entry 2). The critical point in this reaction was the formation of  the imine 
intermediate, since the chemoselectivity of NaBH3CN in this reaction appeared quite low. 
The formation of alcohol 181 could be completely suppressed by stirring a mixture of 180, 
BnNH2 (1.5 equiv.) and AcOH (2 equiv.) for 3 hours before the addition of NaBH3CN, thus 
assuring complete formation of the imine intermediate (Table 3.1, Entry 3) prior to hydride 
attack.  
 
Scheme 3.16: The oxidation-reduction procedure, synthesis of amino piperidines 169. Reagents and 
conditions: a) RNH2, Reducing agent (see Table 3.1); b) MeOH, HCl, rt, 18 h; c) DOWEX 50WX8; d) 
Pd/C, H2, HCl, MeOH, rt, 6 days; e) DOWEX 50WX8, 100%. 
Under these conditions, amine 182a could be recovered in a satisfying 48% yield after 
purification on silica gel. Due to the low chemoselectivity of NaBH3CN, alkylpiperidines 182b 
and 182c were more easily accessed by employing hydrogen as the reducing agent. Ketone 
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180 was left stirring in MeOH, with 3Å molecular sieves and the suitable amine for 40 min, 
then Pd(OH)2/C was added and the mixture was stirred under H2 (baloon) for 20-24 h. Both 
reactions (Table 3.1, Entries 4-5) gave the desired amines in good yields. As a matter of fact, 
hydrogenation also showed complete diastereofacial selectivity, as a consequence of steric 
hindrance to attack at the opposite face.  
Entry 
RNH2 (equiv.) Reducing agent (equiv.) Time (h) 182/181
a) 
ratio 
Yield 
of 182 (%) 
1
b)
 BnNH2 (0.9) NaBH3CN (3.0) 144 1:2 17 
2
c)
 BnNH2 (1.1) NaBH3CN (1.5) 20 1:2 19 
3
d)
 BnNH2 (1.1) NaBH3CN (3.0) 25 >98:2 48 
4 C4H9NH2 (1.5) Pd(OH)2/C, H2 24 >98:2 68 
5 C8H17NH2 (1.5) Pd(OH)2/C, H2 20 >98:2 53 
Table 3.1: The reductive amination of ketone 180 in MeOH. 
a)
Determined by isolation of compounds 
after flash column chromatography. 
b)
All reagents, including 3Å MS and AcOH (2.0 equiv.) were 
mixed together at the same time. 
c)
Ketone, amine and 3Å MS were left stirring for 40 min before 
addition of NaBH3CN and AcOH (2.0 equiv.). 
d)
Ketone, amine, 3Å MS and AcOH (2.0 equiv.) were left 
stirring for 3 h before addition of NaBH3CN.  
Final treatment with methanolic HCl followed by ion-exchange resin afforded the new N-
alkylamino piperidines 169a-c (Scheme 3.16) in good to quantitative yields. Moreover, 5-
amino piperidine 169d was also accessed in quantitative yield by catalytic hydrogenation 
under acid conditions of compound 182a: the acetonide protective group, the Boc 
protection and the benzyl group were all removed in the same step.  
The structure of the aminopiperidines 169 was established on the basis of a careful analysis 
of their 1H NMR and 1D NOESY spectra. In particular, for 169d a strong NOE correlation 
peak between 3-H and 5-H was observed (Figure 3.4), which also established the structure 
of 169a since both compounds derive from 182a. Moreover, the 1H NMR spectrum of 169d 
showed a pseudo triplet with J = 2.5 Hz for 4-H, in agreement with two eq-ax relationships 
with both 3-H and 5-H. For piperidines 169b and 169c, due to the superimposition of 
corresponding NMR signals, 1D NOESY spectra were not useful for structural assignment. 
However, the analysis of the 1H NMR spectrum showed a broad singlet for 4-H in both 169b 
and 169c, that is in agreement with two eq-ax relationships with both 3-H and 5-H. In 
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contrast, the 1H NMR spectrum of 168 (with the opposite configuration at C-5) showed a dd 
for 4-H with J = 8.3 Hz and J = 2.9 Hz, in agreement with an ax-ax relationship and an ax-eq 
relationship with the vicinal protons (Figure 3.4). 
 
Figure 3.4:  Structural assignments by 1D NOESY and 
1
H NMR spectra of piperidines 169 and 168. 
Only the most likely chair conformations with two equatorial and one axial substituents are 
reported. The alternative chair conformation does not affect the reported conclusion. 
3.2.2 Stereoselective Strcker Reaction 
Another synthetic strategy which could provide access to functionalized piperidines from 
aldehyde 166, and in particular to compounds 172-170 (Scheme 3.9), was the Strecker 
reaction followed by deprotection at the anomeric carbon and cyclization. Indeed, we 
envisaged that aldehyde 166 would afford piperidines functionalized at the α-position with 
a cyano group,136 a motif also found to occur in natural products with antitumor activity 
such as Saframycin A, and in related synthetic hybrids.137 We reasoned that such 
compounds could be obtained regioselectively by a Strecker reaction performed on the 
“masked” dialdehyde 166. 
The Strecker reaction, discovered in 1850, 138 is one of the most efficient and 
straightforward methods for the synthesis of aminonitriles,139 which are equivalent 
synthones to imminium moieties and acyl anions. These compounds are versatile 
intermediates for the synthesis of α-amino acids, 1,2-diamines, amides, and various 
nitrogen-containing heterocycles such as thiazoles and imidazoles. Moreover, due to the 
importance of obtaining optically active α-amino acids, enantioselective version of Strecker 
reaction has been widely investigated, exploiting chiral auxiliary based methods (i.e. 
                                                          
136
 D. Enders, J. P. Shilvock, Chem. Soc. Rev. 2000, 29, 359-373. 
137
 E. J. Martinez, E. J. Corey, Org. Lett. 1999, 1, 75-77. 
138
 A. A. Strecker, Ann. Chem. Pharm. 1850, 75, 27-45. 
139
 a) D. Enders, J. P. Shivock, Chem. Soc. Rev. 2000, 29, 359-373; b) M. North, Angew. Chem. Int. Ed. 
2004, 43, 4126-4128. 
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carbohydrate auxiliary, chiral amine auxiliary and cyclic ketamine auxiliary) or catalytic 
asymmetric synthesis (by using metal-based or metal-free catalysts). 140 
In our case, due to the chirality of 166, we expected to obtain diastereoselective Strecker 
reaction. α-Aminonitriles are generally prepared by the nucleophilic addition of cyanide ion 
to the imines using different Lewis acid or base catalysts.140a,141 A variety of cyanating 
agents such as trimethylsiloxy nitriles and diethylphosphorocyanidate have been used for 
the preparation of α-amino nitriles under various conditions.142 In particular, we chose 
trimethylsilyl cyanide (TMSCN) since is a safe, easy-to handle and very effective cyanide 
anion source for the one pot synthesis of α-amino nitriles.143 
 
Entry RNH2 /AcONH4 Solvent a/b
a) Yield of a (%)b) 
1 BnNH2 MeCN
c) >95/5 100d) (80)e) 
2 BuNH2 MeCN
 c) >95/5 100d) (75)e) 
3f) AcONH4 MeCN 62:38 - 
4f) AcONH4 EtOH 81:19 61 
Table 3.2: Strecker reaction of aldehyde 166. a) Determined by 
1
H NMR spectroscopic analysis of the 
crude mixture; b) Isolated yield after flash column chromatography; c) Anhydrous solvent and 3 Å 
MS added; d) Yield of the crude, >95% purity as evaluated by 
1
H NMR spectroscopy; e) Addition of 
1.0 mol% of Cu(OTf)2; f) 1.2 equiv. of TMSCN. 
                                                          
140
 a) H. Gröger, Chem. Rev. 2003, 103, 2795-2827; b) P. Merino, P. E. Marqués-López, T. Tejero, R. P. 
Herrera, Tetrahedron 2009, 65, 1219-1234. 
141
a) B. A. B. Prasad, A. Bisai, V. K. Singht, Tetrahedron Lett. 2004, 45, 9565-9567; b) J. S. Fossey, C. J. 
Richards, Tetrahedron Lett. 2003, 44, 8773-8776; c) E. Takahashi, H. Fujisawa, T. Yanai, T. 
Mukaiyama, Chem. Lett. 2005, 34, 318-319. 
142
 a) K. Mai, G. Patil, Tetrahedron Lett. 1984, 25, 4583-4586; b) S. Harusawa, Y. Hamada, T. Shioiri, 
Tetrahedron Lett. 1979, 20, 4663-4666. 
143
 a) T. K. Chakraborty, G. V. Readdy, K. A. Hussain, Tetrahedron Lett. 1991, 32, 7597-7600; J. P. 
Leblanc, H. W. Gibson, Tetrahedron Lett. 1992, 33, 6295-6298. 
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Aldehyde 166 was first treated with benzylamine (1.0 equiv.) and TMSCN (1.0 equiv.) in dry 
acetonitrile with the addition of 1.0 mol% of Cu(OTf)2 as catalyst.
144 We were delighted to 
observe that mainly one diastereoisomer was formed, in remarkable diastereomeric excess 
(>95:5; Table 3.2, Entry 1). A similar result was observed with BuNH2 as the amine source 
(Table 3.2, Entry 2). However, the presence of a Lewis acid catalyst was found unnecessary 
(Table 3.2, Entries 1 and 2), with cleaner products obtained under these conditions that did 
not require further purification by flash column chromatography. By employing 10 equiv. of 
NH4OAc
145 as source of ammonia in acetonitrile (Table 3.2, Entry 3), adduct 185a was 
obtained in 62:38 diastereoselectivity. A change to EtOH led to an improvement in the 
diastereoselectivity (81:19; Table 3.2, Entry 4) and a quite good isolated yield (61%) of 185a 
was also achieved. The (S) configuration at the newly formed stereocentre was 
unambiguously assigned for 185a on the basis of a single crystal X-ray analysis (Figure 3.5) 
and attributed accordingly to 183a, 184a. 
 
Figure 3.5: X-ray crystal structure of 185a. These data can be obtained free of charge from The 
cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
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 A. S. Paraskar, A. Sudalai, Tetrahedron Lett. 2006, 47, 5759–5762. 
145 a) A. L. Win-Mason, E. M. Dangerfield, P. C. Tyler, B. L. Stocker, M. S. M. Timmer, Eur. J. Org. 
Chem. 2011, 4008–4014; b) A. L. Win-Mason, S. A. K. Jongkees, S. G. Withers, P. C. Tyler, M. S. M. 
Timmer, B. L. Stocker, J. Org. Chem. 2011, 76, 9611–9621. 
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This stereochemical outcome was in agreement to our expectation and can be rationalized 
by a preferred approach of cyanide through a Cram chelated transition state (Figure 3.6), 
where chelation involves the iminium proton and the endocyclic oxygen atom of the sugar 
to give a five-membered ring. According to this model, the cyanide anion would attack from 
the less hindered Si face of the double bond, thus affording adducts 183a, 184a and 185a 
with the S absolute configuration at the newly formed stereocentre with high preference.  
 
Figure 3.6: Cram chelate model for the Strecker reaction on 166 affording stereoselectively α-
aminonitriles 183a, 184a, 185a. 
This stereochemical outcome is in agreement to a recent proposal for the nucleophilic 
attack to acyclic polyhydroxylated aldeyhdes.145 
Unfortunately, attempted deprotection at the anomeric position by catalytic hydrogenation 
on α-aminonitriles 183a-185a, which would induce subsequent cyclization, failed both 
under neutral and acidic conditions and employing different solvents (MeOH, EtOH, 
CH3CN), probably due to catalyst deactivation by the cyanide group. However, the direct 
Strecker reaction with benzylamine on dialdehyde 177 followed by cyclization and in situ 
reduction of the iminium ion intermediate by NaBH3CN, afforded highly regio- and 
stereoselectively the 2-cyano piperidine 186 which was recovered in 50% yield (Scheme 
3.17) after purification over silica gel. Compound 186 had been previously observed as side 
product formed in the reductive amination of 177 with NaBH3CN under neutral 
conditions.130 Their identity was ascertained by 1H NMR comparison of the corresponding 
acetylated derivative 187 (Scheme 3.17). The formation of cyano-substituted compounds as 
by-products during reductive amination reactions with NaBH3CN under neutral or basic 
reaction conditions has been occasionally reported.146 Following these results, we 
considered that the regio- and stereoselective formation of compound 186 from 177 during 
the reductive amination derived from a Strecker reaction occurring at the more reactive 
aldehyde at C-5 followed by intramolecular reductive amination at C-1. 
                                                          
146
 a) J. Neumann, S. Weingarten, J. Thiem, Eur. J. Org. Chem. 2007, 1130–1144; b) J.-P. Liou, Z.-Y. 
Wu, C.-C. Kuo, C.-Y. Chang, P.-Y. Lu, C.-M. Chen, H.-P. Hsieh, J.-Y. Chang, J. Med. Chem. 2008, 51, 
4351–4355. 
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Scheme 3.17: Synthesis of 2-cyano piperidine 186 through direct Strecker reaction on 177 and as by-
product in the reductive amination of 177 in neutral conditions. Reagents and conditions: a) BnNH2, 
3 Å MS, TMSCN, dry CH3CN, rt, 18 h; b) NaBH3CN, CH3CO2H, EtOH, 3 days, 50% over two steps; c) 
BnNH2 (1.2 equiv.), NaBH3CN (2.0 to 3.0 equiv.), MeOH, rt, 2-5 days; d) Ac2O, py, rt, 48 h. 
To get a solid evidence, we modified the anomeric protecting group of the starting sugar 
derivative, in order to demonstrate that the product 183a of the Strecker reaction affords 
piperidine 186 upon a reductive amination/ring closure procedure. A different protecting 
group would eventually allow to perform the cyclization to piperidines functionalized at C-2 
that failed starting from α-aminonitriles 183-185. The simplest protecting group, that could 
be orthogonally removed with respect to the acetonide moiety, was envisaged in the acetyl 
group. Therefore, the differently protected “masked” dialdehyde 167 was synthesized in 
three steps from protected D-mannose 131 (Scheme 3.18). Compound 131 was acetylated 
at the anomeric position affording 188,147 that was deprotected at C-5 and C-6 hydroxy 
groups in aqueous acetic acid affording 189.147a Subsequent oxidative cleavage of glycol 189 
using Silica-Gel-supported sodium metaperiodate in dichloromethane148 led to aldehyde 
167149 in 65% overall yield calculated over three steps (Scheme 3.18). We were delighted to 
observe that also the Strecker reaction on 167 was highly stereoselective. Indeed, the 
reaction of 167 with BnNH2 in the presence of TMSCN afforded the two diastereoisomers 
190a and 190b in 86:14 ratio. 
                                                          
147
 a) D. Vonlanthen, C. J. Leumann, Synthesis 2003, 1987-1090; b) M. I. García-Moreno, P. Díaz-
Pérez, C. Ortiz-Mellet, J. M. García Fernández, J. Org. Chem. 2003, 68, 8890-8901. 
148
 Y.-L. Zhong, T. K. M. Shing, J. Org. Chem. 1997, 62, 2622-2624. 
149
 K. Bischofberger, A. Jordaan, M. Potgieter, P. L. Wessels, S. Afr. J. Chem. 1981, 34, 33-40. 
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Scheme 3.18: Synthesis of aldehyde 167. Reagents and conditions: a) Ac2O, py, rt 3h; b) CH3CO2H, 
H2O, rt, 18 h; c) Silica Gel Supported NaIO4, CH2Cl2, rt, 1h, 65% over three steps. 
The major isomer 190a could be isolated in 68% yield after chromatography on silica gel 
(Scheme 3.19). Structural assignment to the major product as 190a rests on similarity of its 
spectroscopic data to those of 183a but was firmly established by successive 
transformations (see below). A reason for the lower diastereoselectivity of the Strecker 
reaction on aldehyde 167 with respect to its relative 166 may be ascribed to the higher 
hyperconjugative effect given by the acetoxy group, which makes the anti lone pair of the 
endocyclic oxygen less available for intramolecular H-bonding. 
 
Scheme 3.19: The Strecker reaction on aldehyde 167 and synthesis of 2-carbamido piperidines 170a 
and 170b by reductive amination. . Reagents and conditions: a) BnNH2 (1.0 equiv.), dry CH3CN, rt, 40 
min.; b) TMSCN, rt, 18 h; c) Ambersep®900-OH, MeOH, rt, 18 h, 79%; d) HCl, MeOH, rt, 18 h, DOWEX 
50WX8, 80%; e) Pd/C, H2, HCl, MeOH, rt, 48 h, DOWEX 50WX8, 82%. 
A solution of 190a in MeOH was left stirring with Ambersep® 900-OH ion exchange resin at 
room temperature to remove the acetyl group at the anomeric position. After 2 h, the ion 
exchange resin was simply filtered off, NaBH3CN (1.1 equiv.) and AcOH (2.0 equiv.) were 
added to perform the reductive amination reaction and the reaction mixture was stirred at 
room temperature overnight. To our pleasure, the ring closure finally worked, leading to 2-
amido-piperidine 191 in 79% yield (Scheme 3.19). Formation of this compound instead of 
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the expected 2-cyanopiperidine 186 was probably due to concomitant hydrolysis of the 
cyano group under basic conditions during treatment with the resin.150 Treatment with 
methanolic HCl or catalytic hydrogenation in acidic conditions of 191 afforded the 
hydrochloride salts of 170a and 170b, respectively. Final elution through ion-exchange resin 
(DOWEX® 50XW8-100) led to the corresponding free amines in 80% and 82% yields, from 
191 (Scheme 3.19). The structure of 191 was assigned on the basis of the analysis of its 1D 
and 2D NMR spectra. The 1H NMR spectrum showed for 2-H a doublet with J = 4.4 Hz, in 
agreement with an eq-ax relationship with 3-H, and therefore of a cis relationship between 
the amido group and the free hydroxy group at C-3. Remarkably, the relative 
stereochemistry of C-2 in 191 is the same found for the 2-cyanopiperidine 186. This finding 
supports the hypothesis that the selective formation of 186 during the reductive amination 
(see Scheme 3.17) is driven by a Strecker reaction, combined with the following double 
reductive amination, in agreement with our expectation. 
On the basis of these data, the plausible mechanism for the regio- and stereoselective 
formation of compound 186 in the reductive amination of dialdehyde 177 under neutral 
conditions is reported in Scheme 3.20.  
 
Scheme 3.20: Proposed mechanism for the formation of 186 during the reductive amination of 177 
through intermediate cyanide D. 
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Likely, imine A, formed preferentially with respect to imine B (path a vs b, Scheme 3.20), 
leads to adduct C through attack of the hydride ion and therefore to piperidine 176d as the 
major product. However, imine A can undergo attack of the cyanide ion according to the 
Cram chelate model stereoselectively affording α-amino nitrile D and, after cyclization and 
reduction by the hydride ion, the 2-cyano substituted piperidine 186. The alternative 
pathway (path b, Scheme 3.20) would involve reaction of the open-chain form of aldehyde 
177 to afford imine B. Attack of the cyanide ion on B can be ruled out, since piperidines E 
were never observed. Alternatively, reduction of imine B and formation of iminium ion F 
might afford piperidine 186 through cyanide addition at this level occurring 
stereoselectively, which seems unlikely, albeit it cannot be completely excluded.  
Amide 191 is also a suitable intermediate for the synthesis of the new trihydroxypipecolic 
acid 171a, the recently synthesized 171b151 and of 2-aminomethylpiperidine iminosugars 
165a and 165b (Scheme 3.21). Hydrolysis of the amido moiety and concomitant 
deprotection of acetonide group of 191 was achieved upon heating in a 6 M HCl solution 
for 16 h.152 Purification of this hydrochloride salt was achieved by stirring in an aqueous 
NaOH solution for 1 h, followed by elution on an anion exchange resin (Ambersep® 900 OH) 
eluting sequentially with MeOH, H2O and a 6 M solution of HCl. Concentration of the acidic 
fractions afforded pure 171a.HCl in 71% yield (Scheme 3.21).  
 
Scheme 3.21: Synthesis of trihydroxypipecolic acids 171a and 171b and of aminopiperidines 172a 
and 172b. Reagents and conditions: a) 6 M HCl, reflux, 16 h, b) Ambersep®900-OH, 71%; c) Pd/C, H2, 
HCl, MeOH, rt; d) 6 M HCl, reflux, 16 h, 100%; e) LiAlH4, reflux, 1.5 h, 79%; f) MeOH, HCl, rt, 48 h, g) 
DOWEX 50WX8, 89%; h) Pd/C, H2, HCl, MeOH, rt, 3 days; i) DOWEX 50WX8, 95%. 
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 Y. Yoshimura, C. Ohara, T. Imahori, Y. Saito, A. Kato, S. Miyauchi, I. Adachi, H. Takahata, Bioorg. 
Med. Chem. 2008, 16, 8273-8286. 
152
 A. Fadel, N. Lahrache, J. Org. Chem. 2007, 72, 1780-1784. 
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Alternatively, catalytic hydrogenation followed by heating in a 6 M HCl solution for 16 h 
gave 171b.HCl in 100% yield. 
This compound was characterized as the hydrochloride salt since previous obtainment as 
the free amine151 showed great variability in the optical rotation measurement. On the 
other hand, reduction of 191 with LiAlH4 in refluxing THF gave the diamine 192 in 79% yield. 
Treatment with methanolic HCl or catalytic hydrogenation under acidic conditions afforded 
the hydrochloride salts of 165a and 165b,153 respectively. Final elution through ion-
exchange resin (DOWEX® 50XW8-100) led to the corresponding free amines in 89% and 95% 
yields, respectively (Scheme 3.21).  
Compounds 165, ent-164, 168a-g, 169a-d, 170a-b, 171a-b.HCl and 172a-b were assayed as 
glycosidase inhibitors towards a panel of commercially available glycosidases (see Table 3, 
Chapter 3.3). 
3.2.3 Synthesis of Multivalent Piperidine Iminosugars 
In analogy with what reported in Chapter 2.4 for pyrrolidine-containing iminosugars, an 
example of multivalent piperidine-based compound was also synthesised by CuI-catalyzed 
azide-alkyne cycloaddition (CuAAC).  
First of all the tetravalent scaffold 193 was synthesized by propargylation of pentaerythritol 
with propargyl bromide and NaH as previously reported.154 The reaction of 4 equivalents of 
azido derivative 176e with scaffold 193 afforded the expected tetravalent iminosugar 
derivative 194 in 88% yield (Scheme 3.22). Deprotection of adduct 194 was not a trivial 
task, due to the high basicity and hydrophilicity of the deprotected compound. 
Treatment of 194 in acidic MeOH at room temperature for 18 hours gave the hydrochloride 
salt, that was passed onto a ion exchange resin Dowex 50WX8-200 eluting successively with 
MeOH, H2O and 6% aqueous ammonia. However, most of the compound was eluted in the 
first fraction with MeOH as hydrochloride salt, and only a small amount with ammonia in 
the final fraction as free amine. The methanolic fraction was then acetylated by treatment 
with pyridine and acetic anhydride, affording compound 195 with 91% yield after flash 
column chromatography. After treatment with strongly basic resin Ambersep 900 OH, pure 
196 was obtained in 86% yield. 
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 M. Ganesan, R. Vilas Salunke, N. Singh, N. G. Ramesh, Org. Biomol. Chem. 2013, 11, 599-611. 
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Scheme 3.22: Synthesis of the tetravalent piperidine 194. Reagents and conditions: a) CuSO4 (0.3 
equiv.), sodium ascorbate (0.6 equiv.), THF/H2O 2:1 MW 80 °C, 45 min, 88%. 
This compound and the free amine previously recovered by DOWEX elution of 194 with 6% 
aqueous ammonia were proved to be identical by 1H NMR analysis (Scheme 3.23). 
Preliminary biological evaluation of compound 196 and its hydrocholide salt (196 HCl) were 
carried out by measuring their inhibitory activity towards a panel of commercially available 
glycosidases, in the laboratories of Prof. I. Robina of University of Seville (see Table 3.3, 
Chapter 3.3). 
 
Scheme 3.23: Deprotection and purification the tetravalent piperidine 194. Reagents and conditions: 
a) MeOH, 12M HCl, rt, 18 h, 100%; b) Ac2O, Py, rt 18 h, 91%; c) MeOH, Ambersep 900 OH 
rt, 18h, 86%. 
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The tetravalent compound, both as free amine and hydrochloride salt, showed a very 
similar activity respect to the monovalent iminosugar 176e. All three compounds resulted 
modest inhibitors of α-fucosidase, being the monovalent compound a little bit more potent 
than multivalent one (62% vs 45%). This may be ascribed to the nature of the scaffold or 
the linker, which prevents the bioactive piperidine molecule to reach the active site. 
Curiously, the tetravalent free amine 196 resulted less selective with respect to monovalent 
compound showing an increased inhibitory activity towards amyloglucosidase (57% vs 27%) 
and some kind of activity also towards α-glucosidase and α-galactosidase. 
These preliminary results show that the choice of appropriate scaffold and linker is 
crucial.155 
3.3 Biological Evaluation 
Since natural compounds 165 and ent-164 are non-selective moderate inhibitors of 
glycosidases122b it was expected that piperidines derivatives bearing alkyl, aryl or additional 
amino moieties, may reinforce the enzymatic inhibitory properties through allosteric 
interactions or acting as transition state mimetics reinforcing the interaction with the 
glycosidase active site.156 Compounds 165, ent-164, 168a-g, 169a-d, 170a-b, 171a-b.HCl and 
172a-b were assayed as glycosidase inhibitors towards a panel of commercially available 
glycosidases. The results are summarized in Table 3.3. The compounds tested did not 
exhibit significant activity against β-galactosidase from Escherichia coli β-glucosidases from 
rice, β-mannosidase from snail and β-N-acetylglucosaminidase from Jack bean. In our 
hands, known compound ent-164122b presents the best activity towards α-L-fucosidase 
showing a moderate value, IC50 = 90.3 µM, towards this enzyme. Previous results for this 
compound showed worst results with an IC50 = 450 μM towards the same enzyme, and no 
selectivity.157 N-substitution of compound ent-164 reduces the inhibitory activity with a 
greater extent in the isopropyl derivative 11a. The N-butyl derivative 168b showed a 
moderate activity, which is in accordance with the data reported122b for this compound. The 
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 C. Decroocq, A. Joosten, R. Sergent, T. M. Barragán, C. Ortiz Mellet, P. Compain, ChemBiochem 
2013, 14, 2038-2049. 
156
 a) S. Gerber-Lemaire, F. Popowycz, E. Rodríguez-Garcia, A. T. Carmona, and I. Robina, 
ChemBioChem. 2002, 5, 466-470; b) A.T. Carmona, F. Popowycz, S. Gerber-Lemaire, E. Rodríguez-
García, C. Schütz, P. Vogel, and 
 
I. Robina, Bioorg. &  Med. Chem., 2003, 11, 4897-4911; c) F. 
Popowycz, S. Favre, C. Schütz, P. Vogel, S. Gerber-Lemaire, and L. Juillerat-Jeanneret, J. Med. Chem. 
2005, 48, 4237-4246; d) E. Moreno-Clavijo, A. T. Carmona, Y. Vera-Ayoso, A. J. Moreno-Vargas, C. 
Bello, P. Vogel, and I. Robina, Org. Biomol. Chem. 2009, 7, 1192-1202. 
157
 Inhibitory activity against β-galactosidase from coffee bean IC50 = 70 µM, β-galactosidase from 
Aspergillus orizae IC50 = 50 µM and β-glucosidase from almonds IC50 = 100 µM, for details see Ref. 
122b
. 
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presence of a free amino group or an acetamido group at the 1-N-alkyl side chain is 
detrimental for α-L-fucosidase inhibition as shown in compounds 168f and 168g. These 
compounds displayed weak-to-moderate inhibitory activity towards β-galactosidase from 
coffee beans.  
Enzymes 
% of inhibition at 1 mM ( IC50, M) 
Compound 
-L-Fuc-
ase 
-Gal-
ase 
-Gal-
ase 
-Gluc-
ase 
Amylogluc-
ase 
-Gluc-
ase 
-Man-
ase 
ent-164 89 (90.3) n.i. n.i. n.i. n.i. n.i. n.i. 
168a 46 n.i. n.i. n.i. n.i. n.i. n.i. 
168b 72 22 n.i. n.i. n.i. n.i. n.i. 
168c 77 n.i. n.i. 50 36 n.i. n.i. 
168d n.i. n.i. n.i. n.i. n.i. 48 n.i. 
168e 62 n.i. n.i. n.i. 27 n.i. n.i. 
168f n.i. 32 n.i. n.i. n.i. n.i. n.i. 
168g n.i. 64 n.i. 15 n.i. n.i. n.i. 
165 38 n.i. 47
d)
 n.i. n.i. 79 17 
169a n.i. n.i. n.i. n.i. 24 83 (65.3) n.i. 
169b n.i. n.i. n.i. n.i. 21 75 35 
169c n.i. n.i. n.i. n.i. 16 66 n.i. 
169d n.i. n.i. n.i. n.i. 35 n.i. n.i. 
170a n.i. n.i. n.i. n.i. n.i. n.i. n.i. 
170b n.i. n.i. n.i. n.i. n.i. n.i. n.i. 
171a·HCl 18 n.i. n.i. n.i. 37 n.i. 70 
171b·HCl n.i. n.i. n.i. 20 n.i. 35 n.i. 
172a n.i. n.i. n.i. n.i. n.i. n.i. n.i. 
172b 37 n.i. n.i. n.i. n.i. n.i. 51 
196 45 39 n.i. 29
e)
 57 n.i. n.i. 
196
.
HCl 56 n.i. n.i. n.i.
e)
 27 n.i. n.i. 
Table 3.3: Inhibitory activities of compounds ent-164, 168a-g, 165, 169a-d, 170a-b, 171a-b
.
HCl, 
172a-b and tetravalent compound 196 (free amine and hydrochloride salt) toward glycosidases. 
Optimal pH, 35 ºC 
a, b, c
. a) For conditions of measurements see Ref.
111
; b) n.i.: no inhibition was 
detected at 1 mM concentration of the corresponding compound; c) -L-fucosidase from bovine 
kidney, -galactosidase from coffee beans, -galactosidase from Aspergillus orizae, -glucosidase 
from rice, Amyloglucosidase from Aspergillus niger, -glucosidase from almonds, -mannosidase 
from Jack bean; d) -galactosidase from Aspergillus orizae and from Escherichia coli; e) -glucosidase 
from yeast. 
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The inversion of configuration at 5-OH, as in epimer 165, greatly disminished the activity 
towards α-L-fucosidase, showing also weak to moderate inhibition against other 
enzymes.158 The substitution of an OH group in 165 by an amino moiety reduced the 
inhibitory activity towards the panel of tested enzymes displaying only a poor inhibition 
against amyloglucosidase from Aspergillus niger. 
Interestingly, the introduction of an aromatic moiety as in compound 169a, increased the 
inhibitory activity towards β-glucosidase from almonds to an IC50 = 65.3 μM, which is in 
agreement with the data reported for other aryl iminosugars.156,159 Changing the aryl 
moiety to alkyl chains (169b, 169c), the inhibitory activity against β-glucosidase is slightly 
reduced, although is higher than in the aminopiperidine 169d. The inhibitory activity of a 
series of 3,4,5-trihydroxypipecolic acids have been evaluated151 showing weak inhibitory 
properties. In our hands known compound 171b.HCl showed only weak inhibition to α- and 
β-glucosidases.160 The benzyl derivative 171a.HCl significantly presented a moderate 
inhibition against α-mannosidases, which is abolished in the N-benzyl aminomethyl 
derivative 172a and a little reduced in aminomethyl derivative 172b. Changing the acid 
group to an amide group in 170a and 170b lead to a complete reduction of the inhibitory 
activity. 
Finally, the tetravalent compound 196, both as free amine and as hydrocholide salt (196 
HCl), did not present any increase of inhibitory activity respect to the monovalent 
compound 176e. 
3.4 Conclusions 
In conclusion, a straightforward synthetic strategy for the obtainment of diversely 
functionalized polyhydroxy and polyhdyroxyamino piperidines, among which natural 
products 165 and ent-164 is presented in this chapter, that employs the double reductive 
amination strategy or the Strecker reaction on D-mannose-derived aldeydes 166 and 167. 
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 According to Ichikawa and co-workers (see Ref. 
122b
): inhibitory activity against β-galactosidase 
from Aspergillus orizae IC50 = 40 μM, β-glucosidase from almonds IC50 = 8.8 µM and α-mannosidase 
from Jack bean IC50 = 360 μM. 
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 a) Wu, C.-Y.; Chang, C.-F.; Chen, S.-Y. J.; Wong, C.-H.; Lin, C.-H. Angew. Chem. Int. Ed. 2003, 42, 
4661; b) Chang, C. F.; Ho, C. W.; Wu, C.-Y.; Chao, T.-A.; Wong, C.-H.; Lin, C.-H. Chem. Biol. 2004, 11, 
1301. 
160
 According to Takahata and coworkers (see Ref.
151
) this compound exhibited weak activity against 
β-N-acetylglucosaminidase from bovine kidney and from human placenta, α-N-
acetylgalactosaminidase from chicken liver and against β-glucuronidase from bovine liver and from 
E. Coli. 
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This strategy also allowed the synthesis of trihydroxypipecolic acids 171a,b and of 
aminomethylpiperidine iminosugars 172a,b. 
The exploitation of the CuAAC cycloaddition on key azido intermediate 176e with a 
tetravalent alkyne scaffold also allowed the synthesis of the multivalent compound 196. 
Biological evaluation of all the synthesized compounds towards a range of commercially 
available glycosidases has been also reported. 
3.5 Experimental Section 
General methods: Commercial reagents were used as received. All reactions were 
magnetically stirred and monitored by TLC on 0.25 mm silica gel plates (Merck F254) and 
column chromatography was carried out on Silica Gel 60 (32-63 m). Yields refer to 
spectroscopically and analytically pure compounds unless otherwise stated. 1H NMR 
spectra were recorded on a Varian Mercury-400, Varian INOVA-400 or Bruker AVANCE-500. 
13C NMR spectra were recorded on a Varian Gemini-200 or Bruker AVANCE-500. Infrared 
spectra were recorded with a Perkin-Elmer Spectrum BX FT-IR System spectrophotometer. 
ESI full MS were recorded on a Thermo LTQ instrument by direct inlet; relative percentages 
are shown in brackets. Elemental analyses were performed with a Perkin-Elmer 2400 
analyzer. Optical rotation measurements were performed on a JASCO DIP-370 polarimete. 
Synthesis of benzyl 2,3-O-(1-methylethylidene)-α-D-lyxo-pentodialdo-1,4-furanoside 
(166): To a suspension of D-mannose (5.0 g, 27.80 mmol) in acetone (250 mL), iodine (1.47 
g, 5.80 mmol) was added and the mixture was stirred for 2 h at room temperature. The 
reaction mixture was quenched at 0 °C with saturated solutions of sodium thiosulfate (70 
mL) and sodium bicarbonate (70 mL), then extracted with chloroform (200 mL). After 
treatment of the organic phase with a saturated solution of sodium bicarbonate (3x50 mL), 
the organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure 
to give 131 as a pale yellow solid (6.76 g, 26.0 mmol, 93%), which was used without further 
purification in the next step. To a solution of 131 (500 mg, 1.92 mmol) in dry THF (3.84 mL), 
freshly powdered KOH (194 mg, 3.46 mmol), 18-crown-6 (21 .0 mg, 0.08 mmol) and BnBr 
(0.25 mL, 2.11 mmol) were added sequentially. The mixture was stirred at room 
temperature for 16 h and then diluted with CH2Cl2 and washed several times with water. 
Evaporation of the organic phase furnished pure product 173 with quantitative yield. A 
solution of 173 (295 mg, 0.84 mmol), glacial AcOH (6.4 mL) and water (2.7 mL) was stirred 
for 18 h at room temperature and concentrated under reduced pressure. The residue was 
dissolved in AcOEt (14 mL), washed sequentially with saturated aqueous solution of 
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NaHCO3 (2x4 mL), water (2x2 mL) and brine (2x3 mL), dried (Na2SO4) and the solvent was 
concentrated to afford 174 (240 mg, 0.77 mmol, 92%) as a colorless oil. To a vigorously 
stirred suspension of silica-gel supported NaIO4161 reagent (1.54 g) in CH2Cl2 (3.85 mL), a 
solution of 174 (240 mg, 0.77 mmol) in CH2Cl2 (3.85 mL) was added and stirred at room 
temperature for 50 minutes. The reaction mixture was then filtered, washing the residue 
with CHCl3. The combined filtrates were concentrated under reduced pressure and allowed 
to stand at 5 °C overnight to give 166 (200 mg, 0.72 mmo, 93%) as a solid, m.p. 80-81 °C, 
which was pure enough to be employed in the subsequent steps (80% over four steps from 
D-mannose). 
Synthesis of (3R,4S,5R)-5-hydroxy-3,4-O-(1-methylethylidene)-piperidine (175): Aldehyde 
166 (126 mg, 0.45 mmol) and benzylamine (50 µL, 0.45 mmol) were dissolved in MeOH (5.0 
mL) and 60 mg of 3Å pellets molecular sieves were added. The reaction mixture was left 
stirring at room temperature for 40 minutes (formation of imine is attested by 1H NMR 
control), then Pd(OH)2/C (63 mg) was added and the mixture was left stirring at room 
temperature under H2 atmosphere for 25 hours. The catalyst and the molecular sieves were 
filtered, washing several times with MeOH and then the solvent was evaporated under 
vacuum. The crude product was purified using silica gel gradient flash chromatography 
(CH2Cl2/MeOH/NH4OH 6% from 40:1:0.1 to 10:5:0.5) to give compound 175 as a white solid 
(54 mg, 0.31 mmol, 69%), m.p. 117-119 °C. [α]D
24 = - 84.0 (c = 1.01, MeOH). 1H-NMR (400 
MHz, CD3OD) δ = 4.18 (dt, J = 5.5, 3.2 Hz, 1H, 3-H), 3.88 (t, J = 5.9 Hz, 1H, 4-H), 3.67 (ddd, J = 
9.4, 6.5, 4.5 Hz, 1H, 5-H), 3.10 (dd, J = 14.7, 2.2 Hz, 1H, 2-Ha), 2.94-2.89 (m, 1H, 6-Ha), 2.90 
(dd, J = 14.6, 3.4 Hz, 1H, 2-Hb), 2.34 (dd, J = 13.3, 9.4 Hz, 1H, 6-Hb), 1.49 (s, 3H, Me), 1.34 (s, 
3H, Me) ppm. 13C-NMR (50 MHz, CD3OD) δ = 107.7 (s, acetal), 78.0 (d, C-4), 72.0 (d, C-3), 
68.4 (d, C-5), 47.3 (t, C-6), 44.7 (t, C-2), 26.3 (q, Me), 24.4 (q, Me) ppm. IR (KBr): ν = 3299, 
3162, 2981, 2935, 2897, 1557, 1456, 1383, 1373, 1220, 1089, 1054, cm-1. MS (ESI): m/z (%) = 
173.98 (100) [M+H]+. C8H15NO3 (173.21): calcd. C 55.47, H 8.73, N 8.09; found C 55.26, H 
8.79, N 8.05. 
Synthesis of (3R,5R)-3,4,5-trihydroxy-piperidine (ent-164): A solution of 175 (49 mg, 0.28 
mmol) in MeOH (5.0 mL) and HCl 1M (10 drops) was left stirring at room temperature 
overnight. The crude mixture was concentrated to yield the hydrochloride of ent-164 which 
was eluted through an ion-exchange resin (DOWEX® 50XW8-100) with MeOH, H2O and 6% 
NH4OH to give the free amine ent-164 (37 mg, 100%). [α]D
26 = - 65.7 (c = 1.00, MeOH). 1H-
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 Y. L. Zhong, T. K. M. Shing, J. Org. Chem. 1997, 62, 2622-2624. 
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NMR (400 MHz, D2O) δ = 3.88 (br s, 1H, 3-H), 3.67 (td, J = 8.8, 4.4 Hz, 1H, 5-H), 3.45 (dd, J = 
8.6, 2.9 Hz, 1H, 4-H), 2.96 (dd, J = 13.0, 4.3 Hz, 1H, 6-Ha), 2.82 (d, J = 13.9 Hz, 1H, 2-Ha), 2.61 
(d, J = 14.0 Hz, 1H, 2-Hb), 2.30 (dd, J = 12.8, 9.8 Hz, 1H, 6-Hb) ppm. 13C-NMR (50 MHz, D2O) 
δ = 72.8 (d, C-4), 67.6 (d, C-3), 67.3 (d, C-5), 47.6 (t, C-6), 47.3 (t, C-2) ppm. MS (ESI): m/z (%) 
= 156.16 (100) [M+Na]+. C5H11NO3 (133.15): calcd. C 45.10, H 8.33, N 10.52; found C 45.32, 
H 7.98, N 10.39. 
General procedure for the synthesis of N-alkyl piperidines (176a and 176b): Aldehyde 166 
and the appropriate amine (1.0 equiv) were dissolved in MeOH (0.1 M) and 60 mg of 3Å 
pellets molecular sieves were added. The reaction mixture was left stirring at room 
temperature for 40 minutes and, when the complete conversion to imine was observed (1H 
NMR control), Pd(OH)2/C (50% wt) and CH3COOH (2.0 equiv) were added and the mixture 
was left stirring at room temperature under H2 atmosphere for 7 days. The catalyst and the 
molecular sieves were filtered, washing several times with MeOH and then the solvent was 
evaporated under vacuum.  
(3R,4S,5R)-1-Butyl-5-hydroxy-3,4-O-(1-methylethylidene)-piperidine (176a). Application of 
this procedure to 168 mg (0.60 mmol) of 166 with butylamine (59 µL, 0.60 mmol) furnished, 
after purification by flash column chromatography (CH2Cl2/MeOH/NH4OH 6% from 15:1:0.1 
to 10:1:0.1), compound 176a (48 mg, 0.21 mmol, 35%) as a white solid, m.p. 21-23 °C. [α]D
24 
= + 16.4 (c = 1.07, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 4.27 (t, J = 7.2, 6.0 Hz, 1H, 3-H), 4.03 
(t, J = 4.4 Hz, 1H, 4-H), 3.94-3.91 (m, 1H, 5-H), 2.73 (ddd, J = 11.7, 6.2, 1.5 Hz, 1H, 2-Ha), 2.55 
(dd, J = 11.7, 2.8 Hz, 1H, 6-Ha), 2.46 (ddd, J = 11.7, 5.3, 1.4 Hz, 1H, 6-Hb), 2.41-2.30 (m, 3H, 
2-Hb, 1’-H), 1.49 (s, 3H, Me), 1.47-1.39 (m, 2H, 2’-H), 1.34 (s, 3H, Me), 1.32-1.24 (m, 2H, 3’-
H), 0.91-0.87 (t, J = 7.4 Hz, 3H, 4’-H) ppm. 13C-NMR (50 MHz, CDCl3) δ = 109.1 (s, acetal), 
77.3 (d, C-4), 72.2 (d, C-3), 67.8 (d, C-5), 57.5 (t, C-1’), 55.6 (t, C-2), 55.3 (t, C-6), 28.8 (q, 
Me), 28.2 (q, Me), 26.3 (t, C-2’), 20.5 (t, C-3’), 13.9 (q, C-4’) ppm. MS (ESI): m/z (%) = 230.35 
(99) [M+H]+, (10) [M+Na]+. IR (CDCl3): ν =  3604, 3499, 2958, 2935, 2247, 1686, 1456, 1383, 
1219, 1058 cm-1. C12H23NO3 (229.32): calcd. C 62.85, H 10.11, N 6.11; found C 63.12, H 9.78, 
N 6.40. 
(3R,4S,5R)-1-Octyl-5-hydroxy-3,4-O-(1-methylethylidene)-piperidine (176b): Application of 
this procedure to 140 mg (0.50 mmol) of 166 with octylamine (83 µL, 0.50 mmol) furnished, 
after purification by flash column chromatography (CH2Cl2/MeOH/NH4OH 6% from 
15:0.5:0.1 to 10:1:0.1), compound 176b (59 mg, 0.21 mmol, 41%) as a white solid, m.p. 39-
41 °C. [α]D
23 = + 27.0 (c = 0.76, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 4.27 (dt, J = 7.6, 5.1 Hz, 
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1H, 3-H), 4.08 (dd, J = 4.9, 3.9 Hz, 1H, 4-H), 3.95 (dd, J = 7.6, 3.8 Hz, 1H, 5-H), 2.82 (ddd, J = 
7.7, 6.3, 1.5 Hz, 1H, 2-Ha), 2.56 (d, J = 2.4 Hz, 2H, 6-H), 2.43-2.34 (m, 3H, 2-Hb, 1’-H), 1.50 (s, 
3H, Me), 1.48-1.41 (m, 4H) 1.35 (s, 3H, Me), 1.33-1.20 (m, 8H), 0.88 (t, J = 6.8 Hz, 3H, 8’-H) 
ppm. 13C-NMR (50 MHz, CDCl3) δ = 109.2 (s, acetal), 77.0 (d, C-4), 72.1 (d, C-3), 67.6 (d, C-5), 
57.8 (t, C-1’), 55.8 (t, C-2), 55.5 (t, C-6), 31.8, 29.4, 29.2 (t, 3C), 28.2 (q, Me), 27.3 (q, Me), 
26.8, 26.3, 22.6 (t, 3C), 14.0 (q, C-8’) ppm. MS (ESI): m/z (%) = 286.25 (100) [M+H]+. IR 
(CDCl3): ν = 3610, 3472, 2987, 2953, 2927, 2249, 1467, 1219, 1059 cm
-1. C16H31NO3 (285.42): 
calcd. C 67.33, H 10.95, N 4.91; found C 67.31, H 10.73, N 4.54. 
Synthesis of (3R,4S,5R)-5-Hydroxy-1-isopropyl-3,4-isopropylidene- dioxypiperidine (176c): 
Aldehyde 166 (570 mg, 2.05 mmol) and benzylamine (220 µL, 2.05 mmol) were dissolved in 
MeOH (90 mL) and 300 mg of 3Å pellets molecular sieves were added, under N2 
atmosphere. The reaction mixture was left stirring at room temperature for 40 minutes, 
then Pd(OH)2/C (285 mg) was added and the mixture was left stirring at room temperature 
under H2 atmosphere for 4 days (the disappearance of benzyl signals was attested by 
1H 
NMR control). The catalyst and the molecular sieves were filtered, washing several times 
with MeOH, and the solvent was evaporated under vacuum. Purification of the residue by 
flash column chromatography on silica gel afforded pure 176c (121 mg, 0.56 mmol, 27%). 
Rf=0.70 (CH2Cl2/MeOH/NH4OH 6% 10:1:0.1); [α]D
24=+23.0 (c=1.04 in CHCl3); 
1H-NMR (400 
MHz, CDCl3): δ=4.30-4.25 (m, 1H; 3-H), 4.08 (dd,
3J(H,H)=5.0, 3.6 Hz, 1H; 4-H), 3.92 (dd, 
3J(H,H)=6.4, 3.6 Hz, 1H; 5-H), 2.84-2.76 (m, 2H; 2a-H, CH-iPr), 2.61-2.59 (m, 2H; 6-H), 2.38 
(dd, 2J(H,H)=11.6, 3J(H,H)=8.0 Hz, 1H; 2b-H), 1.49 (s, 3H; Me), 1.34 (s, 3H; Me), 1.00 (d, 
3J(H,H)=6.6 Hz, 3H; CH3-iPr), 0.99 ppm (d, 
3J(H,H)=6.6 Hz, 3H; CH3-iPr); 
13C-NMR (50 MHz, 
CDCl3): δ=108.9 (s; acetal), 77.3 (d, C-4), 71.9 (d, C-3), 66.5 (d, C-5), 54.0 (d, NCH(CH3)2), 51.7 
(t; C-2), 50.3 (t, C-6), 28.0 (q, Me), 26.1 (q, Me), 18.0 (q, NCH(CH3)2) 17.5 ppm (q, 
NCH(CH3)2); IR (CDCl3): ν˜=3469, 2938, 2970, 2837, 2249, 1660, 1459, 1405, 1383, 1325, 
1291, 1253, 1219, 1163, 1058 cm-1; MS (ESI): m/z (%): 216.11 (100) [M+H]+; elemental 
analysis calcd (%) for C11H21NO3 (215.29): C 61.37, H 9.83, N 6.51; found C 61.57, H 10.02, N 
6.31.  
Synthesis of (3R,4S,5R)-1-Isopropyl-3,4,5-trihydroxypiperidine (168a): A solution of 176c 
(40 mg, 0.19 mmol) in MeOH (10.0 mL) was left stirring with 12M HCl (8 drops) at room 
temperature for 24 h. The crude mixture was concentrated to yield the hydrochloride salt 
of 168a. The corresponding free amine was obtained by passing the hydrochloride salt 
through a DOWEX® 50XW8-100 ion-exchange resin. Elution with 6% ammonia afforded the 
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free base 168a (33 mg, 0.19 mmol, 100%). [α]D
24=-41.9 (c=0.65 in H2O); 
1H-NMR (400 MHz, 
D2O): δ=3.86 (m, 1H; 3-H), 3.72 (td, 
3J(H,H)=8.8, 4.4 Hz, 1H; 5-H), 3.34 (dd, 3J(H,H)=8.3, 2.9 
Hz, 1H; 4-H), 2.77-2.64 (m, 3H; 2a-H, 6a-H, CH-iPr), 2.31 (dd, 
2J(H,H)=12.4, 3J(H,H)=1.7 Hz, 
1H; 2b-H), 2.12 (t, J(H,H)=10.0 Hz, 1H; 6b-H), 0.91 (d, 3J(H,H)=9.2 Hz, 3H; CH3-iPr), 0.89 ppm 
(d, 3J(H,H)=9.2 Hz, 3H; CH3-iPr); 
13C-NMR (50 MHz, D2O): δ=73.6 (d, C-4), 67.7 (d, C-5), 67.5 
(d, C-3), 54.0 (d, NCH(CH3)2), 52.2 (t, C-6), 50.6 (t, C-2), 17.6 (q, NCH(CH3)2), 16.2 ppm (q, 
NCH(CH3)2); MS (ESI): m/z (%): 198.17 (100) [M+Na]
+; elemental analysis calcd (%) for 
C8H17NO3 (175.23): C 54.84, H 9.78, N 7.99; found C 55.15, H 9.92, N 7.68. 
Synthesis of 2,3-O-(1-methylethylidene)-α-D-lyxo-pentodialdo-1,4-furanose or 3,4-O-(1-
methylethylidene)-D-arabino-pentodialdo-2,5-furanose (177): To a solution of 166 (514 
mg, 1.85 mmol) in MeOH (36 mL), Pd(OH)2/C (257 mg) was added and the reaction mixture 
was left stirring at room temperature under H2 atmosphere for 4 h. The catalyst was 
filtered through Celite® and the filtrate was concentrated under vacuum, to yield 
quantitative 177 (348 mg). 1H NMR of 177 showed the presence of a complex mixture or 
different forms.  
General Procedure for the synthesis of N-alkyl piperidines 176a, 176b and 176d by double 
reductive amination on 177: A 0.06 M solution of dialdehyde 177 in dry MeOH was stirred 
in the presence of 3Å molecular sieves powder for 15 min, under nitrogen atmosphere. 
Then NaBH3CN (3.0 equiv) was added and the reaction mixture cooled at 0°C. Finally R-NH2 
(R = Bn, Bu, Octyl, 0.9 equivalents) and AcOH (2 equiv) were added and the mixture was 
allowed to warm to room temperature and stirred for a total of 3-7 days, under nitrogen 
atmosphere. The molecular sieves were removed by filtration through Celite and the 
filtrate was concentrated under vacuum. The residue was purified by flash chromatography 
(CH2Cl2/MeOH or CH2Cl2/MeOH/6% NH4OH) affording 176a, 176b and 176d in 48-93% 
yields. 
Application of the general procedure to 100 mg of 177 (0.53 mmol) and butylamine (47 μL, 
0.48 mmol) afforded compound 176a (52 mg, 0.23 mmol) in 48% yield after purification by 
flash column chromatography (CH2Cl2/MeOH/NH4OH 6%, 15:0.5:0.1).  
Application of the general procedure to 104 mg of 177 (0.55 mmol) and octylamine (83 μL, 
0.50 mmol) afforded compound 176b (75 mg, 0.28 mmol) in 56% yield after purification by 
flash column chromatography (CH2Cl2/MeOH/NH4OH 6%, 15:0.5:0.1).  
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Application of the general procedure to 122 mg of 177 (0.65 mmol) and benzylamine (64 
μL, 0.59 mmol) afforded compound 176d (144 mg, 0.55 mmol) in 93% yield after 
purification by flash column chromatography (CH2Cl2/MeOH/NH4OH 6%, 15:0.5:0.1 
General procedure for the synthesis of unnatural alkylated piperidines (168b, 168c and 
168d): A 0.05 M solution of 176a, 176b and 176d in MeOH was left stirring with HCl 1M (10 
drops) at room temperature overnight. The crude mixture was concentrated to yield the 
hydrochloride salts of 168b, 168c, 168d. The corresponding free amine was obtained by 
passing the hydrochloride salt through a DOWEX® 50XW8-100 ion-exchange resin. Elution 
with 6% ammonia afforded the free bases 168b, 168c, 168d. 
(3R,5R)-1-Butyl-3,4,5-trihydroxy-piperidine (168b): Application of this procedure to 60 mg 
(0.26 mmol) of 176a furnished the free amine 168b (49 mg, 100%) as a waxy solid. [α]D
27 = - 
42.5 (c = 0.93, H2O). 
1H-NMR (400 MHz, D2O) δ = 3.94-3.91 (m, 1H, 3-H), 3.79 (dt, J = 13.2, 
4.4 Hz, 1H, 5-H), 3.45-3.43 (m, 1H, 4-H), 2.90-2.83 (m, 2H, 2-Ha, 6-Ha), 2.47-2.35 (m, 3H, 2-
Hb, 1’-H), 2.14-2.18 (m, 1H, 6-Hb), 1.43-1.33 (m, 2H, 2’-H), 1.19 (td, J = 14.6, 7.3 Hz, 2H, 3’-
H), 0.78 (t, J = 7.3 Hz, 3H, 4’-H) ppm. 13C-NMR (50 MHz, D2O) δ =  72.2 (d, C-4), 66.3 (d, 2C, 
C-3, C-5), 56.3 (t, C-1’), 55.1 (t, C-6), 54.4 (t, C-2), 26.4 (t, C-2’), 19.2 (t, C-3’), 12.4 (q, C-4’) 
ppm. MS (ESI): m/z (%) = 190.17 (100) [M+H]+. C9H19NO3 (189.25): calcd. C 57.12, H 10.12, N 
7.40; found C 56.77, H 10.39, N 7.84. 
(3R,5R)-1-Octyl-3,4,5-trihydroxy-piperidine (168c): Application of this procedure to 20 mg 
(0.07 mmol)of 176b furnished the free amine 168c as a pale yellow oil (14 mg, 0.06 mmol, 
82%). [α]D
27 = - 19.6 (c = 0.52, MeOH). 1H-NMR (400 MHz, CD3OD) δ = 3.94-3.92 (m, 1H, 3-
H), 3.82 (td, J = 7.4, 3.9 Hz, 1H, 5-H), 3.48-3.42 (m, 1H, 4-H), 2.90-2.83 (m, 2H, 2-Ha, 6-Ha), 
2.52-2.46 (m, 3H, 2-Hb, 1’-H), 2.35-2.22 (m, 1H, 6-Hb), 1.55-1.53 (m, 2H, 2’-H), 1.36-1.25 (m, 
10 H), 0.89 (t, J = 7.1 Hz, 3H, 8’-H) ppm. 13C-NMR (50 MHz, CD3OD) δ = 71.7 (d, C-4), 66.6 (d, 
C-5), 65.7 (d, C-3), 56.7 (t, C-1’), 54.7 (t, C-2), 54.2 (t, C-6), 30.7, 28.2 (t, 2C), 28.1 (t, C-2’), 
26.1, 24.5, 21.4 (t, 3C), 12.2 (q, C-8’) ppm. MS (ESI): m/z (%) = 246.25 (100) [M+H]+, 268.17 
(24) [M+Na]+. C13H27NO3 (245.36): calcd. C 63.64, H 11.09, N 5.71; found C 63.88, H 11.06, N 
5.32. 
(3R,5R)-1-Benzyl-3,4,5-trihydroxy-piperidine (168d): Application of this procedure to 17 
mg (0.07 mmol)of 176d furnished the free amine 168d (10 mg, 0.05 mmol, 69%) as an oil. 
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[α]D
23 = - 25.7 (c = 0.97, MeOH).162 1H-NMR (400 MHz, CD3OD) δ = 7.38-7.25 (m, 5H, Ar), 
3.91 (dt, J = 5.9, 2.9 Hz, 1H, 3-H), 3.81 (dt, J = 7.6, 3.9 Hz, 1H, 5-H), 3.72-3.64 (m, AB system, 
2H, Bn), 3.43 (br s, 1H, 4-H), 2.89-2.87 (m, 1H, 6-Ha), 2.81-2.77 (m, 1H, 2-Ha), 2.44-2.41 (m, 
1H, 2-Hb), 2.28-2.14 (m, 1H, 6-Hb) ppm. 13C-NMR (50 MHz, CD3OD) δ = 135.1 (s, Ar), 128.4-
126.4 (d, 5C, Ar), 72.4 (d, C-4), 67.1 (d, C-5), 66.4 (d, C-3), 60.7 (t, Bn), 55.0 (t, C-6), 54.6 (t, 
C-2) ppm. MS (ESI): m/z (%) = 246.12 (100) [M+Na]+. C12H17NO3 (223.27): calcd. C 64.55, H 
7.67, N 6.27; found C 64.90, H 7.83, N 6.41. 
Synthesis of (3R,4S,5R)-1-(3-Azidopropyl)-5-hydroxy-3,4-isopropyli- denedioxypiperidine 
(176e): To a solution of 177 (147 mg, 0.78 mmol) in dry MeOH (10 mL) a solution of 3-
azidopropyl-1-amine (78 mg, 0.78 mmol) in dry MeOH (13 mL) and 3Å powdered molecular 
sieves were added. The mixture was stirred under N2 atmosphere for 4 h (the aldehyde 
disappearence was attested by 1H NMR control), then NaBH3CN (147 mg, 2.34 mmol) and 
AcOH (90 µL, 1.56 mmol) were added. The reaction mixture was left stirring at room 
temperature for a week and then concentrated under vacuum. The crude product was 
purified by gradient FCC (from DCM/MeOH 20:1 to 10:1), affording 132 mg (0.52 mmol, 
67%) of 176e as a yellow pale oil. Rf=0.26 (CH2Cl2/MeOH 20:1); [α]D
23=+16.3 (c=0.92 in 
CHCl3); 
1H-NMR (400 MHz, CDCl3): δ=4.29 (pq, 
3J(H,H)=5.9 Hz, 1H; 3-H), 4.04 (pt, 3J(H,H)=4.7 
Hz, 1H; 4-H), 3.96-3.93 (m, 1H; 5-H), 3.34 (t, 3J(H,H)=6.8 Hz, 2H; 3’-H), 2.73 (ddd, 
2J(H,H)=12.0, 3J(H,H)=6.0, 4J(H,H)=1.5 Hz, 1H; 2-Ha), 2.60 (dd, 2J(H,H)=11.7, 3J(H,H)=2.9 Hz, 
1H; 6-Ha), 2.50-2.41 (m, 4H; 2-Hb, 6-Hb, 1’-H), 1.75 (quint, 3J(H,H)=6.8 Hz, 2H; 2’-H), 1.50 (s, 
3H; Me), 1.36 ppm (s, 3H; Me); 13C-NMR (50 MHz, CDCl3): δ=109.0 (s, acetal), 76.7 (d, C-4), 
71.8 (d, C-3), 67.5 (d, C-5), 55.3 (t, C-6), 55.2 (t, C-2), 54.3 (t, C-1’), 49.2 (t, C-3’), 28.0 (q, 
Me), 26.0 (t, C-2’), 25.9 ppm (q, Me); MS (ESI): m/z (%): 279.14 (100) [M+Na]+, 257.27 (20) 
[M+H]+; IR (CDCl3): ν˜=3677, 3608, 3487, 2987, 2944, 2823, 2237, 2099, 1456, 1378, 1219, 
1060 cm-1; elemental analysis calcd (%) for C11H20N4O3 (256.30): C 51.55, H 7.87, N 21.86; 
found C 51.91, H 7.94, N 21.61.  
Synthesis of (3R,5R)-1-(3-Azidopropyl)-3,4,5-trihydroxypiperidine (168e): A solution of 
176e (44 mg, 0.17 mmol) in MeOH (2.0 mL) was left stirring with 12M HCl (142 µL, 1.7 
mmol) at room temperature for 18 h. The crude mixture was concentrated to yield the 
hydrochloride salt of 168e. The corresponding free amine was obtained by passing the 
                                                          
162 This value is in agreement to what reported for its enantiomer ([α]D
23
 = +26.7 (MeOH, c= 0.3), G. 
Pandey, K. C. Bharadwaj, M. I. Khan, K. S. Shashidhara, V. G. Puranik, Org. Biomol. Chem. 2008, 6, 
2587-2595. 
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hydrochloride salt through a DOWEX® 50XW8-100 ion-exchange resin. Elution with 6% 
ammonia afforded the free base 168e (33 mg, 0.15 mmol, 88%). [α]D
21=-21.2 (c=0.74 in 
MeOH); 1H-NMR (400 MHz, CD3OD): δ=3.89 (dt, 
3J(H,H)=5.8, 2.9 Hz, 1H; 3-H), 3.78 (td, 
3J(H,H)=7.8, 4.3 Hz 1H; 5-H), 3.40-3.38 (m, 1H; 4-H), 3.36 (t, 3J(H,H)=6.8 Hz, 2H; 3’-H), 2.82-
2.74 (m, 2H; 6-Ha, 2-Ha) 2.46 (t, 3J(H,H)=6.8 Hz, 2H; 1’-H), 2.31 (d, 2J(H,H)=11.2, 1H; 2-Hb), 
2.12-2.09 (m, 1H; 6-Hb), 1.76 ppm (quint, 3J(H,H)=6.8 Hz, 2H; 2’-H); 13C-NMR (50 MHz, 
CD3OD): δ=72.9 (d, C-4), 67.2 (d, C-5), 66.8 (d, C-3), 55.8 (t, C-6), 55.2 (t, C-2), 53.7 (t, C-1’), 
48.2 (t, C-3’), 24.8 ppm (t, C-2’); MS (ESI): m/z (%): 217.17 (100) [M+H]+; elemental analysis 
calcd (%) for C8H16N4O3 (216.24): C 44.44, H 7.46, N 25.91; found C 44.29, H 7.79, N 25.71. 
Synthesis of (3R,5R)-1-(3-Aminopropyl)-3,4,5-trihydroxypiperidine (168f): To a solution of 
168e (40 mg, 0.18 mmol) in MeOH (3 mL) and HCl 12M (6 drops), Pd/C (25 mg) was added 
and the reaction mixture was left stirring at room temperature under H2 atmosphere for 3 
days. The catalyst was filtered through Celite® and the filtrate was concentrated under 
vacuum to yield the hydrochloride salt of 168f which was passed through an ion-exchange 
resin (DOWEX® 50XW8-100). Elution with MeOH, H2O and 15% NH4OH afforded the amine 
168f in quantitative yield (34 mg, 0.18 mol). [α]D
23=-37.1 (c=0.77 in H2O); 
1H-NMR (500 MHz, 
CD3OD) δ=3.94 (td, 
3J(H,H)=5.5, 2.6 Hz, 1H; 3-H), 3.81 (td, 3J(H,H)=8.0, 4.1 Hz, 1H; 5-H), 3.42 
(br s, 1H; 4-H), 3.11 (t, 3J(H,H)=6.6 Hz, 0.5H; 3’-H of HCO3
- salt), 2.90 (t, 3J(H,H)=6.6 Hz, 1.5H; 
3’-H of free amine), 2.87-2.78 (m, 2H; 6-Ha, 2-Ha), 2.59-2,49 (m, 1.5H; 1’-H of free amine), 
2.48-2.41 (m, 0.5H; 1’-H of HCO3
- salt), 2.37-2.24 (m, 1H, 2-Hb), 2.21-2.10 (m, 1H, 6-Hb), 
1.76 (dquint, 2J(H,H)=13.9, 3J(H,H)=6.6 Hz, 1.5H; 2’-H of free amine) 1.68 ppm (quint, 
3J(H,H)= 7.1 Hz, 0.5 H, 2’-H of HCO3
- salt); 13C-NMR (125 MHz, CD3OD): δ=164.5, 160.1 (s, 
HCO3
-), 74.0 (d, C-4), 68.3(d, C-5), 67.9 (d, C-3), 56.9 (t, C-6), 56.0 (t, C-2), 55.8, 55.4 (C-1’, 
HCO3
- and free amine), 39.9, 39.6 (C-3’, HCO3
- salt and free amine), 27.2-26.0 ppm (C-2’, 
HCO3
- salt and free amine ). 1H-NMR (400 MHz, D2O) δ=3.90-3.87 (m, 1H; 3-H), 3.77-3.71 
(m, 1H; 5-H), 3.39-3.37 (m, 1H; 4-H), 2.89 (t, 3J(H,H)=6.8 Hz, 0.8 H; 3’-H of HCO3
- salt),2.78 (t, 
3J(H,H)=6.8 Hz, 1.2 H; 3’-H of free amine), 2.80-2.69 (m, 2H; 6-Ha, 2-Ha), 2.48-2.26 (m, 2H; 
1’-H), 2.21 (br d, 2J(H,H)=11.7 Hz, 1H; 2-Hb), 2.60-1.94 (m, 1H; 6-Hb), 1.65 (quint, 
3J(H,H)=7.3 Hz, 1.3H; 2’-H of free amine), 1.52 ppm (quint, 3J(H,H)= 7.3 Hz, 0.7H, 2’-H of 
HCO3
- salt); 13C-NMR (50 MHz, D2O): δ=73.6 (d, C-4), 67.6 (d, C-3), 67.5 (d, C-5), 56.4 (t, C-6), 
55.5 (t, C-2), 54.7 (C-1’, HCO3
- and free amine), 39.4, 38.8 (C-3’, HCO3
- salt and free amine), 
26.4-25.5 ppm (C-2’, HCO3
- salt and free amine ). MS (ESI): m/z (%): 191.08 (100) [M+H]+.  
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Synthesis of (3R,5R)-1-[3-(Acetylamino)propyl]piperidine-3,4,5-tri-O-acetyl-3,4,5-
trihydroxypiperidine (178): A solution of 168f (13 mg, 0.07 mmol) in pyridine (0.3 mL) and 
Ac2O (0.2 mL) was left stirring at room temperature for 18 h and then concentrated under 
vacuum. The crude product was purified by flash column chromatography on silica gel 
(DCM/MeOH 15:1) affording 22 mg (0.06 mmol, 86%) of 178 as a colorless oil. Rf=0.32 
(DCM/MeOH 15:1); [α]D
25=-58.5 (c=0.93 in CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 6.65 (br s, 
1H; NH), 5.30 (dt, 3J(H,H)= 5.2, 2.7 Hz, 1H; 3-H), 5.11 (dt, 3J(H,H)=8.6, 4.3 Hz, 1H; 5-H), 4.95 
(dd, 3J(H,H)=8.6, 3.6 Hz, 1H; 4-H), 3.46 (td, 2J(H,H)=12.1, 3J(H,H)=5.8 Hz, 1H; 3’-Ha), 3.20-3.12 
(m, 1H; 3’-Hb), 3.04-3.02 (m, 1H; 6-Ha), 2.86-2.83 (m, 1H; 2-Ha), 2.46 (t, 3J(H,H)=6.3 Hz, 2H; 
1’-H), 2.44 (d, 2J(H,H)=11.7 Hz, 1H; 2-Hb), 2.24-2.18 (m, 1H; 6-Hb), 2.08 (s, 3H; Me), 2.04 (s, 
3H; Me), 2.02 (s, 3H; Me), 1.98 (s, 3H; Me), 1.64 ppm (quint, 3J(H,H)=6.3 Hz, 2H; 2’-H); 13C-
NMR (50 MHz, CDCl3): δ=173.5-169.9 (s, 4C, COCH3), 70.7 (d, C-4), 67.9 (d, C-5), 67.7 (d, C-
3), 56.0 (t, C-1’), 54.0 (t, C-6), 53.8 (t, C-2), 38.9 (t, C-3’), 25.5 (t, C-2’), 23.2-20.7 ppm (q, 4C, 
COCH3);
 MS (ESI): m/z (%): 381.41 (100) [M+Na]+; IR (CDCl3): ν˜=3689, 3606, 3451, 3312, 
3950, 2825, 2257, 2245, 1743, 1660, 1522, 1372, 1230, 1050 cm-1; elemental analysis calcd 
(%) for C16H26N2O7 (358.39): C 53.62, H 7.31, N 7.82; found C 53.20, H 7.42, N 8.16. 
Synthesis of (3R,5R)-1-[3-(acetylamino)propyl]-3,4,5-trihydroxy-piperidine (168g): To a 
solution of compound 178 (74 mg, 0.21 mmol) in MeOH (7 mL), 300 mg of Ambersep®900-
OH were added and the mixture was stirred at room temperature. After 2 h, the ion-
exchange resin was filtered washing with MeOH. The solvent was evaporated under 
vacuum affording the pure compound 168g (48 mg, 0.15 mmol, 71%). [α]D
24=-33.1 (c=1.17 
in H2O); 
1H-NMR (400 MHz, D2O): δ=3.88-3.86 (m, 1H; 3-H), 3.73 (td, 
3J(H,H)= 8.8, 4.4 Hz, 
1H; 5-H), 3.37 (dd, 3J(H,H)=8.3, 2.4 Hz 1H; 4-H), 3.06 (t, 3J(H,H)=6.9 Hz, 2H; 3’-H), 2.77-2.71 
(m, 2H; 6-Ha; 2-Ha), 2.36-2.25 (m, 2H; 1’-H), 2.18 (d, 2J(H,H)=12.2 Hz, 1H; 2-Hb), 2.02-1.92 
(m, 1H; 6-Hb), 1.85 (s, 3H; Me), 1.57 ppm (quint, 3J(H,H)=6.8 Hz, 2H; 2’-H); 13C-NMR (50 
MHz, D2O): δ=173.91 (s, COCH3), 75.6 (d, C-4), 67.6 (d, C-3), 67.5 (d, C-5), 56.4 (t, C-1’), 55.5 
(t, C-2), 54.5 (t, C-6), 37.6 (t, C-3’), 25.1 (q, COCH3), 21.8 ppm (t, C-2’);
 MS (ESI): m/z (%): 
255.08 (100) [M+Na]+, 233.17 (72) [M+H]+; elemental analysis calcd (%) for C10H20N2O4 
(232.28): C 51.71, H 8.68, N 12.06; found C 51.61, H 8.39, N 12.10.  
Synthesis of (3R,4R)-5-oxo-3,4-O-(1-methylethylidene)-N-Boc-piperidine (180): To a 
stirred solution of 175 (75 mg, 0.43 mmol) and NaHCO3 (56 mg, 0.67 mmol) in H2O (1.0 mL), 
MeOH (1.0 mL), and Boc2O (141 mg, 0.65 mmol) were added. The mixture was stirred at 
room temperature for 48 h, concentrated and extracted with AcOEt (3x20 mL). The 
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combined organic layers were washed with brine, dried over Na2SO4 and concentrated to 
give 179 (109 mg, 0.40 mmol, 93%) pure enough to be employed in next step without 
further purification. Dess-Martin periodinane (280 mg, 0.66 mmol) was added to a solution 
of 179 (119 mg, 0.44 mmol) in dry CH2Cl2 (4.7 mL) at room temperature. The reaction 
mixture was stirred for 2 h then washed with a NaHCO3 saturated solution, dried over 
Na2SO4 and concentrated. The residue was purified by silica gel flash chromatography 
(PE/AcOEt 2:1) to give 180 (117 mg, 0.43 mmol, 98%), m.p. 63-65 °C. [α]D
24 = + 19.6 (c = 
1.17, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 4.65 (br s, 1H, 3-H), 4.40 (d, J = 7.3 Hz, 1H, 4-H), 
4.38-4.25 (m, 1H, 6-Ha), 3.94 (d, J = 18.4 Hz, 1H, 6-Hb), 3.85-3.68 (m, 1H, 2-Ha), 3.60 (dd, J = 
14.7, 3.9 Hz, 1H, 2-Hb), 1.47 (s, 12H, Me, tBu), 1.38 (s, 3H, Me) ppm. 13C-NMR (50 MHz, 
CDCl3) δ = 203.1 (s, C=O), 154.4 (s, NCOO), 111.5 (s, acetal), 80.8 (s, OCtBu), 77.5 (d, C-4), 
74.9 (d, C-3), 53.8, 53.1 (t, C-6, two rotamers), 45.8, 44.7 (t, C-2, two rotamers), 28.2 (q, 3C, 
tBu), 26.6 (q, Me), 25.0 (q, Me) ppm. MS (ESI): m/z (%) = 294.03 (20) [M+Na]+. IR (KBr): ν = 
3461, 2978, 2935, 2254, 1740, 1692, 1417, 1370, 1245, 1210, 1155 cm-1. C13H21NO5 
(271.31): calcd. C, 57.55; H, 7.80; N, 5.16; found C 57.68, H 7.54, N 4.98. 
Synthesis of (3R,4S,5S)-5-hydroxy-3,4-O-(1-methylethylidene)-N-Boc-piperidine (181): A 
solution of 180 (21 mg, 0.08 mmol) in EtOH (0.5 mL) was cooled to 0°C and NaBH4 (7.6 mg, 
0.20 mmol) was slowly added. The reaction mixture was allowed to warm to room 
temperature and stirred for 18 h. Then, water (0.1 mL) and MeOH (0.3 mL) were added and 
mixture was stirred for 7 h at room temperature and concentrated under reduced pressure. 
The crude product was purified by silica gel flash chromatography (PE/AcOEt 2:1) to give 
181 (16 mg, 0.06 mmol, 76%). [α]D
22 = + 3.54 (c = 0.96, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 
4.35 (br s, 2H, 3-H, 4-H), 3.92-3.84 (m, 1H, 5-H), 3.63-3.58 (m, 1H, 6-Ha), 3.55-3.44 (m, 2H, 
2-H), 3.16 (dd, J = 12.4, 9.6 Hz, 1H, 6-Hb), 2.29 (d, J = 8.3 Hz, 1H, OH), 1.50 (s, 3H, Me), 1.46 
(s, 9H, tBu), 1.37 (s, 3H, Me) ppm. 13C-NMR (50 MHz, CDCl3) δ = 154.7 (s, NCOO), 109.2 (s, 
acetal), 79.7 (s, OCtBu), 73.3, 71.9 (d, 2C, C-3, C-4), 65.5 (d, C-5), 43.8, 43.1 (t, C-6, two 
rotamers), 42.6, 41.5 (t, C-2, two rotamers), 28.1 (q, 3C, tBu), 26.5 (q, Me), 24.6 (q, Me) 
ppm. MS (ESI): m/z (%) = 296.08 (100) [M+K]+. IR (KBr): ν = 3565, 2978, 2935, 2246, 1684, 
1409, 1163 cm-1. C13H23NO5 (273.33): calcd. C 57.13, H 8.48, N 5.12; found C 57.61, H 8.54, 
N 5.06. 
Synthesis of (3R,4s,5S)-3,4,5-trihydroxy-piperidine (165): A solution of 181 (17 mg, 0.06 
mmol) in MeOH (4.0 mL) and HCl 1M (5 drops) was left stirring at room temperature 
overnight. The crude mixture was concentrated to yield the hydrochloride of 165, which 
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was eluted through an ion-exchange resin (DOWEX® 50XW8-100) with MeOH, H2O and 6% 
NH4OH to give the corresponding free amine 165 (8 mg, 100%), m.p. 163-165 °C. [α]D
22 = + 
0.0 (c = 0.60, MeOH). 1H-NMR (400 MHz, D2O) δ = 3.87 (t, J = 2.4 Hz, 4-H), 3.66-3.62 (m, 2H, 
3-H, 5-H), 2.68 (dd, J = 12.7, 4.4 Hz, 2H), 2.61 (dd, J = 12.7, 8.8 Hz, 2H). ppm. 13C-NMR (50 
MHz, D2O) δ = 69.5 (d, C-4), 67.4 (d, 2C, C-3, C-5), 43.9 (t, 2C, C-2, C-6) ppm. MS (ESI): m/z 
(%) = 156.06 (100) [M+Na]+. C5H11NO3 (133.15): C 45.10, H 8.33, N 10.52; found C 44.97, H 
8.39, N 10.43. 
Synthesis of (3R,4S,5S)-N-Boc-3,4-O-(1-methylethylidene)-5-N-benzyl-aminopiperidine 
(182a): A solution of ketone 180 (69 mg, 0.25 mmol) in dry MeOH (4.5 mL) was stirred in 
the presence of 3Å molecular sieves powder,under nitrogen atmosphere, for 15 min before 
adding benzylamine (43 µL, 0.39mmol) and AcOH (22 µL, 0.39 mmol). The reaction mixture 
was left stirring for 3 h and then NaBH3CN (49 mg, 0.78 mmol) and more AcOH (8 µL, 0.13 
mmol) were added. The mixture was stirred for 25 h, under nitrogen atmosphere. The 
molecular sieves were removed by filtration through Celite® and the filtrate was 
concentrated under vacuum. The residue was purified by flash chromatography 
(EP/AcOEt/NEt3 2: 1:0.1) affording 182a (43 mg, 0.12 mmol) in 47% yield. [α]D
25 = +16.25 (c= 
0.8, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ ppm= 7.39-7.23 (m, 5H, Ar), 4.41 (dd, J = 6.8, 2.5 Hz, 
1H, 4-H), 4.27 (br s, 1H, 3-H), 3.90 (m, 2H, Bn), 3.66-3.55 (m, 2H, 2-Ha, 6-Ha), 3.28 (dd, J 
=14.0, 3.9 Hz, 1H, 2-Hb), 2.98 (pt, J = 11.7, 1H, 6-Hb), 2.84 (m, 1H, 5-H), 1.45 (s, 12H, t-Bu, 
Me), 1.34 (s, 3H, Me).  13C-NMR (50 MHz, CDCl3) δ ppm = 155.2 (s, C=O), 139.9 (s, Ar), 128.4-
127.1 (d, 5C, Ar), 108.8 (s, aceal), 79.7 (s, OCtBu), 72.4 (d, 2C, C-3, C-4), 52.4 (d, C-5), 50.5 (t, 
Bn), 42.5 (t, 2C, C-2, C-6), 28.4 (3C, t-Bu), 26.9 (q, Me), 24.9 (q, Me). MS (ESI): m/z (%) = 
385.25 (100) [M+Na]+. IR (CDCl3) ν = 3333, 2981, 2933, 2248, 1685, 1454, 1413, 1163 cm
-1. 
General procedure for the synthesis of N-alkyl aminopiperidines (182b-182c): Ketone 180 
and the appropriate amine (1.5 equiv) were dissolved in MeOH (0.05 M) and 25 mg of 3Å 
pellets molecular sieves were added. The reaction mixture was left stirring at room 
temperature for 50 minutes and, when the complete conversion to imine was observed (1H 
NMR control), Pd(OH)2/C (50% wt) was added and the mixture was left stirring at room 
temperature under H2 atmosphere for 24 h. The catalyst and the molecular sieves were 
filtered, washing several times with MeOH and then the solvent was evaporated under 
vacuum.  
(3R,4S,5S)-N-Boc-3,4-O-(1-methylethylidene)-5-N-butyl- aminopiperidine (182b): 
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 Application of this procedure to 68 mg (0.25 mmol) of 180 with butylamine (37 µL, 0.38 
mmol) furnished, after purification by flash column chromatography (EP/AcOEt 2:1), 
compound 182b (57 mg, 0.17 mmol, 68%) as a colorless oil. 1H-NMR (200 MHz, CDCl3) δ 
ppm= 4.46 (m, 1H, 4-H), 4.29 (br s, 1H, 3-H), 3.59-3.50 (m, 2H), 3.31, (dd, J = 14.3, 3.7 Hz, 
1H), 2.98-2.65 (m, 4H), 1.56-1.16 (m, 19H, t-Bu, Me, 2’-H, 3’-H), 0.86 (t, J = 7.1 Hz, 3H, 4’-H). 
13C-NMR (50 MHz, CDCl3 ) δ ppm= 155.2 (s, C=O), 108.8 (s, acetal), 79.7 (s, OCtBu), 72.4 (d, 
2C, C-3, C-4), 53.5, 46.6, 42.8 (4C, C-2, C-5, C-6, C-1’), 32.4-20.3 (7C, t-Bu, Me, C-2’, C-3’), 
13.9 (q, C-4’). MS (ESI): m/z (%) = 329.25 (100) [M+H]+. 
(3R,4S,5S)-N-Boc-3,4-O-(1-methylethylidene)-5-N-octyl-aminopiperidine (182c): 
Application of this procedure to 52 mg (0.19 mmol) of 180 with butylamine (47 µL, 0.28 
mmol) furnished, after purification by gradient flash column chromatography (EP/AcOEt 
from 5:1 to 2.1), compound 182c (39 mg, 0.10 mmol, 53%). 1H-NMR (200 MHz, CDCl3) δ 
ppm= 4.44 (m, 1H, 4-H), 4.30 (br s, 1H, 3-H), 3.79-3.55 (m, 2H), 3.32 (dd, J = 14.1, 3.5 Hz, 
1H), 2.98-2.68 (m, 4H), 1.99 (m, 2H, 2‘-H), 1.53-1.13 (m, 25H, 3‘-7‘-H, Me, t-Bu), 0.87 (t, J 
=6.3 Hz, 3H, 8‘-H). 13C-NMR (50 MHz, CDCl3): δ ppm= 155.2 (s, C=O), 108.8 (s, acetal), 79.6 
(s, OCtBu), 72.4 (d, 2C, C-3, C-4), 53.5, 46.9 (2C, C-5, C-1’), 42.4 (t, 2C, C-2, C-6), 31.8-22.6 
(11 C, C-2’ -7’, Me, t-Bu), 14.0 (q, C-8’). MS (ESI): m/z (%) = 385.33 (100) [M+H]+. 
General procedure for the synthesis of completely deprotected N-alkyl aminopiperidines  
(169a, 169b and 169c): A 0.02 M solution of 182a-c in MeOH was left stirring with HCl 12M 
(5 drops) at room temperature overnight. The crude mixture was concentrated to yield the 
hydrochloride salts of 169a-c. The corresponding free amine was obtained by passing the 
hydrochloride salt through a DOWEX® 50XW8-100 ion-exchange resin. Elution with 6% 
ammonia afforded the free bases 169a-c. 
(3R,4S,5S)-3,4-dihydroxy-5-N-benzyl aminopiperidine (169a): Application of this procedure 
to 28 mg (0.08 mmol) of 182a furnished the free amine 169a (17 mg, 100%). [α]D
25 = - 3.6 (c 
= 0.74, MeOH). 1H-NMR (400 MHz, D2O) δ ppm= 7.32-7.22 (m, 5H, Ar), 4.04 (br s, 1H, 4-H), 
3.76 (d, J = 13.1 Hz, Bn), 3.69 (d, J = 13.1 Hz, Bn), 3.53 (ddd, J = 10.5, 4.7, 1.9 Hz, 1H, 3-H), 
2.77-2.64 (m, 3H, 6-Ha, 2-Ha, 5-H), 2.55 (t, J = 11.5 Hz, 1H, 2-Hb), 2.43 (t, J = 11.5 Hz, 6-
Hb).13C-NMR (50 MHz, D2O) δ ppm= 137.4 (s, Ar), 127.8-126.6 (d, 5C, Ar), 67.6 (d, C-3), 67.2 
(d, C-4), 54.4 (d, C-5), 48.2 (t, Bn), 43.15 (t, C-2), 41.6 (t, C-6). MS (ESI): m/z (%) = 223.17 
(100) [M+H]+. 
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(3R,4S,5S)-3,4-dihydroxy-5-N-butyl aminopiperidine (169b): Application of this procedure 
to 20 mg (0.06 mmol) of 182b furnished the free amine 169b (12 mg, 100%) as a colorless 
oil. [α]D
26 = - 8.1 (c = 0.44, H2O). 
1H-NMR (400 MHz, D2O) δ ppm= 4.04 (br s, 1H, 4-H), 3.56 
(m, 1H, 3-H), 2.77-3.89 (m, 7H, 2-H, 5-H, 6-H, 1’-H), 1.38 (quint, J = 7.4 Hz, 2H, 2’-H), 1.22 
(sest, J = 7.3 Hz, 2H, 3’-H) 0.78 (t, J= 7.3 Hz, 3H, 4’-H).13C-NMR (50 MHz, D2O) δ ppm= 68.6 
(d, C-3), 67.9 (d, C-4), 56.2 (d, C-5), 44.9 (t, C-1‘) 44.3, (t, C-2), 42.3 (t, C-6), 30.1 (t, C-2‘), 
19.7 (t, C-3‘) 13.1 (q, C-4‘). MS (ESI): m/z (%) = 189.17 (100) [M+H]+. 
(3R,4S,5S)-3,4-dihydroxy-5-N-octyl aminopiperidine (169c): Application of this procedure 
to 38 mg (0.10 mmol) of 182c furnished the free amine 169c (14 mg, 0.06 mmol, 60%) as a 
colorless oil. [α]D
24 = - 2.5 (c = 0.36, MeOH). 1H-NMR (400 MHz, D2O) δ ppm= 4.03 (br s, 1H, 
4-H), 3.57 (d, J = 7.2 Hz, 1H, 3-H), 2.78-2.47 (m, 7H, 2-H, 5-H, 6-H, 1‘-H), 1.42 (br s, 2H, 2‘-H), 
1.17 (m, 10H, 3‘-7‘-H), 0.74 (t, J = 6.8 Hz, 3H, 8‘-H). 13C-NMR (50 MHz, D2O) δ ppm= 67.7 (d, 
C-3), 66.8 (d, C-4), 55.6 (d, C-5), 44.8 (t, C-1‘), 43.7 (t, C-2), 41.4 (t, C-6), 30.6-21.4 (t, 6C,), 
12.8 (q, C-8‘). MS (ESI): m/z (%) = 245.25 (100) [M+H]+. 
Synthesis of (3R,4S,5S)-3,4-dihydroxy-5- aminopiperidine (169d): To a solution of 182a (35 
mg, 0.10 mmol) in MeOH (5 mL) and HCl 12M (3 drops) Pd /C (18 mg) was added and the 
reaction mixture was left stirring at room temperature under H2 atmosphere for 6 days. The 
catalyst was filtered through Celite® and the filtrate was concentrated under vacuum, to 
yield quantitative the hydrochloride of 169d which was eluted through an ion-exchange 
resin (DOWEX® 50XW8-100) with MeOH, H2O and 6% NH4OH to give the free amine 36 (13 
mg, 100%). [α]D
25 = +3.84 (c = 0.25, MeOH). MS (ESI): m/z (%) = 155.11 (100) [M+Na]+, 
133.09 (32) [M+H]+. 
General Procedure for the Strecker Reaction: A 0.2 M solution of compound 166 and the 
appropriate amine source (BuNH2, BnNH2, 1.0 equiv) in dry CH3CN with 3Å pellets molecular 
sieves was stirred at room temperature for 40 minutes. Trimethylsilyl cyanide(1.0 equiv) 
and Cu(OTf)2 (1.0 mol%) were added and the resulting reaction mixture was stirred at room 
temperature for 18 hours, then diluted with AcOEt and washed with water and brine. The 
organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure 
to give the crude products as a >95:5 mixture of two diastereoisomers (as determined by 1H 
NMR analysis), which were purified by flash chromatography (PE/AcOEt) to afford pure 
major diastereoisomers 183a and 184a. 
1-O-Benzyl-5-benzylamino-5-cyano-5-deoxy-2,3-O-(1-methylethylidene)-β-L-erythro-
pentofuranose (183a): Application of the general procedure to 110 mg (0.40 mmol) of 
Chapter 3 
108 
 
aldehyde 166 and benzylamine (44 µL, 0.40 mmol) afforded a crude mixture, that was 
purified by column chromatography on silica gel (PE/AcOEt 8:1) to afford the pure major 
diastereoisomer 183a with 80% yield (125 mg, 0.32 mmol) as a colorless oil. [α]D
25 = +75.5 (c 
= 1.00, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.37-7.17 (m, 10 H, Ar), 5.12 (s, 1H, 1-H), 4.76 
(dd, J = 5.8, 3.9 Hz, 1H, 3-H), 4.60 (d, J = 5.9 Hz, 1H, 2-H), 4.56 (d, J = 12.0 Hz, 1H, O-Bn), 4.41 
(d, J = 12.0 Hz, 1H, O-Bn), 4.10 (dd, J = 7.8, 3.9 Hz, 1H, 4-H), 4.03 (d, J = 12.9 Hz, 1H, N-Bn), 
3.91 (d, J = 7.8 Hz, 1H, 5-H), 3.79 (d, J = 12.9 Hz, 1H, N- Bn), 1.93 (br s, 1H, NH), 1.45 (s, 3H, 
Me), 1.23 (s, 3H, Me) ppm. 13C-NMR (75 MHz, CDCl3) δ = 138.1, 137.0 (s, 2C, Ar), 128.6-
127.6 (d, 10C, Ar), 118.0, 113.6 (s, 2C, CN + acetal), 105.7 (d, C-1), 84.7 (d, C-2), 79.2 (d, C-
3), 78.4 (d, C-4), 69.5 (t, O-Bn), 51.8 (t, N-Bn), 49.6 (d, C-5), 25.2 (q, Me), 24.5 (q, Me) ppm. 
MS (ESI): m/z (%) = 417.00 (71) [M+Na]+. IR (CHCl3): ν = 3335, 3067, 3025, 3010, 2240, 2944, 
1952, 1604, 1497, 1455, 1376, 1262, 1027 cm-1. C23H26N2O4 (394.46): calcd. C 70.03, H 6.64, 
N 7.10; found C 69.73, H 6.80, N 7.18. 
1-O-Benzyl-5-butylamino-5-cyano-5-deoxy-2,3-O-(1-methylethylidene)-β-L-erythro-
pentofuranose (184a): Application of the general procedure to 155 mg (0.56 mmol) of 
aldehyde 166 and butylamine (44 µL, 0.40 mmol) afforded a crude mixture, that was 
purified by column chromatography on silica gel (PE/AcOEt 8:1) to afford the pure major 
diastereoisomer 184a with 75% yield (152 mg, 0.42 mmol) as a colorless oil. [α]D
26 = + 59.7 
(c = 0.95, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.29-7.18 (m, 5 H, Ar), 5.12 (s, 1H, 1-H), 4.75 
(dd, J = 6.3, 3.4 Hz, 1H, 3-H), 4.61 (d, J = 6.3 Hz, 1H, 2-H), 4.59 (d, J = 11.7 Hz, 1H, Bn), 4.43 
(d, J = 11.7 Hz, 1H, Bn), 4.10 (dd, J = 8.3, 3.4 Hz, 1H, 4-H), 3.89 (d, J = 8.3 Hz, 1H, 5-H), 2.83 
(ddd, J = 10.8, 7.8, 6.4 Hz, 1H, 1’-Ha), 2.57 (ddd, J = 11.2, 8.2, 6.3 Hz, 1H, 1’-Hb), 1.51-1.27 
(m, 4H, 2’-H + 3’-H), 1.45 (s, 3H, Me), 1.24 (s, 3H, Me), 0.87 (t, J = 7.3 Hz, 3H, 4’-H) ppm. 13C-
NMR (50 MHz, CDCl3) δ = 137.1 (s, Ar), 128.5-128.0 (d, 5C, Ar), 118.2, 113.5 (s, 2C, CN, 
acetal), 105.9 (d, C-1), 84.7 (d, C-2), 79.2 (d, C-3), 78.5 (d, C-4), 69.4 (t, Bn), 50.5 (d, C-5), 
47.7 (t, C-1’), 31.7 (t, C-2’), 25.3 (q, Me), 24.5 (t, C-3’), 20.3 (q, Me), 13.9 (q, C-4’) ppm. MS 
(ESI): m/z (%) = 382.82 (100), [M+Na]+. IR (CDCl3): ν = 3334, 3067, 3033, 2959, 2874, 2249, 
1455, 1376, 1210, 1084 cm-1. C20H28N2O4 (360.45): calcd. C 66.64, H 7.83, N 7.77; found C 
66.94, H 7.85, N 7.93. 
Synthesis of 1-O-benzyl-5-amino-5-cyano-5-deoxy-2,3-O-(1-methylethylidene)-β-L-
erythro-pentofuranose (185a): To a solution of aldehyde 166 (79 mg, 0.28 mmol) in EtOH 
(3.0 mL), NH4OAc (216 mg, 2.80 mmol)was added. The mixture was stirred at room 
temperature for 40 min, then TMSCN (43 µL, 0.34 mmol) was added dropwise. The solution 
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was stirred at room temperature for 18 h, then diluted with AcOEt, washed with sat. aq. 
NaHCO3, H2O and brine, dried (Na2SO4), filtered and concentrated under vacuum. 
1H NMR 
analysis of the crude mixture showed the formation of two diasteroisomers in 81:19 ratio. 
Purification of the crude product using silica gel gradient flash chromatography afforded 52 
mg (0.17 mmol, 61%) of the major diastereoisomer 185a. Crystallization of 185a (EtOAc) 
yielded fine white needles, m.p. 115-117 °C, which were subjected to a single-crystal X-ray 
diffraction. [α]D
26 = + 74.8 (c = 0.52, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.30-7.21 (m, 5H, 
Ar), 5.12 (s, 1H, 1-H), 4.77 (dd, J = 6.3, 3.4 Hz, 1H, 3-H), 4.62 (d, J = 6.2 Hz, 1H, 2-H), 4.60 (d, J 
= 11.7 Hz, 1H, Bn), 4.40 (d, J = 11.7 Hz, 1H, Bn), 4.07 (d, J = 7.8 Hz, 1H, 5-H), 4.02 (dd, J = 7.8, 
3.4 Hz, 1H, 4-H), 1.69 (br s, 2H, NH2), 1.45, (s, 3H, Me), 1.25 (s, 3H, Me) ppm.
 13C-NMR (50 
MHz, CDCl3) δ = 136.7 (s, Ar), 128.2-127.7 (d, 5C, Ar), 119.4, 113.1 (s, 2C, CN, acetal), 105.4 
(d, C-1), 84.5 (d, C-2), 79.7 (d, C-4), 78.8 (d, C-3), 69.2 (t, Bn), 43.2 (d, C-5), 25.1 (q, Me), 24.1 
(q, Me) ppm. MS (ESI): m/z (%) = 327.06 (100), [M+Na]+, 361.11 (12), [M+H]+. IR (KBr): ν = 
3368, 3261, 3161, 2932, 2360, 2235, 1595, 1376, 1081 cm-1. C16H20N2O4 (304.14): C 63.14, H 
6.82, N 9.20; found C 63.12, H 6.49, N 8.97. 
Synthesis of (3R,4S,5R)-1-benzyl-5-hydroxy-3,4-O-(1-methylethylidene)-piperidine (176d) 
and (2S,3R,4S,5R)-1-benzyl-2-cyano-3-hydroxy-4,5-O-(1-methyethylidene)-piperidine 
(186), Scheme 3.17: To a solution of dialdehyde 177 (323 mg, 1.72 mmol) in MeOH (3.6 
mL), benzylamine (225 µL, 2.06 mmol) and NaBH3CN (216 mg, 3.44 mmol) were added. The 
mixture was stirred at room temperature for a total of five days, until the complete starting 
material disappearance (TLC control) was observed. 1H NMR analysis of the crude mixture 
showed the formation of 176d and 186 in 6:1 ratio. The solvent was evaporated under 
vacuum and the residue was purified using silica gel flash chromatography (CH2Cl3/Et2O 7:1) 
to give 147 mg of a 2.7: 1 mixture of 176d and 186 and 51 mg of pure 176d (0.19 mmol, 
11%).  
176d163: [α]D
24 = + 10.8 (c = 1.16, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.34-7.24 (m, 5H, Ar), 
4.29 (dd, J = 6.9, 5.8 Hz, 1H, 3-H), 4.06 (t, J = 4.8 Hz, 1H, 4-H), 3.93 (dd, J = 7.1, 4.2 Hz, 1H, 5-
H), 3.59-3.51 (m, 2H, Bn), 2.80 (ddd, J = 11.7, 6.1, 1.5 Hz, 1H, 2-Ha), 2.58-2.48 (m, 2H, 6-H), 
2.39 (dd, J = 11.7, 7.4 Hz, 1H, 2-Hb), 1.50 (s, 3H, Me), 1.35 (s, 3H, Me) ppm. 13C-NMR (50 
MHz, CDCl3) δ = 137.5 (s, Ar), 129.0-127.4 (d, 5C, Ar), 109.3 (s, acetal), 77.0 (d, C-4), 72.1 (d, 
C-3), 67.7 (d, C-5), 62.1 (t, Bn), 55.5 (t, C-2), 55.1 (t, C-6), 28.3 (q, Me), 26.4 (q, Me) ppm. MS 
(ESI): m/z (%) = 264.31 (100) [M+H]+, 286.19 (35) [M+Na]+. IR (CDCl3): ν = 3602, 3497, 2988, 
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2938, 2827, 2420, 2248, 1601, 1494, 1454, 1383, 1219, 1058 cm-1. C15H21NO3 (263.33): 
calcd. C 68.42, H 8.04, N 5.32; found C 68.21, H 7.85, N 5.33. 
Synthesis of (2S,3R,4R,5R)-1-benzyl-2-cyano-3-O-acetyl-4,5-O-(1-methyethylidene)-
piperidine (187) as by-product in the reductive amination (Scheme 3.17): A mixture of 
176d and 186 was dissolved in Py:Ac2O (3:2 v/v) and stirred at r.t. overnight, then the 
solvent was evaporated under reduced pressure and the crude purified by flash 
chromatography (CH2Cl2/MeOH from 50:1 to 20:1) affording pure 187. [α]D
24 = - 37.3 (c = 
0.59, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.30-7.19 (m, 5H, Ar), 4.93 (dd, J = 8.4, 4.8 Hz, 
1H, 3-H), 4.32-4.26 (m, 1H, 5-H), 4.18 (dd, J = 8.4, 5.2 Hz, 1H, 4-H), 3.91 (d, J = 4.8 Hz, 1H, 2-
H), 3.73 (d, J = 13.4 Hz, 1H, Bn), 3.52 (d, J = 13.4 Hz, 1H, Bn), 3.29 (d, J = 14.0 Hz, 1H, 6-Ha), 
2.81 (dd, J = 14.0, 2.8 Hz, 1H, 6-Hb), 2.04 (s, 3H, acetyl), 1.49 (s, 3H, Me), 1.30 (s, 3H, Me). 
13C-NMR (50 MHz, CDCl3) δ = 170.1 (s, C=O), 135.6 (s, Ar), 128.8-128.1 (d, 5C, Ar), 113.4 (s, 
CN), 110.1 (s, acetal), 74.3 (d, C-4), 72.9 (d, C-5), 71.1 (d, C-3), 59.2 (t, Bn), 53.3 (d, C-2), 49.3 
(t, C-6), 27.0 (q, Me), 26.2 (q, Me), 20.8 (q, CH3CO) ppm. MS (ESI): m/z (%) = 353.06 (100) 
[M+Na]+. IR (CDCl3): ν = 2989, 2938, 2832, 2257, 1752, 1496, 1455, 1379, 1220 cm
-1. 
C18H22N2O4 (330.38): calcd. C 65.44, H 6.71, N 8.48; found. C 65.61, H 6.93, N 8.37. 
Synthesis of (2S,3R,4R,5R)-1-benzyl-2-cyano-3-O-acetyl-4,5-O-(1-methyethylidene)-
piperidine (187), through Strecker reaction (Scheme 3.17): To a solution of dialdehyde 177 
(132 mg, 0.70 mmol) in dry CH3CN (1.4 mL), benzylamine (77 µL, 0.70 mmol) and 3Å 
molecular sieves were added under N2 atmosphere. The reaction mixture was stirred at 
room temperature for one hour, then TMSCN (71 µL, 0.70 mmol) was added dropwise. The 
solution was stirred at room temperature for 18 h, then, once the starting material 
disappeared (TLC control), NaBH3CN (132 mg, 2.1 mmol), EtOH (1.0 mL) and AcOH (80 µL, 
1.40 mmol) were added. The reaction mixture was left stirring at room temperature for 3 
days under nitrogen atmosphere and then concentrated under vacuum. The crude 
compound was fast purified by silica gel flash chormatography (eluent CHCl3/Et2O 7:1) to 
obtain 186 (101 mg, 0.35 mmol, 50% yield). A small portion of 186 (14 mg, 0.05 mmol) was 
dissolved Py:Ac2O (3:2 v/v) and stirred at r.t. overnight, then the solvent was evaporated 
under reduced pressure and the crude purified by flash chromatography (Et2O/AcOEt 5:1) 
affording pure 187 (10 mg, 0.03 mmol, 62%). 186: [α]D
24 = + 4.7 (c = 0.71, CHCl3). 
1H-NMR 
(400 MHz, CDCl3) δ = 7.35-7.27 (m, 5H, Ar), 4.33-4.31 (m, 1H, 5-H), 4.08 (dd, J = 7.8, 5.4 Hz, 
1H, 4-H), 3.86-3.83 (m, 1H, 3-H), 3.82 (d, J = 13.0 Hz, 1H, Bn) 3.78(d, J = 5.3 Hz, 1H, 2-H), 
3.53 (d, J = 13.0 Hz, 1H, Bn), 3.35 (d, J = 14.2 Hz, 1H, 6-Ha), 2.91 (dd, J = 14.2, 3.2 Hz, 1H, 6-
Hb), 1.53 (s, 3H, Me), 1.38 (s, 3H, Me). 13C-NMR (50 MHz, CDCl3) δ = 135.9 (s, Ar), 129.0-
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128.0 (d, 5C, Ar), 113.9 (s, CN), 109.9 (s, acetal), 77.7 (d, C-4), 73.0 (d, C-5), 70.5 (d, C-3), 
59.2 (t, Bn), 55.3 (d, C-2), 49.9 (t, C-6), 28.2 (q, Me), 26.2 (q, Me) ppm. MS (ESI): m/z (%) = 
311.0 (100) [M+Na]+. IR (CDCl3): ν = 3602.3, 3031.2, 2990.2, 2957.5, 2832.7, 2255.2, 1730.6, 
1603.1, 1455.2, 1383.7, 1218.3, 1090.7, 1045.6 cm-1. C16H20N2O3 (288.34): calcd. C 66.65, H 
6.99, N 9.72; found. C 66.32, H 7.24, N 9.58. 
Synthesis of acetyl 2,3-O-(1-methylethylidene)-α-D-lyxo-pentodialdo-1,4-furanoside (167): 
Compound 131 (7.22 g, 27.8 mmol) was dissolved in pyridine (12 mL) and Ac2O (8 mL) and 
stirred at r.t. overnight. The reaction mixture was diluted in AcOEt (100 mL) and washed 
sequentially with a 1M CH3COOH solution (2x150 mL), saturated aqueous solution of 
NaHCO3 (2x60 mL) and brine (1x60 mL). The combined organic layer was dried over Na2SO4, 
filtered and concentrated under reduced pressure to give 188 (8.21 g, 27.2 mmol, 98%). A 
solution of 188 (8.21 g, 27.15 mmol), glacial AcOH (102 mL) and water (44 mL) was stirred 
for 18 h at room temperature and concentrated under reduced pressure. The residue was 
dissolved in AcOEt (200 mL), washed sequentially with saturated aqueous solution of 
NaHCO3 (2x70 mL), water (2x40 mL) and brine (2x50 mL), dried (Na2SO4) and the solvent 
was concentrated to afford 189 (5.81 g, 22.2 mmol, 82%) as a colorless oil. To a vigorously 
stirred suspension of silica-gel supported NaIO4 reagent (12.1 g) in CH2Cl2 (25 mL), a 
solution of 189 (1.57, 5.99 mmol) in CH2Cl2 (25 mL) was added and stirred at room 
temperature for 1 h. The reaction mixture was then filtered, washing the residue with 
CHCl3. The combined filtrates were concentrated under reduced pressure and the residue 
was purified by gradient flash chromatography (AcOEt: PEt from 1:1 to 7:1), to give 
aldehyde 167 as a colorless oil (1.12 g, 4.87 mmol, 81%). 1H-NMR (400 MHz, CDCl3) δ = 9.59 
(d, J = 1.6 Hz, 1H, aldehyde), 6.29 (s, 1H, 1-H), 5.11 (dd, J = 5.8, 4.3 Hz, 1H, 3-H), 4.73 (d, J = 
5.8 Hz, 1H, 2-H), 4.42 (dd, J = 4.3, 1.6 Hz, 1H, 4-H), 2.05 (s, 3H, OAc), 1.43 (s, 3H, Me), 1.28 
(s, 3H, Me) ppm. 13C-NMR (50 MHz, CDCl3) δ = 197.7 (d, HC=O), 169.2 (s, OC=OCH3), 114.0 
(s, acetal), 100.1 (d, C-1), 85.3 (d, C-4), 84.5 (d, C-2), 80.9 (d, C-3), 25.8 (q, Me), 24.5 (q, Me), 
20.9 (q, OC=OCH3). ppm. MS (ESI): m/z (%) = 285.17 (100) [(M+MeOH)+Na]
+.  
Synthesis of 1-O-Acetyl-5-benzylamino-5-cyano-5-deoxy-2,3-O-(1-methylethylidene)-β-L-
erythro-pentofuranose(190a): To a solution of aldehyde 167 (505 mg, 2.19 mmol) in dry 
CH3CN (11.0 mL), BnNH2 (240 µL, 2.19 mmol) and 3Å pellets molecular sieves were added, 
under N2 atmosphere. The mixture was stirred at room temperature for 40 min, then 
TMSCN (274 µL, 2.19 mmol) was added dropwise. The solution was stirred at room 
temperature for 18 h, then diluted with AcOEt, washed with sat. aq. NaHCO3, H2O and 
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brine, dried (Na2SO4), filtered and concentrated under vacuum. 
1H NMR analysis of the 
crude mixture showed the formation of two diasteroisomers in 86:14 ratio. Purification of 
the crude product using silica gel gradient flash chromatography (AcOEt/EP from 1:2 to 1:1) 
afforded 516 mg (1.49 mmol, 68%) of the major diastereoisomer 190a, as a white solid. 
m.p. 80-82 °C. [α]D
19 = + 70.2 (c = 0.98, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.16-7.04 (m, 
5H, Ar), 6.00 (s, 1H, 1-H), 4.68 (dd, J = 5.8, 3.9 Hz, 1H, 3-H), 4.50 (d, J = 5.8 Hz, 1H, 2-H), 4.03 
(dd, J = 7.8, 3.9 Hz, 1H, 4-H), 3.89 (d, J = 12.9 Hz, NBn), 3.75 (d, J = 7.8 Hz, 1H, 5-H), 3.64 (d, J 
= 12.9 Hz, 1H, NBn), 1.83 (s, 3H, OAc), 1.32 (s, 3H, Me), 1.11 (s, 3H, Me) ppm. 13C-NMR (50 
MHz, CDCl3) δ = 169.1 (s, OC=OCH3), 138.0 (s, Ar), 128.6-127.7 8d, 5C, Ar), 117.7, 114.2 (2C, 
CN, acetal), 100.3 (d, C-19, 84.5 (d, C-2), 80.3 (d, C-49, 78.8 (d, C-3), 51.7 (t, NBn), 49.2 8d, 
C-5), 25.1 (q, Me), 24.5 (q, Me), 21.0 (q, OC=OCH3). ppm. MS (ESI): m/z (%) =369.08 (100) 
[M+Na]+. IR (KBr): ν = 3483, 3350, 2988, 2943, 2920, 2359, 2231, 1747, 1605, 1460 cm-1. 
C18H22N2O5 (346.38): C 62.42, H 6.40, N 8.09; found C 62.79, H 6.27, N 8.05. 
Synthesis of (2S,3R,4S,5R)-1-benzyl-2-carboxamide-3-hydroxy-4,5-O-(1-methyethylidene)-
piperidine (191): To a solution of compound 190a (376 mg, 1.09 mmol) in MeOH (43 mL), 
8.5 g of Ambersep®900-OH were added and the mixture was stirred at room temperature. 
After 2 h, the ion-exchange resin was filtered washing with MeOH and NaBH3CN (75 mg, 
1,20 mmol) and CH3COOH (125 µL, 2.18 mmol) were added. The solution was stirred at 
room temperature for 18 h, until a 1H NMR analysis of the crude mixture attested the 
complete formation of an only new product. The solvent was evaporated under vacuum 
and the residue was purified using silica gel flash chromatography (CH2Cl2/MeOH/NH4OH 
6% 10:1:0.1) to give compound 191 as a waxy solid (262 mg, 0.86 mmol, 79%). 
191: [α]D
29 = - 5.6 (c = 0.76, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 7.35-7.25 (m, 5H, Ar), 5.99 
(brs, 1H, NH), 4.29 (dt, J = 6.9, 3.4 Hz, 1H, 5-H), 4.24 (t, J = 6.4 Hz, 1H, 4-H), 4.17 (m, 1H, 3-
H), 4.02 (d, J = 13.2 Hz , 1H, Bn), 3.86 (d, J = 13.2, 1H, Bn), 3.51 (d, J = 4.4 Hz, 1H, 2-H), 3.15 
(dd, J = 14.2, 3.0 Hz, 1H, 6-Ha), 2.94 (dd, J = 14.2, 3.7 Hz, 1H, 6-Hb), 1.56 (s, 3H, Me), 1.34 (s, 
3H, Me) ppm. 13C-NMR (50 MHz, CDCl3) δ = 176.4 (s, C=O), 138.2 (s, Ar), 128.9-127.5 (d, 5C, 
Ar), 109.2 (s, acetal), 76.0 (d, C-4), 73.6 (d, C-5), 68.8 (d, C-3), 62.3 (d, C-2), 61.0 (t, Bn), 45.9 
(t, C-6), 27.4 (q, Me), 24.6 (q, Me) ppm. MS (ESI): m/z (%) = 329.33 (100) [M+Na]+. IR 
(CDCl3): ν = 3687, 3608, 3498, 3364, 3031, 2991, 2935, 1676, 1384, 1210, 1049 cm
-1. 
C16H22N2O4 (306.36): calcd. C 62.73, H 7.24, N 9.14; found C 62. 76, H 7. 24, N 9.19.  
Synthesis of 1-benzyl-3,4,5-trihydroxypiperidine-2-carboxamide (170a): A solution of 191 
(17 mg, 0.05 mmol) in MeOH (4.0 mL) and HCl 1M (4 drops) was left stirring at room 
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temperature overnight. The crude mixture was concentrated to yield the hydrochloride of 
170a which was eluted through an ion-exchange resin (DOWEX® 50XW8-100) with MeOH, 
H2O and 6% NH4OH to give the free amine 170a (11 mg, 80%). [α]D
26 = +17.0 (c = 0.56, H2O). 
1H-NMR (400 MHz, D2O) δ = 7.30-7.21 (5H, Ar) 3.90-3.85 (m, 3H, 3-H, 4-H, 5-H), 3.71 (d, J = 
13.5 Hz, 1H, Bn), 3.45 (d, J = 13.5 Hz, 1H, Bn), 3.26 (br s, 1H,2-H), 2.86 (dd, J = 12.2, 3.4 Hz, 
1H, 6-Ha), 2.36 (pt, J = 9.0 Hz, 1H, 6-Hb) ppm. 13C-NMR (50 MHz, D2O) δ = 175.7 (s, C=O), 
136.4 (s, Ar), 129.8-127.9 (d, 5C, Ar), 69.7, 69.4, 66.1 (3C, d, C-3, C-4, C-5), 64.6 (d, C-2), 59.2 
(t, Bn), 50.5 (t, C-6) ppm. MS (ESI): m/z (%) = 289.13 (100) [M+Na]+, 267.33 (48) [M+H]+. 
C13H18N2O4 (266.29): calcd. C 58.63, H 6.81, N 10.52; found C 58.15, H 7.26, N 10.32. 
Synthesis of 3,4,5-trihydroxypiperidine-2-carboxamide (170b): To a solution of 191 (50 
mg, 0.16 mmol) in MeOH (4 mL) and HCl 1M (30 drops) Pd /C (25 mg) was added and the 
reaction mixture was left stirring at room temperature under H2 atmosphere for 48 h. The 
catalyst was filtered through Celite® and the filtrate was concentrated under vacuum, to 
yield quantitative the hydrochloride salt of 170b which was eluted through an ion-exchange 
resin (DOWEX® 50XW8-100) with MeOH, H2O and 6% NH4OH to give the free amine 170b 
(23mg, 0.13mmol, 82%). [α]D
21 = + 27.2(c =0.38, H2O). 
1H-NMR (400 MHz, D2O) δ = 4.02 (dd, 
J = 4.3, 2.4 Hz, 1H, 3-H), 3.90 (pt, J = 3.7Hz, 1H, 4-H), 3.83 (ddd, J = 11.0, 5.1, 3.1 Hz, 1H, 5-
H), 3.55 (d, J = 2.4 Hz, 1H, 2-H), 2.84 (dd, J = 12.7, 5.1 Hz, 1H, 6-Ha), 2.62 (dd, J = 12.7, 11.0 
Hz, 1H, 6-Hb) ppm. 13C-NMR (50 MHz, D2O) δ = 174.6 (s, C=O), 69.7 (d, C-3), 69.1 (d, C-4), 
63.9 (d, C-5), 55.7 (d, C-2), 42.7 (t, C-6) ppm. MS (ESI): m/z (%) = 199.08 (100) [M+Na]+,. 
C6H12N2O4 (176.16): calcd. C 40.91, H 6.87, N 15.90; found C 40.35, H 6.85, N.16.05. 
Synthesis of (2R,3R,4R,5R)-1-benzyl-2-carboxy-3,4,5-trihydroxypiperidinium chloride 
(171a): A solution of 191 (50 mg, 0.17 mmol) in 1 mL of HCl 6M was heated to gentle reflux. 
After 16 h the reaction was complete, as attested by a TLC control. The solution was cooled 
to room temperature and then extracted with Et2O (3x4 mL) to remove ether soluble 
material. The hydrochloric acid was evaporated to dryness under reduced pressure, then it 
was dissolved in MeOH (5 mL) and NaOH (13 mg, 0.32 mmol) was added. The reaction 
mixture was left stirring for 1h in order to obtain the corresponding sodium salt, which was 
passed over Ambersep® 900-OH, eluting with MeOH, water and a 6M HCl solution. This 
procedure allowed us to obtained pure 171a (35 mg, 0.12 mmol) as a waxy solid in 71% 
yield. [α]D
23 = +26.6 (c = 0.32, MeOH). 1H-NMR (400 MHz, D2O) δ = 7.44-7.35 (5H, Ar) 4.54 
(d, J = 12.7 Hz, 1H, CH2Ph), 4.27 (d, J = 11.7 Hz, 2H, CH2Ph, H-2), 4.10-4.07 (m, 1H, 5-H), 3.91 
(pt, J = 3.9 Hz, 1H, 4-H), 3.90 (d, J = 11.7 Hz, 1H, 3-H), 3.16 (dd, J = 11.7 Hz, 1H, 6-Ha), 3.02 
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(t, J = 11.7 Hz, 1H, 6-Hb) ppm. 13C-NMR (50 MHz, D2O) δ = 169.0 (s, COOH), 130.9 (s, Ar), 
129.6-126.7 (d, 5C, Ar), 68.7 (d, C-2), 67.0 (d, C-4), 62.2 (d, C-3), 61.0 8d, C-5), 59.7 (t, Bn), 
47.1 (t, C-6). ppm. MS (ESI): m/z (%) = 266.33 (100) [M-H]+. C13H18ClNO5 (303.74): calcd. C 
51.41, H 5.97, N 4.61; found C 51.57, H5.83, N 4.50. 
(2R,3R,4R,5R)-2-carboxy-3,4,5-trihydroxypiperidinium chloride [(2R,3R,4R,5R)-3,4,5-
trihydroxypipecolid acid hydrochloride salt] (171b.HCl): To a solution of 191 (49 mg, 0.16 
mmol) in MeOH (4 mL) and 1M HCl (15 drops) Pd/C (25 mg) was added and the reaction 
mixture was left stirring at room temperature under H2 atmosphere for 16 h. The catalyst 
was filtered through Celite and the filtrate was concentrated under vacuum, then 1 mL of a 
6M HCl solution was added and the mixture heated to gentle reflux. After 16 h reflux the 
reaction was complete, as attested by a TLC control. The solution was cooled at room 
temperature and then extracted one time with Et2O (4 mL) to remove ether soluble 
material. The aqueous layer was evaporated and dried under vacuum to obtain 171b.HCl 
(34 mg, 0.16 mmol) in 100% yield. A little portion of the product was dissolved in MeOH 
and treated with excess NaOH. The reaction mixture was left stirring for 1 h in order to 
obtain the corresponding sodium salt, which was passed over Ambersep 900-OH, eluting 
with MeOH, water and a 6M HCl solution. This procedure allowed us to obtain pure 
171b.HCl. [α]D
25=-79.1 (c=0.32, H2O); 
1H-NMR (400 MHz, CD3OD): δ=4.33 (br m, 1H; 3-H), 
4.15 (br m, 2H; 5-H, 2-H), 3.93 (br m, 1H; 4-H), 3.04 ppm (br m, 2H; 6-Ha, 6-Hb); 13C-NMR 
(100 MHz, CD3OD): δ=168.6 (s, COOH), 69.0 (d, C-3), 68.7 (d, C-4), 61.9 (d, C-5), 55.9 (d, C-
2), 42.0 (t, C-6); MS (ESI): m/z (%): 212.00 (100) [M-H]+. 
Synthesis of (2S,3R,4S,5R)-2-Aminomethyl-1-benzyl-3-hydroxy-4,5-isopropylidenedioxy-
piperidine- (192): A solution of 191 (103 mg, 0.33 mmol) in dry THF (15 mL), was cooled to 
0 °C and LiALH4 (0.99 mL of a 1M solution in THF) was added. The reaction mixture was 
heated to reflux and stirred for one hour and half, under N2 atmosphere, until the complete 
disappearance of the starting material was attested by a TLC control. The reaction solution 
was cooled at room temperature, then an aqueous saturated solution of Na2SO4 was added 
and left stirred for 15 minutes. The mixture was extracted with AcOEt (3x10 mL), the 
combined organic layers were dried over Na2SO4 and concentrated. The crude product was 
purified by flash chromatography (CH2Cl2/MeOH/NH4OH 6% 10: 2:0.2) affording 192 (76 
mg, 0.26 mmol) in 79% yield. [α]D
25 = +24.3 (c = 1.01, CHCl3). 
1H-NMR (400 MHz, CDCl3) δ = 
7.35-7.21 (5H, Ar), 4.31 (dt, J = 6.8, 3.4 Hz, 1H, 5-H), 4.16-4.12 (m, 2H, 4-H, 3-H), 3.89 (s, 2H, 
CH2Ph), 3.26-3.20 (m, 2H, 6-Ha, CH2NH2), 2.88 (dt, J = 3.9, 2.0 Hz, 1H, 2-H), 2.84-2.80 (m, 2H, 
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6-Hb, CH2NH2), 1.54 (s, 3H, Me), 1.34 (s, 3H, Me) ppm. 
13C-NMR (50 MHz, CDCl3) δ = 140.4 
(s, Ar), 128.4-126.9 (d, 5C, Ar), 108.4 (s, acetal), 74.9 (d, C-4), 73.3 (d, 2C, C-5, C-3), 60.4 (t, 
Bn), 56.5 (d, C-2), 47.9 (t, C-6), 43.3 (t, CH2NH2), 27.2 (q, Me), 24.2 (q, Me). ppm.
 MS (ESI): 
m/z (%) = 293.25 (100) [M+H]+. IR (CDCl3) ν = 3689, 3604, 3399, 3086, 3065, 3029, 2991, 
2922, 2868, 2247, 1601, 1561, 1383, 1209, 1027 cm-1. C16H24N2O3 (292.37): calcd. C 65.73, H 
8.27, N 9.58; found C 66.12, H 8.12, N 9.22. 
Synthesis of (2S,3R,4R,5R)-2-Aminomethyl-1-benzyl-2-3,4,5-tri-hydroxypiperidine (172a): 
A solution of 192 (25 mg, 0.09 mmol) in MeOH (2.3 mL) was left stirring with 12M HCl (75 
µL, 0.9 mmol) at room temperature for 48 h. The crude mixture was concentrated to yield 
the hydrochloride salt of 172a. The corresponding free amine was obtained by passing the 
hydrochloride salt through a DOWEX® 50XW8-100 ion-exchange resin. Elution with 33% 
ammonia afforded the free base 172a (20 mg, 0.08 mmol) in 89% yield. [α]D
24=+21.2 (c=1.29 
in MeOH); 1H-NMR (400 MHz, D2O): δ=7.33-7.24 (m, 5H; Ar), 4.00 (dd, 
3J(H,H)=6.9, 3.9 Hz, 
1H; 3-H), 3.89 (dt, 3J(H,H)=7.2, 3.6 Hz 1H; 5-H), 3.85 (d, 2J(H,H)= 13.1 Hz, 1H; Bn), 3.70 (dd, 
3J(H,H)=6.9, 3.6 Hz, 1H; 4-H), 3.62 (d, 2J(H,H)=13.1 Hz, 1H; Bn), 2.99 (d, 3J(H,H)=6.4 Hz, 2H; 
CH2NH2), 2.76-2.73 (m, 1H; 2-H), 2.64 (dd, 
2J(H,H)=13.0, 3J(H,H)= 3.4 Hz, 1H; 6-Ha), 2.46 ppm 
(dd, 2J(H,H)=13.0, 3J(H,H)=7.2 Hz, 1H; 6-Hb); 13C-NMR (50 MHz, D2O): δ=137.6 (s, Ar), 129.7-
127.6 (d, 5C, Ar), 70.1 (d, C-4), 69.0 (d, C-3), 67.1 (d, C-5), 59.1 (d, C-2), 57.7 (t, Bn), 49.9 (t, 
C-6), 36.7 ppm (t, CH2NH2);
 MS (ESI): m/z (%): 253.28 (100) [M+H]+, 275.29 (27) [M+Na]+; 
elemental analysis calcd (%) for C13H20N2O3 (252.31): C 61.88, H 7.99, N 11.10; found C 
61.38, H 8.04, N 10.72. 
Synthesis of (2S,3R,4R,5R)-2-Aminomethyl-3,4,5-trihydroxy-piperidine (172b): To a 
solution of 192 (19 mg, 0.07 mmol) in MeOH (4 mL) and 12M HCl (7 drops) Pd/C (15 mg) 
was added and the reaction mixture was left stirring at room temperature under H2 
atmosphere for 3 days. The catalyst was filtered through Celite® and the filtrate was 
concentrated under vacuum to yield the hydrochloride salt of 172b which was eluted 
through an ion-exchange resin (DOWEX® 50XW8-100) with MeOH, H2O and 15% NH4OH to 
give the free amine 172b (10 mg, 0.06 mmol, 95%). The NMR spectra established that a 
mixture of free amine and the corresponding protonated form was recovered [α]D
23=+4.30 
(c=0.58 in H2O); 
1H-NMR (400 MHz, D2O): δ=3.89-3.72 (m, 3H; 3-H, 4-H, 5-H), 3.01-2.57 ppm 
(m, 5H; 6-H, 2-H, CH2NH2); 
13C-NMR (50 MHz, D2O): δ=69.4, 69.0, 68.8, 68.2 (d, 2C, C-3, C-4), 
64.9, 64.6 (d, 1C, C-5), 52.4, 52.0 (d, 1C, C-2), 43.3, 43.2 (t, 1C, C-6), 40.2, 39.6 ppm (t, 1C, 
CH2NH2); MS (ESI): m/z (%): 185.10 (100) [M+Na]
+.  
Chapter 3 
116 
 
Protected tetravalent iminosugars (194): To a solution of 176e (89 mg, 0.35 mmol) in 1.8 
mL of a 2:1 THF/H2O mixture, CuSO4 (30 mol %, 3.8 mg, 0.024 mmol), sodium ascorbate (60 
mol %, 9.5 mg, 0.048 mmol) and 193 (23 mg, 0.08 mmol) were added. The reaction mixture 
was heated in MW reactor at 80°C for 45 min, until TLC analysis showed disappearance of 
the starting material. After filtration through Celite®, the solvent was removed under 
reduced pressure and the crude was purified by gradient FCC (from CH2Cl2/MeOH 10:1 to 
CH2Cl2/MeOH/NH4OH 6% 10:1:0.1) affording pure 194 (92 mg, 0.07 mmol, 88%) as a pale 
yellow oil. Rf=0.32 (CH2Cl2/MeOH/NH4OH 6% 10:1:0.1); [α]D
24 = +4.88 (c =1.92, CHCl3); 
1H-
NMR (400 MHz, CDCl3) δ = 7.67 (s, 4H, H-Triazole), 4.54 (s, 8H, OCH2Triazole), 4.44 (t, J = 6.6 
Hz, 8H, 3’-H), 4.32 (dd, J = 11.7, 5.3 Hz, 4H, 3-H), 4.05 (t, J = 4.7 Hz, 4H, 4-H), 3.98-3.95 (m, 
4H, 5-H), 3,42 (s, 8H, CCH2O), 2.71 (dd, J = 12.0, 5.3 Hz, 4H, 2a-H), 2.59 (dd, J = 11.7, 2.9 Hz, 
4H, 6a-H), 2.47-2.41 (m, 8H, 2b-H, 6b-H), 2.36 (t, J = 6.6 Hz, 8H, 1’-H), 2.11-2.03 (m, 8H, 2’-
H), 1.49 (s, 12H, Me), 1.35 ppm (s, 12H, Me); 13C-NMR (50 MHz, CDCl3) δ = 145.1 (s, 4C, C-
Triazole), 123.3 (d, 4C, C-Triazole), 109,0 (s, 4C, acetal), 77.3 (d, 4C, C-4), 72.2 (d, 4C, C-3), 
68,9 (t, 4C, CCH2O), 68.0 (d, 4C, C-5), 64.8 (t, 4C, OCH2Triazole), 56.1 (t, 4C, C-6), 54.8 (t, 4C, 
C-2), 53.4 (t, 4C, C-1’), 47.7 (t, 4C, C-3’), 45.2 (s, CCH2O ), 28.3 (q, 4C, Me), 27.3 (t, 4C, C-2’), 
26.3 ppm (q, 4C, Me); MS (ESI): m/z (%) = 1335.83 (100) [M+Na]+; IR (CDCl3): ν = 3629, 3416, 
3143, 2988, 2939, 2826, 2247, 1724, 1665, 1550, 1468, 1383, 1220, 1058 cm-1; elemental 
analysis calcd (%) for C61H100N16O16 (1313.54): calcd. C, 55.78; H, 7.67; N, 17.06; found C 
55.74, H 7.66, N 16.83. 
Peracetylated tetravalent iminosugars (195): To a solution of 194 (85 mg, 0.065 mmol) in 
35 mL of methanol, 0.22 mL (10.0 equiv,) of 37% HCl were added and the mixture was 
stirred at room temp. for 18 hours. After that a TLC analysis showed disappearance of the 
starting material, the solvent was removed under reduced pressure. Successively elution 
with MeOH, H2O and 6% aqueous ammonia onto a ion exchange resin Dowex 50WX8-200 
afforded 9 mg (0.008 mmol) of corresponding free amine and 42 mg (0.032 mmol) of 
hydrochloride salt (MeOH fraction). This fraction was dissolved in pyridine (1.2 mL) and 
acetic anhydride (0.8 mL) was added. The solution was stirred at room temperature for 18 
hours. Then, after concentration under reduced pressure, the crude mixture was purified 
by gradient FCC (from CH2Cl2/MeOH 20:1 to 5:1) affording pure 195 (48 mg, 0.029 mmol, 
91%) as an oil. Rf=0.22 (CH2Cl2/MeOH 10:1 ); [α]D
22 = -42.1 (c =1.45, CHCl3); 
1H-NMR (400 
MHz, CDCl3) δ = 7.55 (s, 4H, H-Triazole), 5.22 (dt, J = 5.4, 2.7 Hz, 4H, 3-H), 5.07 (dt, J = 8.2, 
4.4 Hz, 4H, 5-H), 4.90 (dd, J = 8.8, 3.4 Hz, 4H, 4-H), 4.48 (s, 8H, OCH2Triazole), 4.42-4.29 (m, 
8H, 3’-H), 3.39 (s, 8H, CCH2O), 2.92 (d, J = 8.3 Hz, 4H, 6a-H), 2.77 (dd, J = 12.1, 3.9 Hz, 4H, 
2a-H), 2.40-2.33 (m, 12H, 2b-H, 1’-H), 2.21-2.15 (m, 4H, 6b-H), 2.03 (s, 12H, Ac), 2.01-1.93 
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(m, 8H, 2’-H), 1.99 (s, 12H, Ac), 1.97 ppm (s, 12H, Ac); 13C-NMR (50 MHz, CDCl3) δ = 169.7 8 
(s, 12C, OAc), 144.8 (s, 4C, C-Triazole), 122.6 (d, 4C, C-Triazole), 70.6 (d, 4C, C-4), 68.8 (t, 4C, 
CCH2O), 67.8 (d, 4C, C-5), 67.5 (d, 4C, C-3), 64.7 (t, 4C, OCH2 Triazole), 53.6 (t, 4C, C-2), 53.2 
(t, 4C, C-6), 53.0 (t, 4C, C-1’), 47.4 (t, 4C, C-3’), 45.3 (s, CCH2O ), 27.2 (t, 4C, C-2’), 20.8-20.5 
ppm (q, 12C, OAc); MS (ESI): m/z (%) = 1679.92 (100) [M+Na]+; IR (CDCl3): ν = 3451, 3145, 
2960, 2874, 2825, 2258, 2246, 1743, 1663, 1470, 1437, 1372, 1231, 1049 cm-1; elemental 
analysis calcd (%) for C73H108N16O28 (1657.73): calcd. C, 52.89; H, 6.57; N, 13.52; found C 
52.52, H 6.25, N 13.90. 
Polyhydroxylated tetravalent iminosugar (196): A suspension of 195 (31 mg, 0.019 mmol) 
and ion exchange resin Ambersep 900 OH (500 mg) in 10 mL of methanol was slowly stirred 
at room temp. for 16 h. After filtration of resin on Celite®, the solvent was removed under 
reduced pressure affording pure 196 (19 mg, 0.016 mmol, 86% yield) as a waxy solid. [α]D
23 
= -13.0 (c =1.1, H2O); 
 1H-NMR (400 MHz, D2O): =7.83 (s, 4H, H-Triazole), 4.38 (s, 8H, 
OCH2Triazole), 4.31 (t, J=6.8 Hz, 8H, 3’-H), 3.86-3.82 (m, 4H, 3-H), 3.72 (td, J=8.8, 4.4 Hz, 4H, 
5-H), 3.58-3.34 (m, 4H, 4-H), 3.25 (s, 8H, CCH2O), 2.72, 2.65 (m, 8H, 2a-H, 6a-H), 2.28-2.11 
(m, 12H, 2b-H, 7-H), 2.00-1.91 ppm (m, 12H, 6b-H, 2’-H). 13C-NMR (50 MHz, D2O): =143.2 
(s, 4C, C-Triazole), 124.0 (d, 4C, C-Triazole), 72.8 (d, 4C, C-4), 67.1(t, 4C, CCH2O), 66.8(d, 4C, 
C-3), 66.6 (d, 4C, C-5), 62.6 (t, 4C, OCH2Triazole), 55.7 (t, 4C,C-6), 54.8 (t, 4C, C-2), 52.9 (t, 
4C, C-1’), 47.7 (t, 4C, C-3’), 43.1(s, 4C, CCH2O), 25.4 ppm (t, 4C, C-2’).; MS (ESI): m/z (%) = 
1175.79 (100); elemental analysis calcd (%) for C49H84N16O16 (1153.29): C 51.03, H 7.34, N 
19.43; found: C 50.71, H 7.46, N 19.62. 
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Chapter 4 
Hybrid gold glyconanoparticles: iminosugar-
based multivalent systems as potential 
glycosidases inhibitors 
4.1 Introduction 
The multivalent display of carbohydrate ligands on a scaffold is currently an area of great 
interest, since carbohydrates bind only weakly to their complementary proteins, while 
modulation and enhancement of the biological response can be achieved by means of 
multiple interactions established by multivalent carbohydrates. The multivalent or cluster 
glycoside effect is defined as the affinity enhancement obtained with multivalent ligands 
compared to their monovalent counterparts.164 This concept has been widely investigated 
for studying carbohydrate-lectin interactions,165,166 but has remained essentially unexplored 
concerning specific glycosidase inhibition 167 using iminosugars as glycomimetics up to 
2010. This can be ascribed to the difficulty of preparing functionalized iminosugars grafted 
to a scaffold and to the enzyme receptors themselves, which usually have a single and deep 
active site and therefore do not seem prone to accept multivalent substrates. However, 
although a strong multivalent effect is generally associated with the interaction of 
receptors bearing multiple recognition sites with multivalent sugar ligands, significant 
affinity enhancements have also been observed for systems where the receptors possess a 
single binding centre.165c 
Some examples of relatively low valent (2-4 iminosugar units) monocyclic iminosugars were 
already reported in the literature, but early glycosidase inhibition tests were not 
                                                          
164
 M. Mammen, S.-K. Choi, G. M. Whitesides, Angew. Chem. Int. Ed. Engl. 1998, 37, 2755–2794. 
165
 For reviews, see: a) R. T. Lee, Y. Ichikawa, T. Kawasaki, K. Drickamer, Y. C. Lee, Arch. Biochem. 
Biophys. 1992, 299, 129–136; b) Y. C. Lee, R. T. Lee, Acc. Chem. Res. 1995, 28, 321–327; c) J. J. 
Lundquist, E. J. Toone, Chem. Rev. 2002, 102, 555–578; d) A. Imberty, Y. M. Chabre, R. Roy, Chem. 
Eur. J. 2008, 14, 7490–7499; e) R. Roy, Trends Glycosci. Glycotechnol. 2003, 15, 291–310; f) R. Roy, 
M.-G. Baek, Rev. Mol. Biotechnol. 2002, 90, 291–309; g) M. Lahmann, Top. Curr. Chem. 2009, 288, 
17–65; h) T. K. Dam, C. F. Brewer, Adv. Carbohydr. Chem. Biochem. 2010, 63, 139–164; i) D. Deniaud, 
K. Julienne, S. G. Gouin, Org. Biomol. Chem. 2011, 9, 966–979; j) R. J. Pieters, Org. Biomol. Chem. 
2009, 7, 2013–2025; k) V. Roldós, F. J. Cañada, J. Jiménez-Barbero, ChemBioChem. 2011, 12, 990-
1005. 
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Bundle, Nature 2000, 403, 669–672; b) H. C. Hang, C. R. Bertozzi, Acc. Chem. Res. 2001, 34, 727–736; 
c) B. T. Houseman, M. Mrksich, Top Curr. Chem 2002, 218, 1–44; d) L. L. Kiessling, J. E. Gestwicki, L. E. 
Strong, Angew. Chem. Int. Ed. Engl. 2006, 45, 2348–2368.  
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encouraging.168 In our group we also made some preliminary efforts aimed to synthesizing 
multivalent pyrrolidine-based ligands on calyxarene cores.169 However, the first promising 
example of multivalent effect on a glycosidase was recently reported for a trivalent 1-
nojirimycin derivative, which showed a 6-fold affinity enhancement towards jack bean -
mannosidase.170  
 
Figure 4.1: Recent examples of iminosugar based multivalent systems by Nierenengarten and 
Compain groups, taken from an authors adaptation (Ref. 
171
 and 
172
). 
Much greater effects were demonstrated for fullerene decorated with 12 iminosugar 
residues171 and for a series of cyclodextrins conjugated with 7 or 14 iminosugars.172 In both 
examples the selected iminosugar is an N-alkyl analogue of 1-deoxynojirimycin and the best 
effects were reported with jack bean α-mannosidase. In the case of the 14-valent system, 
an inhibition enhancement up to four orders of magnitude over the corresponding 
monovalent ligand was found (Figure 4.1). A strong multivalent effect was also observed 
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with deoxynojirimycin-decorated cyclodextrins towards a -glucosidase of therapeutic 
interest, namely human GCase, thus showing the applicability of the multivalence concept 
in the development of chaperones for the treatment of Gaucher’s disease173. Relatively 
small trivalent and tetravalent N-butyl deoxynojirimycin analogues were also recently 
found to act as more potent CFTR (cystic fibrosis transmembrane conductance regulator) 
correctors than the monovalent relative iminosugar, thus representing promising new 
candidates for the treatment of cystic fibrosis (CF).174 
All these results suggested the existence of a multivalent effect beyond the expected 
statistical rebinding and local concentration effect that should favor the ligand recapture by 
the glycosidases. This inhibitory multivalent effect may found explication in mechanisms 
involving either secondary binding interactions in regions around the active site (sub-site 
binding), or favorable non-specific interactions in proximity to the enzyme surface .Related 
to the latter issue, a recent work of Nierengarten and co-workers tried to give some insights 
on the importance of non-glycone binding sites in glycosidase inhibition by multivalent 
systems (Figure 4.2) 175  
 
Figure 4.2: Schematic representations of the shift in binding modes after multivalent presentation of 
inhibitors for enzymes having A) a deep catalytic site but accessible aglycone sites or B) accessible 
catalytic as well as aglyconic sites. Taken from Ref. 
175
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In another very recent paper 176the dimeric nature of the Jack Bean α-mannosidase 
(JBαMan) has been recognized as a key characteristic for promoting intermolecular cross-
linking interactions. For this reason, similarly to lectin mechanisms, the spatial presentation 
of iminosugar epitopes can modulate the strength of the multivalent effects. These 
examples show that the rationalization of the mechanisms involved in multivalent 
iminosugar-based systems and glycosidases is far from being achieved because the binding 
modes operating depend on the topology of the multivalent iminosugar system as well as 
on the type of the enzyme under study (e.g. whether the glycosidic site is deep or shallow, 
hidden or exposed, proximal to other binding sites or not). The high inhibitory activity 
enhancements reported for these relatively few examples, together with the need for 
better understanding the interactions of these systems with their enzymatic counterparts, 
highlight the interest in synthesizing multivalent iminosugar-conjugates with well-defined 
structures. In this context, we decided to study the feasibility of using glyconanoparticles 
(GNPs) as versatile scaffolds to multimerize iminosugar analogues, an approach which has 
no precedent in the literature.  
GNPs are water-soluble and biofunctional gold nanoclusters with a three-dimensional 
polyvalent carbohydrate display and globular shape, chemically well-defined composition 
and an exceptionally small core size (Figure 4.3).177  
 
Figure 4.3: General scheme of gold glyconanoparticles (GNPs). GNPs consist of an inorganic core of 
nanometric size which is functionalized with suitably-derivatized carbohydrates (for example, in the 
case of gold nanoparticles, thiol ending neoglycoconjugates). The inorganic core can harbor other 
different types of ligands in addition to carbohydrates.  
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They can display a large number of carbohydrates on a reduced surface with a high local 
concentration of sugars or lower densities. GNPs were originally designed and prepared to 
demonstrate the existence of carbohydrate–carbohydrate interactions by a chemical 
systems.177a In particular, gold nanoparticles coated with the trisaccharide Lewis X (LeX) 
were used to unveil the specific, multivalent, calcium-dependent and reversible LeX self-
interaction in water by different techniques including transmission electron microscopy 
(TEM), isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), and atomic 
force microscopy (AFM). 178 This new integrated approach based on the use of carbohydrate 
self-assembled monolayers (SAMs) on two- and three-dimensional gold surfaces was 
termed glyconanotechnology. GNPs also constitute a good biomimetic model to intervene 
in carbohydrate-mediated biological processes. The first demonstration that these 
nanotools can behave as anti-adhesion agents was reported against progression of lung 
metastasis in mice: GNPs functionalized with lactose neoglycoconjugates were able to 
inhibit the metastasis of melanoma in mice lungs by up to 70%.179  
Another important characteristic of GNPs is the multifunctionality, namely the possibility of 
simultaneously inserting on the gold nanoplatform more the one ligand and to modulate 
the presentation of the ligands. In this sense, the glyconanoparticle platform offers 
advantageous alternatives to protein, polymer, or dendrimer scaffolds. 
Glyconanotechnology allows the preparation of a great variety of water-soluble 
glycoclusters with high (approximately 100 molecules on a 2 nm core gold) and low ligands 
loadings and variable linkers to modulate rigidity and flexibility and to confer accessibility to 
the ligands.180  Some examples of the application of this technology to solve biological 
problems include gold nanoparticles coated with (oligo)mannosides (manno-GNPs) which 
inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells181 and the anti-HIV 
antibody 2G12-mediated neutralization of HIV-1 infection towards T cells.182 In the last 
decade, many examples of multivalent and multifunctional GNPs have been reported to 
study carbohydrate-based interactions.180,183 
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Conversely, only two works where GNPs have been faced to enzymes are present in the 
literature. It has been demonstrated that carbohydrates tailored on GNPs display higher 
enzymatic stability respect to the free species. Gold nanoparticles of 2 nm coated with 
lactose conjugates were resistant to E. coli β-galactosidase-mediated hydrolysis even under 
drastic conditions (enzyme concentration, time, temperature).184 Steric crowding of the 
lactose moieties on the nanoparticle surface probably inhibited enzymatic recognition and 
degradation. By decreasing the lactose density (from 100% to 30% and 5%) on the gold 
nanoparticles, different rates of hydrolysis were achieved. However, the specific activity 
was still very low in comparison with the free neolactoconjugate. Another recent work by 
Jensen’s group demonstrated that maltotriose oxy-amine-GNPs were stable towards the 
glucoamylase-mediated enzyme hydrolysis, while the corresponding maltotriose oxime-
GNPs showed partial hydrolysis of the maltotriose.185 The explanation of this phenomenon 
may reside in the density of sugars on GNPs recognition by enzymes, in fact maltotriose 
oxy-amine derivatives self-assembled on gold nanoparticles in a three time higher amount 
than maltotriose oxime derivatives.  
These results point out that GNPs are generally resistant to enzyme degradation and thus 
simple monosaccharides can be employed as inner component in the preparation of 
multivalent glycosidase inhibitor systems, bearing iminosugars as active component (Figure 
4.4). 
 
Figure 4.4: Schematic representation of an hybrid Au-GNP coated with sugar (inner component) and 
iminosugar (active component) derivatives. 
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In this Chapter, we describe how iminosugars can be multimerized on 2 nm gold 
nanoparticles with the aim of increasing their inhibitory potency towards glycosidases. The 
synthesis and characterization of these multivalent tools will be presented together with 
the preliminary biological tests with commercially available glycosidases. 
4.2 Results and Discussion 
In this PhD Thesis, the first example of gold GNPs coated with iminosugars is reported. 
Hybrid Au-GNPs consisting of a nanometric gold core (around 2 nm) coated with different 
percentage of selected iminosugar derivatives as active components and simple 
monosaccharides as inner components have been designed and prepared (Figure 4.5), 
following a reported protocol.186  
 
Figure 4.5: Schematic representation of Au-GNPs coated with iminosugars. The GNPs consist of: 1) a 
nanometric gold core; 2) an active component R (in red), which is an iminosugar among 160, 168f 
and 157, linked to gold core through an amphiphilic linker. The coupling with the linker could be 
achieved by thiourea or amide formation (bottom right); 3) an inner component which is a simple 
monosaccharide (β-glucose α-mannose) linked to gold core through a short aliphatic linker (bottom 
left). 
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Three biologically active iminosugars (compounds 157, 160 and 168f, Figure 4.6) with 
structures belonging to the classes of polyhydroxylated pyrrolizidines, piperidines and 
pyrrolidines, were selected to be incorporated as active components of the gold 
nanoparticles. These molecules are slight modified analogues of compounds 114, 168b and 
197 (Figure 4.6), in turn obtained through efficient and selective strategies starting from 
carbohydrates, during our studies on the synthesis of polyhydroxylated alkaloids and their 
unnatural analogs (see Chapter 2 and 3).  
 
Figure 4.6: Biologically active iminosugars (top) and their corresponding amino-derivative analogues 
(bottom). From left to right, polyhydroxylated pyrrolizidines, piperidines and pyrrolidines 
compounds. 
In particular, casuarine analogue 114 mimics glucose and is able to inhibit commercial and 
human glucosidases.87 Piperidine 168b showed to be a selective inhibitor of commercial 
and human α-L-fucosidase, in agreement with literature data reported for the non-alkylated 
analogue.187 The N-octyl DAB-1 (1,4-dideoxy-1,4-imino D-arabinitol) derivative 197, 
obtained by reductive amination of DAB-1 with the suitable aliphatic aldehyde106 resulted 
to inhibit not only commercial α- and β-glucosidases but also human α-mannosidase, 
according to preliminary not yet published biological evaluations. 
In order to attach biologically active compounds 114, 168b and 197 to gold nanoparticles, 
their structures were modified by introducing an amino moiety (synthesis reported in 
Chapter 2 and Chapter 3) for further functionalization with long and amphiphilic thiol-
ending linkers (Figure 4.6). The choice of this kind of linkers was made on the basis of 
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previous works186,188. In particular, the amphiphilic nature of mixed aliphatic/polyethylene 
glycol linker imparts flexibility and assists the solubility of whole nanoparticle. Furthermore, 
these long linkers allow the active component (iminosugars) to protrude above the gold 
surface with respect to the inner component (monosaccharides glucose and mannose). It 
should be noticed that the structure modifications of the iminosugars left unchanged the 
sugar mimic moiety of compound, which is responsible for the recognition with the 
glycosidase binding site. 
On the other hand, two different natural hexoses, β-glucopyranose and α-mannopyranose, 
were selected as inner component. In this case, a short (C5), aliphatic linker was chosen to 
impart rigidity to the GNPs. The preparation of GNPs with two different sugars has been 
planned to evaluate if the inner component could play any role in the glycosidases 
inhibition process. Moreover the GNPs incorporating only β-glucose and only α-mannose 
have been prepared as controls in the biological tests. 
4.2.1 Synthesis of Thiol-Ending Ligands 
In order to prepare GNPs, suitable thiol-ending linkers have to be synthesized to exploit the 
gold–sulphur affinity in attaching the ligands to the gold nanocluster surface.189 
To this aim, sugar-based ligands 198 (GlcC5S) and 199 (ManC5S ) were employed as inner 
components. These neoglycoconjugates have been prepared following a well-established 
protocol, while the conjugation of iminosugars 157, 160 and 168f to different amphiphilic 
linkers to obtain active component ligands has been investigated and reported herein for 
the first time. 
Sugar-based ligands: GlcC5S and ManC5S conjugates 198 and 199 were easily prepared 
starting from the peracetylated sugars which are commercially available, according to 
published procedures (Scheme 4.1).186,190  
Briefly, the pentacetate glycoside was glycosylated with 4-penten-1-ol in Fisher conditions, 
followed by free radical mediated tioacetilation with thioacetic acid; the subsequent 
deprotection with sodium methoxide in MeOH afforded desired derivative in good overall 
yields. 
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Scheme 4.1: a) CH2Cl2, BF3
.
 Et2O, rt, 22h; b) CH3COSH, AIBN, THF, reflux, 2h; c) NaOMe, MeOH, Ar, rt, 
2h. 
Iminosugar-based ligands: the conjugation of amino-functionalized iminosugars 157, 160 
and 168f to a bifunctional linker bearing a thiol-protected ending group and a carboxylic or 
an isothiocyanate group at the other terminus was reported herein for the first time and 
was performed by modification of a procedure reported for amino-sugars.186  
As a first attempt, we investigated the conjugation of the amino derivative 160 with the 
linker 201 bearing an isothiocyanate group (Scheme 4.2), since the formation of a thiourea 
linkage is a well-established reaction in bioconjugation. The isothiocyanate linker 201 was 
obtained in 68% yield from the corresponding alcohol 200191 by a straightforward 
conversion of the alcohol group to azide and subsequent conversion of the azido group into 
the isothiocyanate functionality by treating the crude intermediate with carbon disulfide 
(Scheme 4.2A). Both linker 201 and iminosugar derivative 160 resulted well soluble in 
MeOH and could be coupled at room temperature without any additional reagent. The 
reaction afforded compound 202 in good yield after purification by column 
chromatography. The thioacetyl derivative 202 was treated with sodium methoxide (2.0 
equiv.) in MeOH, under Ar atmosphere, in order to liberate the thiol group. The reaction 
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proceeded in eight hours affording quantitatively disulfide derivative 203, after purification 
by size exclusion (Sephadex LH-20) chromatography (Scheme 4.2B). 
 
Scheme 4.2: Synthesis of A) isothiocyanate linker 201 and B) pyrrolizidine conjugate 203 by thiourea 
formation. Reagents and conditions: a) PPh3, CBr4, CH2Cl2, rt, 10 min, 80%; b) NaN3, DMF, rt, 14 h; iii) 
PPh3, CS2, toluene, 50 °C, 16 h, 68%; c) MeOH, rt, 18 h, 72%; d) NaOMe, MeOH, rt, 8 h, 100%. 
The same protocol was applied to compound 168f and afforded, after Sephadex LH-20 
purification, the conjugate 205 as a 1:1 mixture of thiol and disulfide. In this case, an 
inseparable by-product, presumably coming from the rearrangement of linker 201, was 
unfortunately present. Then, the mixture was reduced with PPh3 and further purified by 
column chromatography (eluent: CH2Cl2/MeOH/6% NH4OH 10:1:0.1), affording pure 205 in 
56% yield (Scheme 4.3). 
 
Scheme 4.3: Synthesis of piperidine conjugate 205 by thiourea formation. Reagents and conditions: 
a) MeOH, rt, 18 h, b) NaOMe, MeOH, rt, 8 h, 100%, c) PPh3, CH2Cl2/ MeOH 1:1, rt, 60h, 56% over 3 
steps. 
Since the GNPs synthesized with these conjugates were not soluble in water (see Chapter 
4.2.2), the conjugation of compound 157 with linker 201 was not performed. In order to 
overcome this problem, amidic coupling was used as an alternative. The coupling of 
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iminosugar derivatives 157, 160 and 168f with carboxylated linker 206 was thus performed. 
In this case, the linker was easily synthesized by Jones oxidation of the alcohol 200192 
(Scheme 4.4A) and the conjugates 207-209 were prepared employing different coupling 
conditions (Scheme 4.4B and 4.5). 
 
Scheme 4.4: Synthesis of A) carboxylated linker 206 and B) pyrrolizidine conjugate 207 by amidic 
bond formation. Reagents and conditions:a) Acetone, Jones reagent, rt, 20 min, 69%; b) HBTU, HOBt, 
DIPEA, DMF, rt, 15 h, 51%. 
The reaction with amino-pyrrolizidine derivative 160 was performed in dimethylformamide, 
employing 1–hydroxybenzotriazole (HOBt) and O-(Benzotriazol-1-yl)-N,N,N',N'-
tetramethyluronium hexafluorophosphate (HBTU, 97.5 mg, 257 µmol) as coupling agents. 
The crude mixture was first triturated with n-hexane to remove the unreacted linker and 
subsequently purified over silica gel, affording pure 207 in 51% yield. 
Unfortunately, these coupling conditions failed in the synthesis of piperidine analogue 208, 
but a change to (1-ethyl-3-(3-dimethylaminopropyl)carbodimide (EDC) as coupling agent 
and dimethyl sulfoxide as solvent allowed to obtain compound 208 in very good yield after 
trituration and column chromatography (Scheme 4.5A).  
Employing these latter conditions (EDC in DMSO), the pyrrolidine conjugate 209 (Scheme 
4.5B) was obtained as a major product of an unseparable mixture of compounds. Attempts 
of purification by trituration and flash column chromatography were in fact unsuccessful. A 
small amount of the triturated crude was subjected to semi-preparative reverse LC 
(gradient from H2O/MeOH 30/70 to MeOH in 45 min; retention time of the product: 10 
minutes). After evaporation of the solvents, the pure product was obtained and 
characterized. The low amount of pure product recovered was not enough to prepare the 
corresponding GNPs. 
The amidic linker conjugates 207 and 208 were completely characterized since the 
corresponding de-acetylated compounds were directly employed in the GNPs synthesis 
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without further purification in order to reduce the disulfide formation (see “General 
Procedure for the in situ deprotection of S-acetyl conjugates”, Chapter 4.5). 
 
Scheme 4.5: Synthesis of A) piperidine conjugate 208 and B) pyrrolidine conjugate 209 by amidic 
bond formation. Reagents and conditions a) EDC, HOBt, DIPEA, DMSO, Ar, rt, 65 h. 
The iminosugar-based ligands synthesized by thiourea (203 and 205) or amide 
(deacetylated 207 and 208) linkage were then employed in the preparation of GNPs, as 
described in the next section. 
4. 2.2 Preparation of Glyconanoparticles 
There are several methods to prepare gold nanoparticles functionalized with 
carbohydrates.183 In this PhD Thesis, the so-called direct in situ formation of 
glyconanoparticles based on a modification of Brust’s method193 and developed by the 
group of Penadés177a was used (Figure 4.7). The protocol consists in treating a water 
solution of a gold(III) salt with a reductive agent in the presence of an excess of thiol-ending 
neoglycoconjugates. 
 
Figure 4.7: Schematic representation of the direct (in situ) synthesis of gold glyconanoparticles. 
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This in situ synthesis permits control of the growth of the metal cluster by varying the 
organic materials/Au(III) molar ratio and the simultaneous insertion of different ligands. 
Water-soluble and stable gold GNPs of 2-nm average diameter were obtained by adding an 
aqueous solution of tetrachloroauric acid (HAuCl4, 1 equiv.) to a methanolic solution of a 
mixture of thiol-derivatized conjugates (active iminosugar conjugate and inner sugar 
component, 3 equiv.) in the desired proportion. The resulting mixture was reduced with an 
excess of NaBH4 (27 equiv.) as reducing agent and the suspension was vigorously shaken for 
2 h at 25 °C. The supernatant was removed, the nanoparticles were washed with methanol 
and the residue was dissolved in milliQ water, purified by dialysis and characterized by 1H 
NMR spectrometry, transmission electron microscopy (TEM), infrared spectroscopy (IR), 
and ultraviolet spectroscopy (UV). Glyconanoparticles with different density of active 
component were obtained by changing the ratio of iminosugar conjugate respect to sugar 
derivative as inner component (GlcC5S or ManC5S) in the initial mixture before GNP 
formation. The ratio of the components was controlled by 1H NMR. The proportion of the 
ligands on the gold surface was also examined by 1H NMR after cluster formation (analysis 
of the supernatant and washings) as well as performing qNMR of GNPs in deuterium oxide 
with an internal reference. The hybrid GNPs reported in this Chapter can be classified 
according to the iminosugar-based ligand employed as active component: pyrrolizidine 
alkaloid (PA), piperidine alkaloid (PIPA) and pyrrolidine alkaloid (PYRRA). 
In a first attempt, hybrid GNPs employing 20% of PA thiourea linker conjugate 203 and 80% 
of GlcC5S in the starting ligand mixture were synthesized. Unfortunately, the nanoparticles 
formed in the above described conditions resulted insoluble in water even under vigorous 
stirring, or after adding growing amounts of different acids (HCl, AcOH, TFA) in order to 
protonate the amine moiety of iminosugar residues. Also GNPs employing 13% of PIPA 
thiourea linker conjugate 205 and 87% of GlCC5S showed similar solubility problems: the 
formed GNPs could be solubilized in water under vigorous stirring, but they precipitated 
during the dialysis purification (Scheme 4.6). These results suggested that insolubility in 
water of the nanoparticles did not depend either on the kind, the density or protonation 
state of the iminosugar derivatives. Curiously these GNPs resulted also completely insoluble 
in all the solvents subsequently tested (including iPrOH, DMF, DMSO), hampering the 
purification and characterization of these systems. The dispersibility of nanoparticles in 
water is an important feature both from a synthetic point of view (since their purification 
could be easily performed by dialysis) and for any further potential applications in biological 
fields. Thus, we reasoned to change the coupling strategy of the iminosugar to the linker 
(see Chapter 4.2.1). 
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Scheme 4.6: Failed synthesis of GNPs employing thiourea linker conjugates. 
We switched from the thiourea linkage to an amidic bond in order to evaluate if the nature 
of the coupling moiety (amide instead of thiourea) could affect the solubility of these 
systems in water. To our delight, this protocol afforded water soluble GNPs both when 20% 
and 40% of iminosugar ligands were used in the starting mixture. After purification by 
dialysis, GNPs with two different densities of the active component (Figure 4.8-4.9) were 
thus obtained. 
For the preparation of these new hybrid GNPs, iminosugar conjugates 207-208 were 
deacetylated and, without purification, mixed in situ with GlCC5S or ManC5S in the proper 
ratio, before adding the gold(III) solution and the reductive agent. When conjugates 207-
208 were deacetylated and purified by Sephadex, a complete oxidation to the 
corresponding disulfide occurred. This resulted in a lower incorporation of the iminosugar 
ligands respect to the sugar ligands on the nanoparticle surface, as attested by the 1H NMR 
spectra performed before and after cluster formation. Indeed, sugar derivatives GlCC5S or 
ManC5S were used as thiols because their oxygen-mediated oxidation to the corresponding 
disulfide was 20% at most, indicating a lower tendency to pass from thiol to disulfide 
respect to the iminosugar derivatives. 
On the contrary, when conjugates 207-208 were deacetylated under Ar atmosphere and 
immediately employed in the preparation of GNPs without further purification, the ratio 
between iminosugar ligands and sugar ligands was preserved from the starting mixture to 
the gold cluster surface. 
In particular, the PA-Au GNPs were prepared by using β-GlcC5S (PA-Au-Glc) or α-ManC5S 
(PA-Au-Man) as inner component, since an additive or synergetic effect of β-Glc (inner 
component) and PA (active component) could potentially be observed in the inhibition 
towards β-glucosidases (Figure 46). On the contrary, due to the extreme selectivity of PIPA 
towards α-L-fucosidases, only β-GlcC5S was employed as inner component.  
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Figure 4.8: Complete scheme of synthesized hybrid PA-GNPs A) with β-GlCC5S as inner component 
and B) with α-ManC5SH (PA-Au-Man) as inner component. Reagents and conditions a) CH3ONa, 
MeOH, Ar, rt, 2 h. The percentage is referred to the ligand ratio in the starting mixture, which is 
maintained in the mixture after the nanoparticle formation. 
All the resulting GNPs showed an exceptionally small core (1–2 nm), as demonstrated by 
TEM analysis. TEM micro-graphs showed uniform dispersion of the GNPs and no 
aggregation was evident. The UV/Vis spectra were often characterized by a surface 
plasmon band at around 520 nm, except in the case of the smallest core-sized GNPs, for 
which the plasmon was scarcely visible. The 1H NMR spectra of the GNPs featured broader 
peaks compared to those of the corresponding ligands. 
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Figure 4.9: Complete scheme of synthesized hybrid PIPA-GNPs with β-GlcC5S as inner component. 
Reagents and conditions a) CH3ONa, MeOH, Ar, rt, 2 h. 
The ligands loading on the PA-GNPs and PIPA-GNPs was also evaluated by quantitative 
NMR (qNMR) using 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP-d4) as an internal 
standard in the D2O solution of the PA-GNPs or PIPA-GNPs. An example of GNP 
characterization is shown in Figure 4.10.  
 
Figure 4.10: Characterization of glyconanoparticles 214 (40% PA-Au-Man): a) TEM micrograph in 
H2O; b) size-distribution histogram obtained by measuring 300 nanoparticles (average diameter 1.2 ± 
0.2 nm); c) 
1
H NMR spectra of mixture of ManC5S and derivative 210 before (C-1) and after (C-3) GNP 
formation, and of the corresponding GNP 214 (C-2); D) UV/Vis spectrum. 
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As mentioned above, all of the GNPs were found to be water-soluble and were stable for 
months under physiological conditions without flocculation. Based on the gold core size 
(determined by TEM) an average molecular formula and the corresponding molecular 
weights were estimated comparing the literature194 and the values obtained from qNMR. 
GNPs 100%-functionalized with glucose (GlcC5-Au) or mannose (ManC5-Au) were also 
prepared as control systems, following a reported procedure186 (Figure 4.11). 
 
Figure 4.11: 100%-glucose gold nanoparticles GlcC5-Au and 100%-mannose gold nanoparticles 
ManC5-Au. 
All GNPs prepared in this project together with their main characteristics have been 
summarized in Table 4.1, while their complete characterization is reported in Chapter 4.5. 
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GNP Diameter 
(nm) 
Iminosugar 
loading 
Scheme 
211 1.3±0.3 
100 µg/mL = 
6.6 nmol/mL 
(6.6 µM) of 
pyrrolizidine 
 
211: 20% PA 80% β-GlcC5S 
212: 40% PA 60% β-GlcC5S 
212 1.4±0.4 
100 µg/mL = 
18 nmol/mL 
(18 µM) of 
pyrrolizidine 
213 1.9±0.4 
100 µg/mL = 
6.3 nmol/mL 
(6.3 µM) of 
pyrrolizidine 
 
213: 20% PA 80% α-ManC5S 
214: 40% PA60% α-ManC5S 
214 1.2±0.2 
100 µg/mL = 
24 nmol/mL 
(24 µM) of 
pyrrolizidine 
216 1.6±0.3 
100 µg/mL = 
12 nmol/mL 
(12 µM) of 
piperidine 
 
216: 20% PIPA 80% β-GlcC5S 
217: 40% PIPA 60% β-GlcC5S 
217 1.7±0.4 
100 µg/mL = 
21.5 
nmol/mL 
(21.5 µM) of 
piperidine 
218 1.7±0.4 _                    
218: 100% βGlcC5S 
219 1.1±0.2 _ 
219: 100% αManC5S  
Table 4. 1: Hybrid gold GNPs functionalized with iminosugars, structure and main characteristics. 
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4. 3 Biological Evaluation  
Thanks to a collaboration with the group of Prof. I. Robina (University of Seville), the GNPs 
212, 214, 217, 218, 219 and  were preliminary assayed towards a panel of eleven 
commercially available glycosidases (Table 4.2). Since we were searching for a remarkable 
enhancement of the GNPs inhibitory activity respect to the monovalent compounds (which 
are usually evaluated at 1mM concentration), a first trial was carried out using low 
concentrations (around 10 µM) of iminosugars on the GNPs.  
 212 
40% PA 
60% Glc 
214 
40% PA 
60% Man 
217 
40% PIPA 
60% Glc 
218 
Glc 
219 
Man 
α-L-fucosidase EC 3.2.1.51 
1-bovine kidney 
n.i. n.i. n.i. n.i. n.i. 
α-galactosidase EC 3.2.1.22 
2-coffee beans 
n.i. n.i. n.i. n.i. n.i. 
-galactosidase EC 3.2.1.23 
5-Escherichia coli 
8-Aspergillus orizae 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
-glucosidase EC 3.2.1.20 
10-yeast  
11-rice 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
 
n.i. 
n.i. 
amyloglucosidase EC 3.2.1.3  
13-Aspergillus niger 
7% 7% n.i. n.i. n.i. 
-glucosidase EC 3.2.1.21 
15-almonds 
n.i. n.i. n.i. n.i. n.i. 
-mannosidase EC 3.2.1.24 
16-jack beans 
n.i. n.i. n.i. n.i. n.i. 
-mannosidase EC 3.2.1.25 
18-snail
n.i. n.i. n.i. n.i. n.i. 
-N-acetylglucosaminidase 
EC 3.2.1.30 
21-jack beans
 
n.i. n.i. n.i. n.i. n.i. 
Table 4.2: Inhibitory activities of GNPs 212, 214, 217, 218, 219 toward glycosidases. Percentage of 
inhibition at 0.016 mg/mL of GNP. Optimal pH, 35 ºC (a-b). a) For conditions of measurements see 
Ref111b
) n.i.: no inhibition was detected at 0.016 mg/mL concentration of the corresponding 
compound. 
Unfortunately, at the tested concentration (0.016 mg/mL in terms of GNP), none of the 
GNPs showed inhibition to the screened enzymes, except a no relevant 7% of inhibition 
towards amyloglucosidases from Aspergillus niger in the cases of compounds 212 and 214. 
GNPs 
ENZYME 
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It should be noticed that also the control Glc-GNPs and Man-GNPs did not inhibit any 
screened enzyme. 
These preliminary results seem to indicate that multimerization of PA and PIPA iminosugars 
onto gold nanoparticles do not lead to significant multivalent effects towards the tested 
enzymes. However, experiment with higher concentration of nanoparticles are still needed 
before excluding the employing of these systems as glycosidases inhibitors. Furthermore,, 
experiments with cellular systems, instead of purified enzymes, are currently underway to 
check wheter the capacity of easy internalization of GNPs onto cells can help in reducing 
the dosis of iminosugar required to reach a significant inhibition of selected enzymes. In 
particular, the inhibitory activity of PIPA-Au-GNPs towards human α-L-fucosidase is also 
currently under evaluation in monocyte cells. 
4. 4 Conclusions  
In this chapter the first example of gold GNPs coated with iminosugars has been  reported.  
Hybrid Au-GNPs consisting of a nanometric gold core and bearing different percentage of 
selected iminosugar derivatives as active components and simple monosaccharides as inner 
components were prepared by direct synthesis and characterized by different techniques. 
The sugar based thiol-ending ligands (GlcC5S and ManC5S) were synthesized as inner 
components following a well-established protocol. Then, pyrrolizidine (PA) and piperidine 
(PIPA) iminosugar-based ligands were synthesized as active components by coupling amino-
funtionalized PA or PIPA to a protected thiol-ending linker through thiourea or amide 
linkage. Only in the latter case, the GNPs subsequently prepared resulted dispersible and 
well stable in water. GNPs with two different densities (20% and 40%) of PA and PIPA 
amide-linked iminosugars were prepared, purified and characterized by TEM analysis, 
UV/Vis spectrophotometry, IR, 1H NMR and quantitative NMR (qNMR). 
Until now, only three of these GNPs were assayed towards a panel of commercial 
glycosidase, together with the relative control GNPs (100% GlcC5S and 100% ManC5S). The 
preliminary inhibition results were not promising in terms of implication of multivalent 
effect, but other experiments are currently underway in order to get more information on 
the potential use of GNPs as multivalent systems for glycosidases inhibition. 
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4.5 Experimental Section 
Laboratory of GlycoNanotechnology, Biofunctional Nanomaterials Unit, CIC biomaGUNE, 
Paseo Miramón 182, 20009, San Sebastián, Spain 
General methods: All chemicals were purchased as reagent grade from Sigma–Aldrich, 
except chloroauric acid (Strem Chemicals), and were used without further purification. 
Reactions were monitored by thin-layer chromatography (TLC) on silica gel 60 F254 
aluminium-backed sheets (Merck) with visualization under UV (254 nm) and/or by staining 
with p-anisaldehyde solution [anisaldehyde (25 mL), H2SO4(25 mL), EtOH (450 mL), and 
CH3COOH (1 mL)], 10% H2SO4 solution in EtOH, ninhydrin solution [ninhydrin (0.25 mL), 
EtOH (100 mL)] followed by heating at over 200 °C. Size-exclusion column chromatography 
was performed on Sephadex LH-20 (GE Healthcare). Flash column chromatography (FCC) 
was performed on silica gel 60 (0.063–0.200 mm; Merck). UV/Vis spectra were measured 
with Beckman Coulter DU 800 UV/Vis spectrophotometer. Infrared (IR) spectra were 
recorded from 4000 to 750 cm-1 with a Thermo Nicolet 6700 FT-IR model spectrometer; 
solids were pressed into KBr pellets and oils were subjected to attenuated total reflection 
(ATR). 1H and 13C NMR spectra were recorded on Bruker 500 MHz (high resolution) 
spectrometer. Chemical shifts (δ) are given in ppm relative to the residual signal of the 
solvent used. Coupling constants (J) are reported in Hz. Splitting patterns are described by 
using the following abbreviations: br, broad; s, singlet; d, doublet; t, triplet; q, quartet; quin, 
quintet; m, multiplet. Mass spectra were measured with an Esquire 6000 ESI-Ion Trap 
spectrometer from Bruker Daltonics. High-resolution mass spectra (HRMS) were obtained 
using the MALDI technique with a 4700 Proteomics Analyzer (Applied Biosystems) operated 
in MALDI-TOF-TOF configuration. Optical rotations were determined with a Perkin–Elmer 
341 polarimeter. For transmission electron microscopy (TEM) examinations, a single drop (2 
µL) of an aqueous solution (ca. 0.05 mgmL-1 in Milli-Qwater) of the gold glyconanoparticles 
(GNPs) was placed on a copper grid coated with a carbon film (Electron Microscopy 
Sciences). The grid was left to dry in air for several hours at room temperature. TEM 
analysis was performed with a JEOL JEM-2100Fmicroscope, both operating at 200 kV. The 
average diameters and numbers of gold atoms of the GNPs were deduced as described in a 
previous study. 186Laboratory distilled water was further purified using a Milli-Qreagent 
grade water system (Millipore). 
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Preparation and characterization of linker and iminosugar conjugates. 
Synthesis of 22-(thioacetyl)-2,5,8,11-tetraoxadocosan-1-oic acid (206):192 [11-
(methylcarbonylthio) undecyl]tetra(ethylene glycol) (289 mg, 0.68 mmol) was dissolved in 
acetone (2.0 mL) and 0.65 mL of Jones reagent (6.68 g CrO3, 5.75 mL H2SO4, and H2O to 25 
mL) was added dropwise. The reaction mixture was left stirring for 20 minutes at 25 °C and 
then stopped by addition of 2-propanol (8-10 drops). Water (5 mL) was added to solubilize 
the chromium salts and the mixture was extracted with CH2Cl2(4 x 10 mL). The combined 
organic layers were washed with water (2 x 20 mL), brine (1 x 20 mL), dried over anhydrous 
Na2SO4 and the solvent was evaporated under vacuum. The crude compound was purified 
by gradient column chromatography (from DCM to DCM/MeOH 9 : 1), affording 206 (205 
mg, 0.47 mmol) as a colorless oil in a 69% yield. Rf = 0.33 (DCM/MeOH 9 : 1). 
1H NMR (500 
MHz, CDCl3): δ = 4.15 (s, 2H), 3.76-3.61 (m, 12H), 3.48 (t, J = 6.9 Hz, 1H), 2.87 (t, J = 7.4 Hz, 
1H), 2.33 (s, 3H), 1.62-1.54 (m, 4H), 1.39-1.27 (m, 14H). 
Synthesis of pyrrolizidine alkaloid (PA) derivative (207): A solution of compound 206 (74.5 
mg, 171 µmol), 1–hydroxybenzotriazole (HOBt, 34.7 mg, 257 µmol) and O-(Benzotriazol-1-
yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU, 97.5 mg, 257 µmol) in DMF 
(2 mL) was left stirring for 30 min and then added to a solution of amino casuarine 
derivative 160 (33.5 mg, 178 µmol) and N,N-diisopropylethylamine (47 µL, 267 µmol) in 
DMF (1.8 mL). The reaction mixture was left stirring at room temperature for 15 hours, 
then diluted with AcOEt (10 mL) and washed with H2O (5 x 4 mL). The organic layer was 
then washed with a saturated solution of NaHCO3 (3 x 10mL), water (2 x 10 mL) and brine (1 
x 8 mL), dried over anhydrous Na2SO4 and concentrated under vacuum. Purification through 
gradient column chromatography (DCM/MeOH from 10:1 to 5 : 1) afforded 207 (53 mg, 87 
µmol) in a 51% yield. Rf = 0.30 (DCM/MeOH 7 : 1). [α]D
29 = + 9.6 (c = 0.78, MeOH). 1H NMR 
(500 MHz, CD3OD) δ = 4.54 (quin, J = 6.4 Hz, 1H, 6-H), 4.02 (s, 2H, HNCOCH2-), 3.84-3.77 (m, 
3H, 1-H, 2-H, 8-Ha), 3.72-3.59 (m, 13H, OCH2, 8-Hb), 3.53 (q, J = 6.5 Hz, 1H, 7a-H), 3.49 (t, J = 
6.7 Hz, 2H, OCH2(CH2)11SAc), 3.22 (dd, J = 11.6, 5.9 Hz, 1H, 5-Ha), 3.05 (dd, J = 11.6, 6.3 Hz, 
1H, 5-Hb), 2.88 (t, J = 7.3 Hz, 3H, -CH2SAc, 3-H), 2.32 (s, 3H, SAc), 2.22 (dt, J = 12.5, 6.0 Hz, 
1H, 7-Ha), 2.09 (dt, J = 12.5, 7.5 Hz, 1H, 7-Hb), 1.62-1.55 (m, 4H, -CH2CH2SAc, -OCH2CH2), 
1.40-1.29 (m, 14H, -CH2-) ppm. 
13C NMR (125 MHz, CD3OD) δ = 193.3 (s, SCOCH3), 171.3 (s, 
CONH2), 80.8 (d, C-1), 77.2 (d, C-2), 70.1 (d, C-3), 70.0-69.8 (t, 8C, OCH2), 67.1 (d, C-7a), 61.6 
(t, C-8), 58.7 (t, C-5), 47.8 (d, C-6), 35.4 (t, C-7), 29.3-25.8 (11C, t,-CH2-, q, SCOCH3) ppm. IR 
(KBr): ν = 3351, 2925, 2854, 1691, 1660, 1542, 1465, 1108 cm-1. HRMS (ESI): m/z calcd for 
C29H54N2O9S: 629.36. [M+Na]
+; found: 629.34. 
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Synthesis of piperidine alkaloid (PIPA) derivative (208): A solution of EDC.HCl (1-Ethyl-3-(3-
dimethylaminopropyl)carbodimide hydrochloride (32.0 mg, 168 µmol), 1–
hydroxybenzotriazole (HOBt, 21.0 mg, 158 µmol) and 206 (47.0 mg, 108 µmol) in DMSO 
(0.4 mL) was left stirring for 10 min. and then added to a solution of piperidine derivative 
168f (20.0 mg, 105 µmol) and N,N-diisopropylethylamine (33 µL, 189 µmol) in DMSO (0.3 
mL). The reaction mixture was left stirring at room temperature, under Ar atmosphere, for 
65 hours, then diluted with AcOEt (10 mL) and washed with H2O (5 x 4 mL). The organic 
layer was then washed with water (2 x 6 mL) and brine (1 x 4 mL), dried over anhydrous 
Na2SO4 and concentrated under vacuum. The crude was triturated with n-Hexane (5 x 2 mL) 
and then purified by column chromatography (DCM/MeOH 10:1) affording 56 mg of 208 
(92 µmol, 89% yield). Rf = 0.52 (DCM/MeOH 7 : 1). [α]D
29 = - 12.5 (c = 0.80, MeOH). 1H 
NMR (500 MHz, CD3OD) δ = 4.03 (s, 2H, HNCOCH2-), 3.99 (br s, 1H, 3-H), 3.88 (td, J = 7.1, 3.7 
Hz, 1H, 5-H), 3.77-3.48 (m, 17H, 1-H, OCH2, 4-H, 3’-H), 2.97-2.95 (m, 1H, 6-Ha), 2.88 (t, J = 
7.4 Hz, 3H, -CH2SAc, 2-Ha), 2.68-2.60 (m, 2H, 1’-H), 2.58-2.48 (m, 1H, 2-Hb), 2.32 (s, 4H, Sac, 
6-Hb), 1.82 (quin, 6.8 Hz, 2H, 2’-H), 1.64-1.55 (m, 4H, -CH2CH2SAc, -OCH2CH2), 1.43-1.29 (m, 
14H, -CH2-) ppm. 
13C NMR (125 MHz, CD3OD) δ = 196.2 (s, SCOCH3), 171.5 (s, CONH2), 71.1 
(d, C-4), 71.0-69.8 (8 C, t, NHCOCH2O, CH2O), 69.7 (d, C-3), 68.3 (d, C-5), 54.8 (3C, t, C-2, C-6, 
C-1’), 36.7 (t, C-3’), 29.4-29.1 (7C, t, -CH2-), 28.8 (q, SAc), 28.5 (t, -CH2-), 25.4 (t, CH2SAc), 
25.8 (t, -CH2-), 25.7 (t, C-2’).ppm. IR (KBr): ν = 3319, 2924, 2854, 1691, 1663, 1541, 1456, 
1352, 1112 cm-1. HRMS (ESI): m/z calcd for C29H56N2O9S: 610.37. [M+2H]
+, found: 610.16. 
Synthesis of pyrrolidine alkaloid (PYRRA) derivative (209): A solution of EDC.HCl (1-Ethyl-3-
(3-dimethylaminopropyl)carbodimide hydrochloride (13.5 mg, 70 µmol), 1–
hydroxybenzotriazole (HOBt, 8.9 mg, 66 µmol) and 206 (19.6 mg, 44.9 µmol) in DMSO (0.3 
mL) was left stirring for 10 min. and then added to a solution of pyrrolidine derivative 157 
(10.2 mg, 44 µmol) and N,N-diisopropylethylamine (13.8 µL, 79 µmol) in DMSO (0.2 mL). 
The reaction mixture was left stirring at room temperature, under Ar atmosphere, for 64 
hours, then diluted with AcOEt (4 mL) and washed with H2O (3 x 2 mL). The organic layer 
was then washed with water brine (2 x 4 mL), dried over anhydrous Na2SO4 and 
concentrated under vacuum. Trituration with n-Hexane (5 x 2 mL) afforded 209 impure of 
an unknown byproduct. A small amount of crude 209 was purified by semi-preparative 
reverse LC (gradient from H2O/MeOH 30/70 to MeOH in 45 min; retention time of the 
product: 10 minutes) and characterized. 1H NMR (500 MHz, CD3OD) δ = 4.00 (s, 2H, 
HNCOCH2-), 3.98-3.95 (m, 1H, 3-H), 3.93-3.91 (m, 1H, 4-H), 3.75-3.59 (m, 14H, OCH2, 6-H), 
3.50 (t, J = 6.6 Hz, 2H, -OCH2(CH2)11SAc), 3.26 (t, J = 7.2 Hz, 2H, 6’-H), 3.07 (d, J = 10.4 Hz, 1H, 
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2-Ha), 2.88 (t, J = 7.3 Hz, 3H, -CH2SAc, 1’-Ha), 2.72-2.70 (m, 1H, 2-Hb), 2.52-2.45 (m, 1H, 5-
H), 2.41-2.34 (m, 1H, 1’-Hb), 2.32 (s, 3H, SAc), 1.63-1.50 (m, 8H, 2’-H, 5’-H, -CH2CH2SAc, -
OCH2CH2), 1.45-1.28 (m, 18H, 3’-H, 4’-H, -CH2-) ppm. 
13C NMR (125 MHz, CD3OD) δ = 196.4 
(s, SCOCH3), 171.2 (s, CONH2), 79.3 (d, C-4), 75.7 (d, C-3), 73.2 (d, C-5), 71.0 (t, -
OCH2(CH2)11SAc), 70.2-69.8 (6C,t, OCH2), 69.7 (t, OCH2CONH2), 61.0 (t, C-6), 58.7 (t, C-2), 
55.1 (t, C-1’), 38.5 (t, C-6’), 29.9-25.8 (15C, t ,CH2SAc, C-2’-C-5’, q, SCOCH3 ) ppm. HRMS 
(ESI): m/z calcd for C32H62N2O9S: 651.42 [M+H]
+, 673.42. [M+Na]+, 689.42. [M+K]+, found: 
651. 54, 673.53, 689.52. 
General Procedure for the “in situ” deprotection of S-acetyl conjugates 207 and 208: To a 
0.03 M MeOH solution of iminosugar derivative (207, 208) solid CH3OMe (10 equiv.) was 
added and the reaction mixture was left stirring for 2 hours at 25 °C under Ar. The complete 
disappearance of starting material was attested via 1H NMR and the crude was directly used 
for the preparation of PA-GNPs and PIPA-GNPs. 
Preparation and characterization of GNPs. 
The hybrid gold NPs coated with iminosugars (PA or PIPA) and simple monosaccharide 
glucose or mannose (PA-GNPs, Figure 4.12 and PIPA-GNPs, Figure 4.13) were prepared by 
reduction of an Au(III) salt using sodium borohydride in the presence of a mixture of thiol-
ending iminosugar conjugate (210, 215) and GlcC5S 198 or ManC5S 199, as ligands, in 
different ratios following a reported procedure.186 A 1:4 or a 2:3 ligands ratio was used to 
prepare 20% PA-GNPs and 40% PA-GNPs, respectively. For the analysis of the ratio between 
the iminosugar ligands and GlcC5S (in the case of PA-Au-Glc or PIPA-Au-Glc) or ManC5S (in 
the case of PA-Au-Man) ligands, 1H NMR spectra of the initial mixture and of the 
supernatant after GNPs formation were recorded. The ligands loading on the PA-GNPs and 
PIPA-GNPs was also evaluated by quantitative NMR (qNMR) using 3-
(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP-d4) as an internal standard in the D2O solution 
of the PA-GNPs or PIPA-GNPs. The prepared PA-GNPs and PIPA-GNPs were freeze-dried and 
stored at 4 °C. In these conditions, the hybrid gold NPs can be stored for months 
maintaining their biophysical properties.  
The GNPs coated only with simple monosaccharide (Figure 4.14) were also prepared as 
previously describedErrore. Il segnalibro non è definito. and used as controls in this study: gold 
nanoparticles 100%-coated with 5-mercaptopentyl β-D-glucopyranoside 198 (GlcC5S-GNP, 
218) and gold nanoparticles 100%-coated with 5-mercaptopentyl α-D-mannopyranoside 199 
(ManC5S-GNP, 219). 
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General Procedure for the preparation of GNPs coated with iminosugars: An aqueous 
solution of HAuCl4 (25 mM, 1 equiv.) was added to a 12 mM methanolic solution of a 
suitable mixture of thiol-ending iminosugar conjugate and β-Glc or α-Man conjugate (3 
equiv.). An aqueous solution of NaBH4 (1 M, 27 equiv.) was then added in four portions, 
with vigorous shaking. The black suspension formed was shaken for 2 hours at 25 °C. After 
that, the supernatant was removed and analysed by 1H NMR to study the nanoparticle 
ligands composition. The residue was washed several times with MeOH. In order to well 
separate the nanoparticles from the supernatant a centrifugation (4000 xg, 10 °C, 2 min) is 
required in some cases. The residue was dissolved in a minimal volume of HPLC Gradient 
grade water and purified by dialysis (SnakeSkin® Pleated Dialysis Tubing, 10,000 MWCO). 
Iminosugar coated GNPs were obtained as a dark-brown powder after freeze-drying and 
characterized via 1H NMR, UV-Vis Spectroscopy and TEM analysis. The average number of 
gold atoms was calculated on the basis of the average diameter obtained by TEM 
micrographs194 and molecular formulas of the GNPs were estimated according to previous 
work.186  
20% PA-Glc-GNPs (211): A 1:4 mixture of thiol-ending PA conjugate 210 (7.5 mg, 13.2 µmol) 
and GlcC5S 198 (14.6 mg, 51.7 µmol) in MeOH (5.4 mL) was used, to afford 5.6 mg of 211 
(98% yield in Au). TEM (average diameter): 1.3 ±0.3 nm (main population, >85%). 
Quantitative 1H NMR (500 MHz, D2O containing 0.05 wt. % of 3-(trimethylsilyl)propionic-
2,2,3,3-d4 acid, sodium salt as an internal standard): 0.58 mg of PA-GNPs were dissolved in 
180 μL of D2O and 40 μL of D2O containing 0.05 wt.% TSP were added and 38 nmoles of PA 
conjugate were found.195 Significant peaks: δ = 4.36 (br s, from GlcC5S), 4.00 (s, NHCOCH2- 
from PA conjugate), 3.84-3.22 (m), 3.05-2.97 (m, from PA conjugate), 2.78-2.66 (m, from PA 
conjugate), 2.15-1.14 (m); ratio between PA conjugate and GlcC5S signals ~1 to ~4.6. This 
result is in fair agreement with the molar ratio of conjugates per nanoparticle (20% of PA 
conjugate and 80% of GlcC5S) as estimated by NMR analysis of the ligand mixture before 
and after nanoparticles formation.  IR (KBr): ν ~ 3388, 2921, 2852, 1635 (amide), 1383, 1077 
cm-1. UV/Vis (H2O, 0.05 and 0.10 mg/mL): λ =516 nm (gold surface plasmon band). 
Estimated average molecular weight for (C27H51N2O8S)3(C11H21O6S)27Au140: ~37.0 KDa.  
40% PA-Glc-GNPs (212): A 2:3 mixture of thiol-ending PA conjugate 210 (3.7 mg, 6.6 µmol) 
and GlcC5S 198 (2.8 mg, 9.9 µmol)in MeOH (1.4 mL) was used, to afford 1.1 mg of 212 (77% 
yield in Au).TEM (average diameter): 1.4±0.4 nm. Quantitative 1H NMR (500 MHz, D2O 
                                                          
195
In the quantitative NMR (qNMR) the 7-Ha proton signal of PA-conjugate was selected for 
integration as it falls in a spectral region free of other signals.  
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containing 0.05 wt. % of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt as an 
internal standard): 0.32 mg of PA-GNPs were dissolved in 180 μL of D2O and 25 μL of D2O 
containing 0.05 wt.% TSP were added and 56 nmoles of PA conjugate were found.195 
Significant peaks: δ = 4.50-4.36 (m, from PA conjugate), 3.99 (s, NHCOCH2- from PA 
conjugate), 3.84-3.14 (m), 3.07-2.97 (m, from PA conjugate), 2.77-2.65 (m, from PA 
conjugate), 2.15-2.03 (m, from PA conjugate), 1.97-1.87 (m, from PA conjugate), 1.81-1.01 
(m); ratio between PA conjugate and GlcC5S signals is impossible to define since the GlcC5S 
anomeric signal disappeared from the spectrum; this phenomenon is in agreement with the 
literature186 and it is probably due to the fact that at this densities the long active ligand 
folds and collapse on the glucose shell hampering a proper proton relaxation196. IR (KBr): ν 
~3419, 2922, 2853, 1663, 1631, 1600 (amide), 1383, 1108 cm-1. UV/Vis (H2O, 0.05, 0.10 and 
0.20 mg/mL): maximum absorption at 520 nm (gold surface plasmon band) not observed. 
Estimated average molecular weight for (C27H51N2O8S)9(C11H21O6S)14Au140: ~36.5 kDa.  
20% PA-Man-GNPs (213): A 1:4 mixture of thiol-ending PA conjugate 210 (4.7 mg, 8.2 
µmol) and ManC5S 199 (9.3 mg, 33.0 µmol) in MeOH (3.4 mL) was used, to afford 4.4 mg of 
213 (96% yield in Au). TEM (average diameter): 1.9±0.4 nm. Quantitative 1H NMR (500 MHz, 
D2O containing 0.05 wt. % of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt as an 
internal standard): 0.60 mg of PA-GNPs were dissolved in 180 μL of D2O and 25 μL of D2O 
containing 0.05 wt.% TSP were added and 38 nmoles of PA conjugate were found.195 
Significant peaks: δ = 4.41-4.32 (m, from PA conjugate), 4.00 (s, NHCOCH2- from PA 
conjugate), 3.96-3.19 (m), 3.05-2.98 (m, from PA conjugate), 2.78-2.65 (m, from PA 
conjugate), 2.19-1.06 (m); ratio between PA conjugate and ManC5S signals is impossible to 
define since the Man anomeric signal is covered by the solvent residual peak. IR (KBr): ν 
~3368, 2922, 2848, 1675, 1633 (amide), 1447, 1092 cm-1. UV/Vis (H2O, 0.05 and 0.10 
mg/mL): λ=528 nm (gold surface plasmon band). Estimated average molecular weight for 
(C27H51N2O8S)4(C11H21O6S)19Au140: ~35 kDa.  
40% PA-Man-GNPs (214): A 2:3 mixture of thiol-ending PA conjugate 210 (6.0 mg, 9.9 
µmol) and ManC5S 199 (4.2 mg, 14.8 µmol) in MeOH (2.0 mL) was used, to afford 1.8 mg of 
214(84% yield in Au). TEM (average diameter): 1.2±0.2 nm. Quantitative 1H NMR (500 MHz, 
D2O containing 0.05 wt. % of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt as an 
internal standard): 0.33 mg of PA-GNPs were dissolved in 180 μL of D2O and 25 μL of D2O 
containing 0.05 wt.% TSP were added and 79 nmoles of PA conjugate were found.195 
                                                          
196
 M. Reynolds, M. Marradi, A. Imberty, S. Penades, S. Perez, Chem. Eur. J. 2012, 18, 4264-4273. 
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Significant peaks: δ = 4.43-4.29 (m, from PA conjugate), 3.99 (s, NHCOCH2- from PA 
conjugate), 3.85-3.18 (m), 3.05-2.95 (m, from PA conjugate), 2.78-2.61 (m, from PA 
conjugate), 2.14-2.02 (m, from PA conjugate), 1.97-1.84 (m, from PA conjugate), 1.72-0.74 
(m); ratio between PA conjugate and ManC5S signals is impossible to define since the Man 
anomeric signal is covered by the solvent residual peak. IR (KBr): ν ~ 3418, 2924, 2856, 
1660, 1628, 1437, 1383, 1093, 1064 cm-1. UV/Vis (H2O, 0.05 and 0.10 mg/mL): maximum 
absorption at 520 nm (gold surface plasmon band) not observed. Estimated average 
molecular weight for (C27H51N2O8S)9(C11H21O6S)14Au140: ~36.5 kDa. 
20% PIPA-Glc-GNPs (215): A 1:4 mixture of thiol-ending PIPA conjugate 215 (3.1 mg, 5.5 
µmol) and GlcC5S 198 (6.0 mg, 21.3 µmol) in MeOH (5.4 mL) was used, to afford 1.6 mg of 
215 (64%% yield in Au). 
TEM (average diameter): 1.6 ±0.3 nm. Quantitative 1H NMR (500 MHz, D2O containing 0.05 
wt. % of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt as an internal standard): 
0.32 mg of PIPA-GNPs were dissolved in 180 μL of D2O and 25 μL of D2O containing 0.05 
wt.% TSP were added and 56 nmoles of PA conjugate were found.197 Significant peaks: δ = 
4.34 (br s, from GlcC5S), 3.99 (s, NHCOCH2- from PIPA conjugate), 3.94-2.98 (m), 2.94-2.75 
(m, from PIPA conjugate), 2.52-2.22 (m, from PIPA conjugate), 2.18-1.99 (m, from PIPA 
conjugate), 1.82-0.72 (m).  IR (KBr): ν ~ 3424, 2920, 2848, 1637 (amide), 1438, 1381, 1076 
cm-1. UV/Vis (H2O, 0.05 and 0.10 mg/mL): λ =514 nm (gold surface plasmon band). 
Estimated average molecular weight for (C26H51N2O8S)7(C11H21O6S)28Au140: ~39.0 KDa. In this 
case a 20% of PIPA conjugate match perfectly with the quantitative analysis, albeit a 15% 
amount of PIPA conjugate was attested by the NMR analysis of the ligand mixture before 
and after nanoparticle formation. 
40% PIPA-Glc-GNPs (217): A 2:3 mixture of thiol-ending PA conjugate 215 (3.7 mg, 6.5 
µmol) and GlcC5S 198 (2.8 mg, 9.8 µmol)in MeOH (1.4 mL) was used, to afford 1.1 mg of 
217 (77% yield in Au).TEM (average diameter): 1.7±0.4 nm. Quantitative 1H NMR (500 MHz, 
D2O containing 0.05 wt. % of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt as an 
internal standard): 0.33 mg of PA-GNPs were dissolved in 180 μL of D2O and 25 μL of D2O 
containing 0.05 wt.% TSP were added and 71 nmoles of PA conjugate were found.197 
Significant peaks: δ = 4.50-4.36 (m, from PA conjugate), 3.99 (s, NHCOCH2- from PIPA 
conjugate), 3.91 (br s from PIPA conjugate), 3.80-3.30 (m), 3.56 (q, Et2O), 3.27 (s, MeOH), 
3.25-3.17 (m, from PIPA conjugate), 3.06-2.82 (m, from PIPA conjugate), 2.70-2.45 (m, from 
                                                          
197
 In the quantitative NMR (qNMR) the multiplet corresponding to 1’-H, 2-Hb and 6-Hb proton 
signals (δ = 2.65-2.02 ppm, 4H) of PIPA-conjugate, was selected for integration as it falls in a spectral 
region free of other signals. 
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PIPA conjugate), 1.82-1.20 (m), 1.16 (t, Et2O); ratio between PA conjugate and GlcC5S 
signals is impossible to define since the GlcC5S anomeric signal disappeared from the 
spectrum; see comment on 212, Ref.195. IR (KBr): ν ~3436, 2920, 2856, 1631 (amide), 1392, 
1364, 1033 cm-1. UV/Vis (H2O, 0.05, 0.10 and 0.20 mg/mL): maximum absorption at 520 nm 
(gold surface plasmon band) not observed. Estimated average molecular weight for 
(C26H51N2O8S)9(C11H21O6S)14Au140: ~36.5 kDa.  
100% αManC5-coated gold nanoparticles (219, Man-Au): Reaction of a 199 (12.0 mg, 42.5 
µmol) MeOH solution (3.54 mL) with HAuCl4 (568 µL, 0.025 M) and NaBH4 (383 µL, 1 N) 
gave 219 (3.0 mg) as a dark-brown powder. TEM (average diameter): 1.1±0.2 nm; 1H NMR 
(500 MHz, D2O): δ = 4.80 (s, 1H; 1-H), 4.05–3.00 (m, 8H), 2.15–1.06 ppm (m, 6H); UV/Vis 
(H2O, 0.05 mgmL
-1): due to the exceptionally small core size of the GNPs, not a real surface 
plasmon resonance band was seen, but an absorption around λ = 520 nm (gold surface 
plasmon band); Estimated average molecular weight for (C11H21O6S)60Au116: ~40 kDa).  
100% βGlcC5-coated gold nanoparticles (218, Glc-Au): Reaction of a 198 (12.0 mg, 42.5 
µmol) MeOH solution (3.54 mL) with HAuCl4 (568 µL, 0.025 M) and NaBH4 (383 µL, 1 N) 
gave 218 (2.4 mg) as a dark-brown powder. TEM (average diameter): 1.7±0.4 nm; 1H NMR 
(500 MHz, D2O): δ = 4.37 (s, 1H; 1-H), 4.04–2.83 (m, 8 H), 2.12–1.11 ppm (m, 6H); UV/Vis 
(H2O, 0.05 mgmL
-1): λ = 519 nm (gold surface plasmon band); Estimated average molecular 
weight for (C11H21O6S)35Au140:~37 kDa. 
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